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Heart disease is the leading cause of death in many developing and industrialized 
countries.  The loss of cardiomyocyte (CM) proliferation in the post-natal myocardium is the 
major barrier to myocardial regeneration, which leads to a loss of functional myocytes and thus 
contractile function after injury.  While significant advances in cardiac tissue engineering as an 
alternative strategy for treatment have been made in the recent years, the application for repair of 
the injured myocardium remains to be realized.  However, tissue engineering as an in vitro 
model system for characterizing functional properties of cardiac tissue can be used as a powerful 
tool now.  
The overall goal of this doctoral thesis was to determine the role of mechanical strain on 
CM differentiation within a 3D engineered tissue to use as a system for evaluation of strategies 
for enhancing directed CM differentiation and tissue contractile properties.  Substantial progress 
towards this goal was made by a combination of testing new strategies for monitoring differential 
CM differentiation and contractile function, such as using MDSCs in a 3D collagen gel 
bioreactor to induce CM differentiation and applying mechanical strain to determine the 
responsive cell type, and by developing new tools and methods for characterizing CM 
differentiation and cell morphology changes.  Our in vitro engineered cardiac tissue from 
fetal/developing native cardiac cells maintained CM proliferative activity and contractile 
properties similar to the native myocardium which increased in response to mechanical stretch.  
THE ROLE OF MECHANICAL FORCES IN CARDIOMYOCYTE 
DIFFERENTIATION IN 3D CULTURE 
Kelly Christina Clause, Ph.D. 
University of Pittsburgh, 2010
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The implanted graft maintained CM proliferative activity in vivo, survived as a donor myocardial 
tissue, and contributed to the cardiac functional recovery of injured myocardium better than a 
graft with post-natal cardiac cells.  Skeletal muscle derived stem cell (MDSC) aggregate 
formation and 3D collagen gel bioreactor (3DGB) culture (MDSC-3DGB) triggered 
differentiation of cells with an immature functioning CM phenotype in vitro. In addition, 
mechanical strain directed cell morphology changes were significant factors in directing CM 
differentiation from MDSCs within MDSC-3DGB.  In conclusion, our 3D collagen gel 
bioreactor culture, with capabilities for spatial and temporal monitoring, represents a powerful 
model for elucidating the role of specific environmental factors and their underlying mechanisms 
on directed cell proliferation and differentiation. 
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1.0  INTRODUCTION 
Heart disease is the leading cause of human mortality in many developing and 
industrialized countries.  It is estimated that one in three adults in the United States has one or 
more types of cardiovascular diseases, with estimated direct and indirect costs equaling 475.3 
billion dollars for 2009 alone(1).  The lifetime risk of developing coronary heart disease, which 
accounts for nearly one in five cases of all cardiovascular diseases, is 49% for men and 32% for 
women after the age of forty, where approximately 38% of those afflicted will die within a year 
of a coronary event(1, 2).  Half of all patients with coronary heart disease will suffer a heart 
attack(1).  The developing fetal myocardium has a high cell proliferation rate, which rapidly 
declines following birth(3, 4).  The loss of cardiomyocyte (CM) proliferation in the post-natal 
myocardium is the major barrier to myocardial regeneration, which leads to a loss of functional 
myocytes and thus contractile function after injury.  Thus, the high mortality rate for patients of 
coronary heart disease reflects the fact that the adult myocardium does not significantly 
regenerate after injury.    
The adult population is not the only population that suffers from heart disease.  In the 
pediatric population, 9 defects per 1000 live births are expected in the United States.  Of these, 
several studies suggest that 2.3 per 1000 live births require invasive treatment or result in death 
in the first year of life(1, 5).  From 1995-2005 the death rates for congenital cardiovascular defects 
declined 42.1%, whereas the actual number of deaths declined 27.3%.  However, there was a 
 1 
suggested 192,000 life-years lost before 55 years of age because of deaths from congenital 
cardiovascular defects, which is about the same as the life-years lost from leukemia, prostate 
cancer, and Alzheimer’s disease combined(1, 6).  
Currently, the best treatment option available for end-stage heart failure is total heart 
transplantation.  However, there are several disadvantages associated with this treatment: limited 
donor organ supply, organ mismatch, and disadvantages of immunosupression, all of which are 
exacerbated in the pediatric population.  Despite the current pharmacological and surgical 
approaches, alternative strategies for treatment are necessary. 
1.1 ALTERNATIVE TREATMENTS TO MYOCARDIAL INFARCTION 
Much of the understanding of the structural and functional changes that occur during 
heart disease is derived from experiments using laboratory animal models.  While these can only 
approximate aspects of human pathology and may not necessarily translate to human patients, 
they remain an invaluable tool in understanding the disease process and developing novel 
therapeutic approaches.  Recent studies have suggested cell-based or tissue-engineered 
approaches as promising new therapies for repairing the damaged myocardium, including: 1) 
activation and stimulation of host myocardial regeneration by transplanted cells via angiogenic 
and/or paracrine effects(7, 8); 2) direct transplantation of functional CMs or myogenic cells(9-11); 
and 3) implantation of tissue constructs containing CMs(12, 13).  In the first case, a range of cell 
types have been employed in strategies to repair the damaged myocardium which include bone 
marrow derived stromal and stem cells, fibroblasts, skeletal myoblasts, mesenchymal stem cells, 
embryonic stem cells, and resident cardiac stem cells(14).  Many of these cell therapies provide 
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indirect beneficial effects, or paracrine effects, mostly through angiogenesis.  In the latter two 
cases, the ideal donor CMs possess a high potential for division during cell preparation and 
potential for further proliferation following implantation to form a viable myocardial tissue 
within the surrounding injured recipient myocardium.  However, cellular cardiomyoplasty also 
has the added disadvantages of low cell retention rate (more than 90% of injected cells are 
typically lost)(15), inadequate tracking mechanisms(16), as well as induced injury at the injection 
site.  In order to resolve these issues the potential of functional cardiac tissue engineering has 
been investigated. 
1.1.1 Functional cardiac tissue engineering approaches 
  Cardiac morphogenesis depends on complex cell-cell and cell-matrix interactions within 
a dynamic four dimensional environment (three dimensional (3D) plus time).  Previous studies 
have shown that close cell-cell interactions and 3D culture conditions are often necessary 
prerequisites for CM differentiation(17-19) and that cardiac cells within 3D cultured tissues display 
distinct features that are more representative of native tissues(20-22) than are cells within 2D 
culture(23, 24).  3D growth of cells in aggregate spheres has been shown to direct and facilitate 
cell-cell interactions as well as to modify the differential expression of both morphogenic and 
angiogenic pathways in CMs(17) and hepatocytes(25).  Cell aggregate culture has been shown to 
enhance CM gene expression patterns(17), increase the synthesis and release of ECM 
components(26), and accelerate CM differentiation efficiency of embryonic stem cells(27) and liver 
stem cells(18).  Similarly, Albrecht et al. found that chondrocyte matrix biosynthesis was 
dependent on cell cluster size, rather than overall cell density(28).  Aggregate culture has also 
been used to enhance survival and differentiation of various stem cell types(27, 29, 30), versus static 
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culture.  These studies suggest that aggregation imparts many of the necessary structural cues 
required for maintaining differentiated phenotype, including proper dimensionality, shape, cell–
ECM, and cell–cell interactions.  Bursac et al. investigated the effect of 3D vs. 2D culture on CM 
properties and found that the 3D microenvironment plays critical role in maintenance of CM 
metabolism, sarcomere formation, cell-to-cell connections, and electrophysiological 
properties(31).  3D growth of fibroblasts(14, 32), endothelial cells(33), and mammary gland cells(34) 
also exhibits cell morphology and function similar to native tissue over 2D culture(35).  
Eschenhagen et al. described physiologic contractile force and action potentials in 3D neonatal 
engineered heart tissue(13, 22, 36-39).  These studies show that a 3D environment is required for the 
proper cell-cell and cell-matrix interactions that drive proper CM differentiation and maturation 
with contractile function.  Tissue engineering offers these advantages as well as flexibility of size 
and shape, high cell retention, and the ability to monitor three-dimensional tissue formation and 
function in vitro.  Studies using various cell types and scaffolds, both natural and synthetic, have 
been successful in creating engineered cardiac tissue that resembles the native heart muscle in 
morphological, biochemical, and functional properties(13, 20, 38, 40-45). 
1.1.1.1 Cell sources and composition 
Various types of cells have been used in cardiac tissue engineering, including primary 
cardiac myocytes(20, 37, 40-42, 46-50).  Freshly isolated primary cardiac myocytes are used because of 
their structural and physiologic attributes as well as their intrinsic contractile properties.  
Engineered cardiac constructs from cardiac myocytes have been created in a number of forms: 
free floating monolayers, chambers, ring-like structures, rectangular patches, and cylinders(13, 20, 
40, 41, 51, 52).  These have been constructed with many different natural and synthetic scaffolds, 
such as gelatin, fibrin glue, collagen, porous alginate, polyglycolic acid, and polyurethane(46-48, 51, 
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53-57).  They can generate an active stress between 1 and 2 mN/mm2 (20) which, although it is less 
than 5% of the average isometric maximum twitch stress generated by a papillary muscle from 
the rat heart, 44.4 ± 3.37 kPa(58), is 10 times better than engineered tissue from non-primary 
cardiac myocytes(209).   
It is also important to understand the role of non-myocyte cells in the heart, of which 
tissue engineering can provide the controlled experimental system to elucidate.  During early 
embryonic development, CMs require direct cell-to-cell contact or paracrine signaling from non-
cardiac endoderm cells to differentiate into working CMs(59, 60).  A similar observation was 
reported in CM induction from stem cells(61, 62).  Other studies showed that non-cardiac cells, 
such as fibroblast and/or endothelial cells, are required for CMs to maintain contractile function 
and cell survival(63-65).  CM function, morphology, and survival are also influenced by 
extracellular matrices(66).  Therefore, cell-cell interactions, both homo- and hetero-typic, and 
proper cell-ECM contact under 3D environment are also important in maintaining functioning 
CM differentiation, maturation, and survival. 
 While engineered cardiac tissue generated from freshly isolated primary cardiac 
myocytes are beneficial because of their intrinsic contractile properties, structural, and 
physiologic attributes, they are contraindicated for clinical use.  Stem cells provide an alternative 
cell source.  The original assumption in the stem cell field was that transplanted cells would 
directly participate in tissue formation and recovery; however, it is now clear that paracrine 
effects are important.  A number of stem cell cardiomyoplasty studies in adult heart infarct 
models have shown improvement in the recipient heart function through paracrine effects, 
mostly through angiogenesis(7, 8).  However, in the pediatric population, congenital heart defects, 
or structural problems arising from abnormal formation of the heart or major blood vessels, are 
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the major problem and in many cases the underlying heart structure is not always present.  A 
number of stem cell populations have been used in cardiac tissue engineering, including 
embryonic stem cells or embryonic stem cell-derived cells, endothelial progenitor cells, bone 
marrow stromal and stem cells, skeletal muscle cells, and others(56, 65, 67-73).  Being stem cell 
populations, they also have the property of multipotency, allowing the possibility of myocyte and 
non-myocyte populations within the engineered tissue.  However, despite some promising 
results(74), the rate of CM differentiation from transplanted stem cells remains insufficient to fully 
recover the recipient myocardial function(14, 33, 34, 75, 76).  Current findings suggest that cellular 
cardiomyoplasty remains to be improved toward the ultimate (or long-term) goal of completely 
healing the injured myocardium.  Thus, while stem cell cardiomyoplasty plays an important role 
in protection of myocardial tissue loss, mainly through a paracrine mechanism and/or angiogenic 
effects within insufficient levels of cardiomyocyte differentiation, it is not enough to regenerate 
healthy myocardium.  Therefore, a preferred strategy for cellular cardiomyoplasty might be the 
delivery of progenitor/stem cell-derived CMs, rather than undifferentiated cells, into injured 
myocardial tissue(77).  Though tissue engineered strategies provide evidence as promising 
therapeutic options to treat the damaged myocardium, practical benefits remain inconclusive due 
to inconsistent results, weak function, small size, and a limited understanding of the underlying 
mechanisms.  To begin to address these issues, it is necessary to understand the basic structural 
and functional properties of the native myocardium. 
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1.2 THE NATIVE MYOCARDIUM 
1.2.1 Cellular components in the myocardium 
Cardiomyocytes comprise approximately only 30% of the ventricular cell population(78).  
Transmission and scanning electron microscopy have identified five types of non-muscle cells 
within the adult myocardium: endothelial cells, fibroblasts, pericytes, smooth muscle cells, and 
macrophages, which comprise approximately 65-70% of ventricular cells(79).  In addition to these 
cell types, the 3D extracellular matrix (ECM) of the myocardium plays an important role in its 
function.  The myocardium ECM consists of collagen, fibronectin, elastin, and laminin, as well 
as various growth factors, proteoglycans, and glycosaminoglycans(80, 81).  Collagen is the most 
abundant ECM component in the heart and contributes to structural stability and integration of 
cardiomyocytes and myofibrillar bundles(82).  The various components of the myocardium, cells 
and matrix, play important roles in both the healthy and diseased heart.  However, as stated 
previously, cardiac morphogenesis is a complex process within a 4D environment.  Thus we 
must also examine the myocardium over time.   
1.2.2 Fetal vs. post-natal cardiomyocytes 
There are marked phenotypic differences between fetal and post-natal CMs, including 
age-dependent changes in protein kinase expression, β-adrenergic signaling(83), contractile 
apparatus maturity, and the hyperplastic(84) versus hypertrophic(85) responses to mechanical 
stress.  The accumulation of maturation specific isoforms of sarcomeric proteins including 
cardiac myosin heavy chain, sarcomeric actin and actinin, titin, cardiac troponin-T and -I, and the 
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maturation of sarcolemmal and SR ion channels(86-88) allow the functional characterization of CM 
identity and maturation.  These characteristics determine the overall phenotypic appearance of 
CMs, which can differ depending on their location.  
Stem cell derived-CMs have been suggested as a promising option for use in tissue 
engineered constructs, however, there is currently no standard as to what a stem cell derived-CM 
is.  Many groups use the expression of early cardiac genes: Nkx2.5 or GATA4 and the presence 
of rhythmic beating.  This is not necessarily sufficient because skeletal and smooth muscle also 
contracts.  Also, it has been widely accepted that terminally differentiated mature cardiac muscle 
does not express proteins that are specific to skeletal muscle.  However, studies have shown that 
several skeletal muscle specific proteins, such as skeletal muscle specific troponins or ion 
channels, are transiently present in the developing heart(89, 90).  Similarly, “cardiac” and 
“skeletal” excitation-contraction coupling mechanisms co-exist in the developing skeletal muscle 
with the “cardiac” type dominant in the early phases of myogenesis and the “skeletal” 
dominating in more mature muscle(91).  These studies suggest the co-existence of many cardiac 
and skeletal muscle specific proteins (MHCs, troponins, etc.) as well as excitation-contraction 
coupling mechanisms within the developing tissue, but also within cultured cells, especially 
those that are considered to be immature.  Thus, the functional characterization of CMs for 
extrapolation to composite tissue engineered specimens is another fundamental step in 
optimizing approaches for cellular repair. 
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1.3 THE EFFECTS OF THE MECHANICAL ENVIRONMENT ON NATIVE AND 
ENGINEERED TISSUES 
The effects of mechanical factors on myocardial mechanical properties, CM 
differentiation, proliferation, death, and molecular mechanisms in the developing myocardium 
have been well documented(4, 92-105).  A detailed understanding of the cellular responses to 
exogenous stimuli is critical in order to elucidate and therefore control tissue development and 
remodeling for the generation of optimal tissue engineered grafts for myocardial repair.  Time-
varying changes in stresses and strains significantly influence the fundamental cellular response 
in terms of cell morphology, phenotype, and function of growing cardiac tissue(92-95).  Sedmera et 
al.(4) showed that altered mechanical loads on developing embryonic myocardium influenced cell 
proliferation; however, cellular apoptosis was not changed.  These studies indicate that 
mechanical stimulation is one of the key factors that regulate developing fetal CM proliferation, 
tissue formation, contractile function, and cell survival. 
Mechanical strain has been shown to elicit cell responses in engineered cardiac tissue, 
including activation of MAPKs(106-109), reprogramming of gene expressions(106, 107), increasing 
protein synthesis(106, 107), and triggering adaptive responses in muscle phenotype via the 
expression of contractile proteins(108, 110).  Embryonic rat CMs subjected to cyclical mechanical 
stretch resulted in parallel orientation of CM and their intracellular myofibrils(111, 112).  With 
neonatal CMs, passive mechanical stretch has been reported to upregulate myosin heavy chain 
expression and induce parallel CM orientation(113).  Adult CMs were however weakly stimulated 
by passive mechanical load(114).  Mechanical stretching of neonatal CMs induced secretion of 
growth promoting factors(115), as well as upregulation of connexin-43(116) and myosin heavy 
chain(117), which are markers of CM maturity.  Fink et al. reported that six days of phasic, 
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unidirectional stretch led to cardiac myocyte hypertrophy with marked improvement in 
contractility and cellular morphology in 3D engineered heart tissue(118).  Akhyari et al. observed 
similar behavior in cultured gelatin extracts seeded with cardiac myocytes in which tensile 
strength and stiffness were increased and cell proliferation, collagen matrix formation, and 
sarcomere organization were improved(119).  We have shown previously in engineered early 
embryonic cardiac tissue that developing fetal CM within 3D engineered tissue subjected to 
cyclic mechanical stretch by increasing cellular proliferation and contractile function(20); 
specifically, that mechanical stretch positively regulates CM proliferation, but not non-CM 
proliferation(120).  The in vitro tissue culture conditions necessary for controllable and highly 
proliferative donor CM preparation remains to be determined.  Similarly, few studies have 
looked at the role of mechanical forces in regulating structural and mechanical properties within 
in vitro engineered tissue constructs(121-123). 
The chemical and physical microenvironment has been shown to modulate stem cell 
proliferation, migration, differentiation, and survival(124-126).  However, few studies have been 
devoted to understanding the role of the mechanical environment in CM induction from 
progenitor/stem cells, CM maturation, and contractile function(121-123).  Various methods have 
been used to manipulate endogenous and exogenous progenitor cells to differentiate into 
CMs(127) with the focus being on chemical or growth factors and co-culture.  However, previous 
studies have shown that soluble induction factors tend to be less selective than mechanical 
factors in driving cell specification and cannot reprogram mesenchymal stem cells that are 
precommitted(128).  Aggregate culture has been used to enhance survival and differentiation of 
various stem cell types(27, 29, 30), but the emergence of CM in spheroid cultures remains 
stochastic(129, 130).  The ability of mechanical forces to stimulate stem cell differentiation into 
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cardiovascular lineages has only recently been shown(131) and the mechanisms controlling CM 
differentiation remain unknown.  Therefore, strategies for directing differentiation of pluripotent 
stem cells into CMs are needed. 
1.3.1 Cell shape regulation of fate switching  
The regulation of stem cell differentiation has been a challenge in regenerative medicine.  
Stem cell commitment toward a particular program is highly context dependent and requires both 
the activation and suppression of interdependent signaling pathways in order to shift molecular 
cascades between migration, growth, differentiation, and apoptosis(132, 133).  Changes in cell 
shape, via mechanical cues, and binding of specific growth factors and ECM proteins to their 
respective cell surface receptors all switch cells between these same discrete cell fates(132, 134, 135).  
Engler et al. has shown that hMSCs could be induced to differentiate into multiple tissue lineages 
by simply altering substrate compliance(128).  However, Chicurel et al. has shown that when cells 
are forced to become round, they undergo apoptosis even though they receive growth factor 
stimulation and remain attached to the ECM, which would normally induce proliferation(136).  
Thus, one physical parameter, cell distortion, can control the switch between multiple cell fates.  
Recent studies have also revealed that mesenchymal stem cells can be reliably switched between 
different lineages (e.g., bone versus fat) through changes of cell shape(137) and that cells are tuned 
mechanically so that they preferentially differentiate on ECM with a mechanical stiffness similar 
to that of their natural tissue(138).  Yang et al. has shown that embryonic mesenchymal cells 
attached to microsurfaces with a diameter less than the cell diameter conserved their original 
round shape, whereas cells attached to surfaces with diameters larger than the cell diameters 
became elongated with a shape similar to their in vivo counterparts. Within 24hrs the elongated 
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cells differentiated into smooth muscle while the round cells remained undifferentiated as long as 
they conserved their shape(139).  Thus, generalized cell deformation can produce discrete changes 
in cellular phenotype. 
Despite numerous proof-of-principle studies showing that mechanical conditioning can 
improve the structural and functional properties of engineered tissues, little is known about the 
specific mechanical forces or regimes that are stimulatory for a particular tissue or for inducing a 
particular stem cell down a selected lineage.  Similarly, despite studies indicating cell 
deformation can produce cell phenotype changes, whether mechanical forces are the only factor 
responsible for these cell shape changes is unclear.  In addition, engineered tissues at different 
stages of development might require different regimes of mechanical conditioning owing to the 
increasing accumulation of extracellular matrix and developing structural organization.  In this 
context, bioreactors can have an important role, providing controlled environments for 
reproducible and accurate application of specific regimes of mechanical forces to 3D constructs.  
Thus, an adequate model to analyze mechanically driven stem cell derived CM induction, 
differentiation, and contractile maturation within the context of a developing engineered tissue is 
necessary. 
1.4 AIMS OF THE STUDY  
With this in mind we hypothesize that there are unique aspects of the 3D culture 
microenvironment and associated biophysical factors that are essential for CM phenotype 
induction.  Thus, the objective of the present study is to 1) determine the underlying mechanisms 
that regulate native cardiomyocyte proliferation within an engineered tissue both in vitro and in 
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vivo, and 2) analyze mechanically driven stem cell derived CM differentiation and contractile 
maturation within the context of a developing engineered tissue, specifically by investigating the 
relationship between regional mechanical strain variations and CM induction efficiency.  
Achieving these aims will have an impact in tissue engineering, developmental biology, and 
regenerative medicine research while lending to the overall goal of developing a functional 
cardiac graft to repair congenital as well as acquired heart disease. 
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2.0  EFFECT OF MECHANICAL STRETCH ON ENGINEERED CARDIAC TISSUE 
FROM NATIVE CARDIAC CELLS 
2.1 INTRODUCTION 
The developing fetal myocardium has a high cell proliferation rate, which rapidly 
declines following birth(3, 4).  The loss of cardiomyocyte (CM) proliferation in the post-natal 
myocardium is the major barrier to myocardial regeneration following injury in higher 
vertebrates.  With heart-related diseases being the leading cause of death in America and an 
inadequate supply of donor organs, there is an increasing demand for alternative therapeutic 
options.  The long-term goal of cardiac tissue engineering is to create heart tissue constructs for 
clinical use that have morphologic and functional properties similar to native heart muscle.  In 
the short term, engineered tissues can also provide powerful model systems for in vitro 
investigations. 
As discussed in section 1.0, there are several approaches to increase the number of CM 
within injured myocardium including implantation of functional CMs or myogenic cells or tissue 
constructs containing CMs, with the ideal donor CMs possessing a high potential for division 
and potential for further proliferation following implantation.  In this vein, studies suggest that 
fetal, finitely proliferating CMs display the best cell survival, functional integration, and 
sustained cardiac recovery and that 3D in vitro culture conditions may be optimal for donor CM 
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preparation(11, 12, 16, 75).  Tissue engineered cardiac tissue constructs provide the necessary 3D 
environment for efficient cell survival, functional integration, and sustained cardiac recovery(12, 
13).  
Researchers have reported findings that mechanically stimulating engineered cardiac 
tissues during culture resulted in more highly differentiated cardiac tissues that resembled the 
adult native myocardium(47), induced cardiac myocyte hypertrophy(118), improved contractile 
function(20, 118), and increased collagen content(140).  A study where cyclic mechanical stretch was 
applied to a gelatin scaffold seeded with human heart cells also reported improved cell 
proliferation and cell distribution, enhanced matrix organization, and increased tensile strength 
of the construct(119).  We have recently developed a 3D engineered cardiac tissue from chick 
early embryonic ventricular cells (EEECT) that maintains high cellular proliferation activity and 
contractile properties that mimic the native developing fetal myocardium(20).  In a study using 
our EEECT we found that tissues that were cyclically stretched during culture displayed 
significant improvements in active contractile function such that active contractile stress nearly 
doubled in fetal cardiac tissues that were under cyclical mechanical stretching(20).  Also, 
mechanical stretch stimulation of EEECT induces increased cellular proliferation, not cellular 
hypertrophy, a response noted in adult and neonatal CMs(20).  However, it remained unclear 
which cellular subpopulation, CMs or non-CMs, responds to the cyclic mechanical stretch within 
this in vitro engineered cardiac construct.   
Numerous signaling pathways alone, or in combination with growth factors and/or 
environmental factors, have been investigated to identify the regulation of CM proliferation(141).  
p38-mitogen-activated protein kinase (p38MAPK) is a highly conserved signal transduction 
molecule which mediates extracellular signals to a variety of intracellular responses.  p38MAPK 
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has been extensively studied in post-natal CM growth (hypertrophy) and survival(10, 142-144).  
Recent studies have also shown that p38MAPK plays a key role in CM proliferation in both 
developing fetal and post-natal myocardium(87, 143, 145, 146).  Therefore, the purpose of the present 
study was to elucidate the factors that regulate the proliferation activity of immature CMs within 
an in vitro engineered cardiac tissue construct independent of the non-CM population 
proliferation activity.  We tested the hypotheses that cyclic mechanical stretch increases 
specifically CM proliferation within EEECT, mediated by p38MAPK activity and the inhibition 
of p38MAPK activity decreases CM proliferation.  
2.2 METHODS 
2.2.1 Chick engineered early embryonic cardiac tissue (EEECT) construction 
Fertile White Leghorn chicken eggs (Utah State University, Logan, Utah) were incubated 
in a forced-draft, constant-humidity incubator until Hamburger-Hamilton (HH) stage 31(147).  
Cells isolated from 10-15 embryonic ventricles were used to construct each individual 
EEECT(102).  Our research protocols conform to the Guide for the Care and Use of Laboratory 
Animals published by the National Institutes of Health (NIH Publication No. 85-23, Revised 
1985).  Embryonic ventricles were then enzymatically digested by 2mg/ml of collagenase type II 
followed by 0.05% trypsin-EDTA solution (Invitrogen).  Isolated cells were preplated for 1 hour 
and then cultured on a gyratory shaker (60 or 50 rotations/min for chick and rat respectively) for 
24 hours to reaggregate viable CMs(20).  Approximately 5.0x105 cells were mixed with acid-
soluble rat-tail collagen type I (Sigma, St. Louis, MO) and matrix factors (Matrigel, BD Science, 
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Franklin Lakes, NJ) to generate a single construct(20).  Briefly, isolated cells were suspended 
within a culture medium (Modified Dulbecco’s Essential Medium. Invitrogen) containing 20% 
FBS (Invitrogen).  Acid-soluble collagen type I solution (pH 3) was neutralized with alkali 
buffer (0.2 M NaHCO3, 0.2 M HEPES, 0.1 M NaOH) on ice.  Matrigel (17% of total volume, 
BD Sciences) was then added and the cell suspension and matrix solution mixed to reach a final 
collagen type I concentration of 0.67 mg/ml.  Cylindrical-shaped EEECT were constructed using 
collagen type I-coated silicone membrane culture plates (Tissue Train, Flexcell International, 
Hillsborough, NC) and FX-4000TT system (Flexcell International) as follows: 1) the center of 
the silicone membrane of a Tissue Train culture plate was deformed by vacuum pressure to form 
a 20-mm-length x 2-mm-width trough using a cylindrical loading post (Tissue Train and FX-
4000TT). 2) Approximately 200 µl of cell/matrix mixture was poured into the trough and then 
incubated for 120 min in a standard CO2 incubator (37°C, 5% CO2) to form a cylindrical-shaped 
construct.  Both ends of the construct were held by anchors attached to the Tissue Train culture 
plate.  When the tissue was formed, the culture plate was filled with a growth medium containing 
10% FBS and 1% chick embryo extract (SLI, Horsted Keynes, UK).  The vacuum pressure was 
then gradually released, allowing the construct to float within the culture plate.  Growth medium 
was exchanged every 48 hours. 
2.2.2 Mechanical Stretch Stimulation and p38MAPK inhibition 
To determine the effect of cyclic mechanical stretch and/or p38MAPK inhibition on 
EEECT cell proliferation, contractile force, and p38MAPK and Akt phosphorylation, we 
exposed culture day 10 EEECT to either uniaxial cyclic mechanical stretch (0.5Hz, 5% 
elongation), inhibition of p38MAPK with a selective inhibitor, SB202190 (10μM), or concurrent 
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p38MAPK inhibition (SB202190) with cyclic mechanical stretch.  In the preliminary study, we 
found that 0.5Hz, 5% strain of cyclic stretch increased both EEECT contractile force generation 
and cellular proliferation activity with minimal technical EEECT loss due to detachment of the 
tissue from anchors of the culture plate.  We performed cyclic mechanical stretch stimulation or 
p38MAPK inhibition for 2 hours or 48 hours beginning on culture day 10.  For 48 hours 
p38MAPK inhibition, we treated EEECTs with SB202190 containing culture medium and the 
culture medium was changed with fresh SB containing culture medium at 24 hours after initial 
treatment.  For cyclic mechanical stretch stimulation, we also changed culture medium at 24 
hours after the beginning of cyclic mechanical stretch stimulation. 
2.2.3 CM and non-CM proliferation assays  
Each EEECT was fixed with 4% paraformaldehyde/PBS for 15 minutes.  For BrdU 
staining each tissue was incubated with 60µg/ml bromodeoxyuridine (BrdU, Sigma, St. Louis, 
MO) for 16 hours prior to fixation(20).  Samples were then embedded in a 13% polyacrylamide 
gel oriented in the longitudinal direction, and 150µm thickness serial sections were made using a 
standard vibrating microtome (Vibratome-1000, Vibratome.com, St Louis, MO)(20).  Sections 
were permeabilized with 0.1% Triton X-100 for 30 minutes and stained for BrdU using an Alexa 
Fluor 594 conjugated mouse-monoclonal anti-BrdU antibody (Invitrogen, Carlsbad, CA) and 
DAPI (Vector Laboratories, Burlingame, CA).  To differentiate between proliferating CM and 
non-CM within EEECT we used phospho-Histone H3 (ser10, Upstate cell signaling solutions, 
Temecula, CA) and Alexa Fluor 594 secondary antibody (Invitrogen) staining to detect cells 
undergoing mitosis while also counterstaining for CM phenotype with α-sarcomeric actinin 
(EA53, Sigma, St. Louis, MO) and Alexa Flour 488 secondary antibody (Invitrogen).  
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We reconstructed 3D projection images from stacks of z-axis optical scans (1µm 
scanning interval, up to 50µm thickness) using a standard laser confocal microscope system 
(FV1000, Olympus, Tokyo, Japan) and Scion Image software (Scion Corp, MD)(20).  The 
reconstructed composite 3D projection images were visualized at different rotation angles to 
identify proliferating CMs by co-localization of phospho-histone H3 positive nuclei staining and 
α-sarcomeric actinin staining.  Overlapping positive histone-H3 and sarcomeric α-actinin 
staining in all views confirmed CM phenotype (Figure 2-1).  To quantify total cellular and CM 
proliferation activities, 10-20 regions from 3D composite images from each EEECT were 
randomly chosen for analysis.  Cellular proliferation and CM proliferation rates were calculated 
as: [BrdU (+) nuclei] / [DAPI (+) nuclei] (%) and [Histone H3 (+) nuclei within α-sarcomeric 
actinin (+) cells] / [DAPI (+) nuclei] (%), respectively.  We also calculated CM cell ratio (%) by 
[DAPI (+) nuclei with α-sarcomeric actinin (+) cells] / [DAPI (+) nuclei] (%). 
 
Figure 2-1. Identification of phospho-histone positive CMs and non-CMs within EEECT. (A) EEECT were 
stained for α-sarcomeric actinin (green), phospho-histone H3 (pink), and DAPI (blue). 3D projection images 
were reconstructed using a laser confocal microscopy.  Scale bar indicates 10 μm in A. Red boxed areas in A 
are shown at a higher magnification and Histone positive nuclei (?; CM and *; non-CM) were visualized at 
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several different rotation angles. At 0o rotation, the nuclei were sliced in half (white dotted line) and were 
visualized at 90o rotation angle. A proliferating CM was identified as a histone positive nucleus surrounded by 
sarcomere (upper panel). Non-CMs were not surrounded by sarcomere staining in all views (lower panel). 
Scale bar indicates 5 μm in higher magnification views. 
2.2.4 SDS-PAGE Western Blot and ELISA assays 
Whole cell lysates were prepared from EEECT and separated by SDS-PAGE (7.5% 
separating gel, Bio-Rad Laboratories).  Immunoblotting was carried out using routine protocols. 
Each lane contained 20µg of total protein.  Mouse monoclonal β-actin antibody (Abcam), mouse 
monoclonal anti-p38MAPK activated (diphosphorylated p38) antibody (Sigma, St. Louis, MO), 
and mouse monoclonal anti-p38MAPK non-activated antibody (Sigma) and mouse-monoclonal 
α-sarcomeric actinin primary antibody (EA53, Sigma) were visualized with IR-Dye 800 donkey 
anti-mouse secondary antibody (Rockland Immunochemicals, Gilbertsville, PA).  Rabbit 
monoclonal phospho-Akt antibody (Cell Signaling) was visualized with IR-680 donkey anti-
rabbit secondary antibody (Rockland Immunochemicals).  All proteins were visualized using an 
infrared western blot imaging system (Odyssey, LI-COR Biosciences Lincoln, NE).  
Immunoblots were quantified using densitometry and an expression ratio was calculated (Scion 
Image, Scion Corp.).  Standard ELISA protocols from phospho-p38α-MAPK sandwich ELISA 
kit (Cell Signaling) and Akt [pS473] ELISA kit (Biosource) were used to assay p38MAPK and 
Akt phosphorylation.  We pooled 3 to 4 EEECTs for a single western blot or ELISA assay, and 
all western blot and ELISA assays were completed in triplicate (total 9 to 12 EEECTs were used 
per experimental group).  
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2.2.5 Contractile force measurement 
EEECT passive and active forces were recorded as previously described(20).  In brief, 
each construct was excised and transferred to a cold (25oC) calcium free Ringer solution 
containing (in mM): 135.0 NaCl, 4.0 KCl, 10.0 Trizma-HCl, 8.3 Trizma-base, 11.0 glucose, and 
gassed with 95% O2 /5% CO2 (pH 7.4).  One end of the construct was attached using 10-0 mono-
filament nylon sutures to a force transducer (model 403A, Aurora Scientific, Ontario, Canada) 
and the other end to a rigid stainless bar mounted on a micromanipulator.  The perfusion 
chamber containing the construct was then filled with warmed buffer (37oC, 2 cc total volume) 
and perfused at 1ml/min with 2mM Ca2+ Ringer solution.  The construct was field-stimulated 
(1Hz, 4ms, 70 to 100v) using a stimulator (Harvard Apparatus, Holliston, MA).  Construct length 
was increased stepwise in 5% increments up to a 15% elongation from original length or until 
total force reached maximum (Lmax).  Construct external diameters were recorded at each stretch 
increment using a video microscopy system (Model KPD-50, Hitachi, Japan and PowerMac 
8600 system, Apple, CA) and cross-sectional area (mm2) was calculated assuming cylindrical 
geometry.  Force (mg) was normalized by each specimen’s adjusted cross-sectional area to yield 
active stress (mN/mm2). 
2.2.6 Statistical analysis 
Data are expressed as mean ± SE. One factor analysis of variance (ANOVA) with Tukey 
post-hoc test was performed to compare the p38MAPK and Akt activities after 2 and 48 hours 
stimulation.  Two-factor ANOVA with a Tukey test was performed to compare the BrdU 
positive ratio, the phospho-histone H3 positive ratio, the p38-MAPK or Akt kinase 
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phosphorylation ratios, and α-actinin/β-actin expression ratios.  Two-factor repeated ANOVA 
with a Tukey test was performed to compare the active contractile force.  Statistical significance 
was defined by a value of P<0.05.  All calculations were performed using SigmaStat (Systat 
Software Inc, Point Richmond, CA). 
2.3 RESULTS 
2.3.1 Effect of cyclical mechanical stretch and p38MAPK inhibition on EEECT CM and 
non-CM proliferation activity 
Culture day 12 EEECT, which developmentally corresponds to late fetal chick 
myocardium with the cumulative age of 19 incubation days of 21 incubation days (hatching), 
displayed a high BrdU positive ratio comparable to native embryonic myocardium and cyclic 
mechanical stretch further increased the BrdU positive ratio (Table 2-1).  EEECT CM cell ratio 
also increased in response to cyclic mechanical stretch [75.3 ± 3.4% (stretch, n=3), vs. 63.9 ± 
7.0% (control, n=3), P<0.05].  These results are consistent with our previous study(20).  Both 
p38MAPK inhibition, SB202190 treatment, and concurrent p38MAPK inhibition and 
mechanical stretch stimulation decreased the EEECT BrdU positive ratio (Table 2-1).  Phospho-
histone positive ratios followed similar trends to the BrdU positive ratios (Table 2-1, Figure 2-2).  
Notably, the increase in histone positive cell ratio following cyclic mechanical stretch occurred 
only in the CM fraction not the non-CM fraction.  In contrast, p38MAPK inhibition, SB202190 
treatment, decreased both the CM and non-CM phospho-histone positive ratios.  Concurrent 
p38MAPK inhibition and mechanical stretch stimulation also decreased the CM and non-CM 
 22 
phospho-histone positive ratios, similar to p38MAPK inhibition alone.  Thus, the negative CM 
proliferation effect of SB202190 treatment was not reversed by concurrent cyclic mechanical 
stretch stimulation. 
Table 2-1. Effects of cyclic mechanical stretch and p38MAPK inhibition on EEECT CM and non-CM 
proliferation. Data are mean ± SE. n; number of samples. *; P<0.05 vs. Control EEECT within group. †; P<0.05 
vs. Stretch EEECT. §; P<0.05 vs. Control EEECT CM fraction.  ¥; P<0.05 vs. Control EEECT non-CM 
fraction.  ‡; P<0.05 vs. Stretch non-CM fraction. SB: p38MAPK inhibition, SB202190 treatment. Stretch+SB: 
concurrent cyclic mechanical stretch and p38MAPK inhibition (SB202190). Stretch: uniaxial cyclic mechanical 
stretch (0.5Hz, 5% elongation). 
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 Figure 2-2. Quantification of CM and non-CM Histone H3 positive fractions in each group. *P<0.05 vs. 
control EEECT CM fraction. †P<0.05 vs. control EEECT non-CM fraction. 
2.3.2 Effect of cyclical mechanical stretch and SB202190 treatment on p38MAPK and 
Akt activities 
 Western blots indicated that total p38MAPK and α-actinin (normalized by β-actin) 
expression did not change in response to 48 hours cyclic mechanical stretch stimulation 
suggesting CM proliferation (Figure 2-3A).  ELISA analysis showed that both p38MAPK and 
Akt phosphorylation levels increased following 2 hours cyclic mechanical stretch and decreased 
following 2 hours SB202190 treatment or concomitant SB202190 treatment with cyclic 
mechanical stretch (Figure 1-3B and 1-3C) at which EEECT contractile force and CM 
proliferation rate did not change from control EEECT (data not shown).  Phosphorylated 
p38MAPK and Akt consistently increased following 48 hours cyclic mechanical stretch and 
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decreased following 48 hours SB202190 treatment or concomitant SB202190 treatment with 
cyclic mechanical stretch (Figure 2-3B and 2-3C).     
 
 
Figure 2-3. Representative western blots and ELISA analysis of EEECT p38MAPK and Akt expression 
following mechanical stretch stimulation and/or p38MAPK inhibition.  (A) Stimulation or inhibition did not 
change β-actin, α-actinin, or p38MAPK non-phosphorylated expression.  Stretch stimulation increased EEECT 
phosphorylated p38MAPK and phosphorylated Akt expression while inhibition and concurrent stretch and 
inhibition decreased phosphorylated p38MAPK and phosphorylated Akt expression. (B and C) phosphorylated 
p38MAPK and Akt expression increased following 2 and 48 hours of cyclic stretch, decreased following 2 and 
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48 hours of p38MAPK inhibition, and decreased following 2 and 48 hours of concurrent stretch and p38MAPK 
inhibition.  *P<0.05 vs. normalized control EEECT expression. †P<0.05 2h vs. 48h stimulation. 
2.3.3 EEECT contractile force 
All EEECT specimens displayed a positive Frank-Starling response to increased 
construct length (P<0.05).  Cyclic mechanical stretch stimulation for 48 hours increased EEECT 
active stress at Lmax [1.64 ± 0.09 mN/mm2 (n=10), P=0.017] while p38MAPK inhibition reduced 
active stress [0.53 ±0.07 mN/mm2 (n=8), P=0.04], as did the combination of p38MAPK 
inhibition and mechanical stretch [0.46 ±0.05 mN/mm2 (n=8), P=0.025] compared to control 
EEECTs [1.00 ±0.06 mN/mm2 (n=10)] (Figure 2-4).   
 
Figure 2-4. Active contractile force at Lmax of culture day 12 EEECT. Active force of culture day 12 EEECT 
increased in response to cyclic stretch stimulation for 48 hours and decreased following either p38MAPK 
inhibition or concomitant stretch and p38MAPK inhibition. *P<0.05 vs. control EEECT. 
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2.4 DISCUSSION 
Increased mechanical loads trigger various molecular signaling pathways that can result 
in cardiac growth or pathologic hypertrophy in post-natal myocardium(106, 107, 148).  In contrast, 
the immature embryonic/fetal myocardium responds to increased mechanical loads via cellular 
proliferation (myocardial hyperplasia)(4, 149, 150).  In our previous study, we showed that 
engineered cardiac tissue from chick early embryonic ventricular cells, termed EEECT, 
maintains a relatively high cellular proliferation activity and cyclic mechanical stretch 
stimulation further increases cellular proliferation similar to the developing fetal myocardium(20).  
However, it was unclear which cellular subpopulation, CMs or non-CMs, responds to the 
mechanical stretch within this in vitro engineered cardiac construct.  In the present study, we 
found that both CMs and non-CMs proliferate within EEECT and that CMs, but not non-CMs, 
increase proliferation in response to cyclic mechanical stretch stimulation.  In addition, 
mechanical stretch increased p38MAPK phosphorylation, which preceded increases in EEECT 
contractile force and CM proliferation.  In contrast, the inhibition of p38MAPK significantly 
decreased CM proliferation activity and the negative effects of p38MAPK inhibition overrode 
the positive cyclic mechanical stretch stimulation effects on EEECT contractile function and CM 
proliferation.   
 There are currently conflicting results regarding the role of p38MAPK in the regulation 
of CM growth (hypertrophy) and survival(106, 142).  Many of these studies investigate post-natal 
(neonatal or adult) CMs.  Extrapolation of the results from post-natal CMs to fetal CMs is 
difficult because of the marked phenotypic differences between fetal and post-natal CMs, 
including age-dependent changes in protein kinase expression, β-adrenergic signaling(83), 
contractile apparatus maturity, and most importantly, by the hyperplastic(84) versus 
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hypertrophic(85) responses to mechanical stress.  Zimmermann et al. reported that culture day 14 
engineered heart tissue (EHTs) generated using neonatal rat CMs morphologically resembled 
adult myocardium and the addition of mechanical stretch to the EHTs induced cardiac 
hypertrophy(47).  In our EEECT made from embryonic cardiac cells, we found that EEECT 
resembled the developing immature fetal myocardium and that mechanical stretch induced CM 
proliferation, not hypertrophy(20, 120).  The disparate culture time and CM type is likely 
responsible for these differing results, underlining the phenotypic differences between post-natal 
and fetal CMs.  Olson et al. recently reported that p38MAPK activity increased in response to 
increase in hemodynamic loads in a fetal ovine myocardium suggesting a role for p38MAPK in 
regulating fetal CM proliferation(145, 151).  The stretch-induced increase in CM over non-CM 
phospho-histone H3 expression shown here may be dependent upon the activation of p38MAPK 
since it was abolished by the selective inhibitor SB202190.  These results suggest that 
p38MAPK is a mediator of stretch induced fetal type CM proliferation within in vitro engineered 
cardiac tissue. 
The observation that an increase in p38MAPK phosphorylation by cyclic mechanical 
stretch occurred coincident with increased Akt phosphorylation suggests that p38MAPK may 
regulate EEECT cell proliferation via Akt.  Akt is a serine–threonine kinase and has been 
implicated in numerous intracellular processes including cell growth and survival(152, 153).   Akt 
has also been shown to be a downstream target of p38MAPK that can be directly regulated via 
gene transcription as well as by protein activation during myogenesis(154).  Previous work has 
indicated that both Akt(155) and p38MAPK(156) are important for myogenesis.  Gude et al. has 
recently shown that Akt acts as a facilitator of cellular proliferation for cardiac progenitor cells 
and young committed CMs in the heart and that an increase in Akt correlated not only with 
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replicating cells, but also with increased GATA-4 expression(157).  Some myogenic specific 
transcription factor downstream targets of p38MAPK including GATA-4 and MEF2 have been 
shown to be activated directly by p38MAPK(158-160) and recent work has shown that the PI3 
kinase pathway is involved in activating MEF2(154, 155).  Aouadi et al. reported that inhibition of 
p38MAPK activity reduced MEF2C expression and blocked CM lineage induction in embryonic 
stem cells suggesting that the p38MAPK effect could be due to MEF2C regulation(161).  We have 
shown that cyclic mechanical stretch stimulates p38MAPK and results in Akt activation and that 
inhibition of p38MAPK reduces Akt activation.  These changes in p38MAPK and Akt content 
and activity within EEECT parallel changes in the CM proliferation.  Therefore, it is likely that 
even though p38MAPK and Akt function via distinct, though parallel, signaling pathways, 
p38MAPK functions upstream of Akt in the response to mechanical stretch, suggesting that Akt 
function may be another important link in the regulation of CM proliferation. 
Our data also suggests that p38MAPK activity within EEECT impacts contractile 
function in addition to cell proliferation.  EEECT responded to mechanical stretch with increased 
active force and CM proliferation, which is similar to the developing fetal myocardium(92, 102, 162).  
Cyclic mechanical stretch has previously been shown to induce a variety of cellular processes 
including activation of MAPKs(106-109), reprogramming of gene expressions(106, 107), and an 
increase in protein synthesis(106, 107) as well as trigger adaptive responses in muscle phenotype via 
the expression of contractile proteins(108, 110).  Recent studies in adult CMs have shown that 
p38MAPK activation upregulates Na+-Ca2+ exchanger expression similar to cardiac hypertrophy 
and failure in adult myocardium(163).  In contrast, immature proliferative (not hypertrophic) 
embryonic/fetal CMs have different Na+-Ca2+ exchanger properties from adult CMs and the 
changes in its properties depend on developmental stages(164, 165).  Some regulatory factors, PKA, 
 29 
PKC, and cyclic nucleotides, of the Na+-Ca2+ exchanger could also change expression, location, 
or compartmentalization with respect to developmental stages(165) which would also lead to 
altered Na+-Ca2+ exchanger function in embryonic/fetal CMs compared to adult CMs.  There are 
no previous reports that investigated the relationship between p38MAPK (and other MAPKs) 
and Na+-Ca2+ exchanger function within developing immature CMs.  We speculate that cyclic 
mechanical stretch mediated p38MAPK activity within EEECT may not upregulate Na+-Ca2+ 
exchanger expression like what is seen in adult, mature CMs.  Further investigation into the Na+-
Ca2+ exchanger functions within EEECT and its role in regulating the active contractile force 
along with CM proliferation following stretch induced p38MAPK activation is necessary. 
2.4.1 Limitations 
Several limitations should be noted in the present study.  First, cyclic mechanical stretch 
selectively increased CM proliferation and both p38MAPK and Akt phosphorylation whereas 
p38MAPK inhibition reduced both CM and non-CM proliferation activities as well as reduced 
Akt activity.  These results suggest that the positive cyclic mechanical stretch effects on CM 
proliferation may not be directly mediated by p38MAPK activity of CMs.  The noted increase in 
p38MAPK activity and Akt activity induced by mechanical stretch may be independent events.  
It is also important to note that EEECT contains both CM population [65 to 75% in cell number, 
more than 90% in cellular volume ratio(20)] and non-CM population, such as fibroblasts, 
endothelial cells, vascular smooth muscle cells, etc. CM-to-non-CM and CM-to-extracellular 
matrix interactions may greatly influence CM proliferation and p38MAPK/Akt activities.  
Second, the p38MAPK inhibition dose used in the current study (10µM, SB202190) may also 
have toxic effects on both CM and non-CM populations other than its noted effects on cellular 
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proliferation.  In our preliminary study, we found that 1 and 5µM SB202190 treatment for 48 
hours tended to decrease p38MAPK phosphorylation levels and CM proliferation rate (by 
histone H3 positive cell counting) while there was no change in the EEECT contractile force.  
Only 10µM SB202109 treatment showed statistically significant decreases in p38MAPK 
phosphorylation, CM proliferation, and EEECT contractile force production.  We note that 
EEECT tissue architecture stained by α-sarcomeric actinin did not vary between treatment doses.  
Therefore, we chose the 10μM SB202190 treatment dose for p38MAPK inhibition for the 
current study.  However, other factors remain to be investigated, such as CM apoptosis, or 
altered CM metabolism, which could be triggered by p38MAPK inhibition(166).  Third, we have 
not yet determined the roles of other MAP-kinases, such as JNK, or ERK that have also been 
closely associated with the regulation of CM growth, survival, and proliferation.  These alternate 
kinases may directly or indirectly participate in the regulation of both CM and non-CM 
responses to cyclic mechanical stretch.  Forth, while our current cyclic mechanical stretch 
protocol significantly increased EEECT force generation and CM proliferation, alternate stretch 
protocols may be optimal for immature CMs at different developmental stages.  Finally, our 
finding of positive mechanical stretch effects on immature CM derived from avian and rat 
embryo (unpublished data) myocardium need to be confirmed for immature CM derived from 
large mammals or in stem / progenitor cell-derived CMs.  Nevertheless, our results suggest that 
immature CM proliferation can be positively regulated by cyclic mechanical stretch and 
unwanted, excessive CM and non-CM proliferation can be negatively regulated by p38MAPK 
inhibition within this in vitro tissue culture environment which is one of the key factors for the 
development of an optimal tissue culture method of functioning CM preparation for cardiac 
repair.  
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2.4.2 Conclusion  
In summary, immature (fetal) CMs within a 3D engineered cardiac construct increased 
CM proliferation in response to cyclic mechanical stretch and this proliferative response is 
blocked by p38MAPK inhibition.  Our findings confirm a role for cyclic mechanical stretch and 
p38MAPK in the regulation of CM proliferation within tissue engineered cardiac constructs that 
may be relevant in designing optimized donor CM preparation and culture approaches for 
cardiac repair paradigms.  Further research is required to define the underlying mechanisms by 
which p38MAPK activation regulates the fetal CM proliferation, growth, and mechanical 
properties. 
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3.0  ENGINEEDED FETAL CARDIAC GRAFT PRESERVES CM PROLIFERATION 
AND SUSTAINS CARDIAC FUNCTION WITHIN POST-INFARCTED MYOCARDIUM 
3.1 INTRODUCTION 
Recent studies suggest that a three-dimensional (3D) tissue culture environment is 
necessary for efficient CM survival, functioning myocardial tissue formation in vitro, functional 
integration, and sustained cardiac recovery(12, 13, 37, 42, 45, 53, 118).  Primary neonatal rat cardiac 
myocytes have an intrinsic ability to contract synchronously in culture and attach to 3D matrix 
scaffolds, and therefore have been used extensively for generating spontaneously beating 
engineered cardiac tissues(37, 40-42, 46-49, 50).  Using neonate CMs, pioneering studies from 
Eschenhagen and Zimmermann validated an engineered heart tissue paradigm for cardiac graft 
implantation onto post-infarct left ventricular (LV) myocardium(12, 13).  Their results were 
reported for 4 weeks following graft implantation, and graft survival required the use of 
immunosuppression(13). 
In contrast to neonatal CMs, studies suggest that fetal CMs display a high level of cell 
survival and sustained cardiac function when transplanted into injured myocardium(11, 13, 75, 167-
1172).  Embryonic/fetal CMs possess high proliferative activity during development which 
declines shortly after birth and terminally differentiated mature CMs have limited proliferative 
activity(173, 174). 
 33 
As shown previously and in 2.0, EEECT, 3D engineered cardiac tissue from embryonic 
chick cardiac cells, maintains high cellular proliferation activity and contractile properties that 
mimic the native developing fetal myocardium(20).  In response to cyclic mechanical stretch 
stimulation, chick EEECT increases CM proliferation, rather than the cellular hypertrophy 
response noted in adult and neonate CMs(20, 120).  Therefore, in the current study, we tested the 
hypothesis that the proliferating fetal CMs within engineered cardiac tissue graft maintain CM 
proliferative activity in vivo, survive as a donor myocardial tissue, and contribute to the cardiac 
functional recovery of injured recipient myocardium in a syngeneic rat model. 
3.2 METHODS 
3.2.1 Experimental animals 
Gestational day 14 time-pregnant, neonatal day 3, and 12 week-old adult female Lewis 
rats weighing 200g to 250g were used (Harlan Sprague Dawley Inc., Indianapolis, IN).  In order 
to track the fate of implanted GFP(+)-CMs within EFCT, we used gestation day 14 EGFP(+)-
transgenic rat fetal hearts identified by using a fluorescent light (Dark Reader Stop Lamp, Clare 
Chemical Research, Dolores, CO) during heart excision from the fetuses and female adult nude 
rats as recipients (200 to 250g body weight).  The EGFP-transgenic rats were originally 
generated by Dr. Masaru Okabe (University of Osaka, Osaka, Japan)(175) and EGFP transgenic 
rat colonies were maintained within the animal facility of the Children’s Hospital of Pittsburgh 
of UPMC.  All experimental protocols followed the National Institutes of Health guidelines for 
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animal care and were approved by the University of Pittsburgh’s Institutional Animal Care and 
Use Committee and Children’s Hospital of Pittsburgh Animal Research Care Committee. 
3.2.2 Rat engineered fetal cardiac tissue (EFCT) and engineered neonatal cardiac tissue 
(ENCT) construction  
For EFCT construction, pregnant mothers were anesthetized using 3% isoflurane 
inhalation with 100% oxygen and hysterectomy was performed.  Immediately after 
hysterectomy, the mother was euthanized by induced asystole under 5% isoflurane anesthesia.  
The excised uteri were transferred to a sterilized Petri-dish filled with cold PBS buffer and 1% 
antibiotic-antimycotic solution, which contains 100units/mL of penicillin, 100units/mL of 
streptomycin, and 0.25µg/mL of amphotericin-B (Invitrogen, Carlsbad, CA), and the fetuses 
were excised by hysterotomy, and then fetal hearts were harvested.  Great vessels and atrium 
were removed from each fetal heart and ventricular tissue was collected and pooled.  For ENCT 
construction, neonatal day 3 rat pups were euthanized by cervical truncation under 5% inhaled 
isoflourane with 100% oxygen and the ventricular tissue was excised and pooled.  Pooled fetal or 
neonatal ventricles were then enzymatically digested by 2mg/ml of collagenase type II followed 
by 0.05% trypsin-EDTA solution (Invitrogen).  Isolated cells were preplated for 1 hour and then 
cultured on a gyratory shaker (50 to 55 rotations/min) for 24 hours to reaggregate viable CMs(20).  
Approximately 5.0 x 105 of cardiac cells / construct  (350cells/cell aggregate, 3.0 x 106/ml) were 
mixed with acid-soluble rat-tail collagen type I (Sigma, St. Louis, MO) and matrix factors 
(Matrigel, BD Science, Franklin Lakes, NJ)(20).  Cell/matrix mixture was performed as follows. 
1) Cells were suspended within a culture medium (Modified Dulbecco’s Essential Medium, 
Invitrogen) containing 20% FBS (Invitrogen). 2) Acid-soluble collagen type I solution (pH 3) 
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was neutralized with alkali buffer (0.2 M NaHCO3, 0.2 M HEPES, 0.1 M NaOH) on ice. 3) 
Matrigel (15% of total volume, BD Sciences) was added to the neutralized collagen solution. 4) 
Cell suspension and matrix solution were mixed.  The final concentration of collagen type I was 
0.67 mg/ml.  
Cylindrical-shaped EFCT or ENCT were constructed by using a collagen type I-coated 
silicone membrane culture plate (Tissue Train, Flexcell International, Hillsborough, NC) and 
FX-4000TT system (Flexcell International).  Briefly, the center of the silicone membrane of a 
Tissue Train culture plate was deformed by vacuum pressure to form a 20-mm-length x 2-mm-
width trough using a cylindrical loading post (FX-4000TT).  Approximately 200µl of cell/matrix 
mixture was poured into the trough and incubated for 120min in a standard CO2 incubator (37°C, 
5% CO2) to form a cylindrical-shaped construct.  Both ends of the construct were held by 
anchors attached to the Tissue Train culture plate.  When the tissue was formed, the culture plate 
was filled with a growth medium containing 10% FBS (Invitrogen) and 1% 
antibiotics/antimycotics solution (Invitrogen).  The vacuum pressure was then gradually released, 
and the construct was floated within the growth medium.  Constructed engineered tissue was 
cultured for 7 days and the culture medium was changed every other day. 
3.2.3 Contractile force measurement 
Contractile force was measured on culture day 7 EFCT (n=6) and ENCT (n=7) as 
previously described(20).  In brief, each engineered cardiac construct was excised from anchors of 
Bioflex culture plate and transferred to a cold (25oC) calcium free Ringer solution containing (in 
mM): 135.0 NaCl, 4.0 KCl, 10.0 Trizma-HCl, 8.3 Trizma-base, 11.0 glucose and gassed with 
95% O2 /5% CO2 (pH 7.4).  One end of the EFCT or ENCT was attached using 10-0 mono-
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filament nylon sutures to a rigid stainless steel bar connected to force transducer (model 403A, 
Aurora Scientific, Ontario, Canada) and the other end to a rigid stainless steel bar mounted on a 
micromanipulator (Figure 3-1A).  The perfusion chamber containing the construct was then 
filled with warmed buffer (37oC, 2ml chamber volume) perfused at 1ml/min with 2mM [Ca2+] 
Ringer solution.  We performed measurement of force-length relations followed by 1µM 
isoproterenol (ISP) treatment from the same construct.  After 10 minutes pre-conditioning of the 
construct at a slack length (by adjusting construct length as the same length as that in a Bioflex 
culture plate) under perfusion of oxygenized, 2mM [Ca2+] ion containing warmed ringer solution 
(baseline ringer solution), the tissue was electrically stimulated at 1Hz, 4msec, 50 to 70V using a 
field stimulator for 5 minutes.  We then measured active force-length relations.  The active 
contractile force was measured at given strain (0, 5, 10, and 15% elongation from the original 
length).  We repeated force measurement at given length 3 times and averaged in each construct.  
We note that the weakening of force was not found throughout the test at all given tissue length. 
Measured force at given length were averaged in each construct.  The construct was then 
maintained at L0.15 (15% elongation from the original length) and was perfused for 5 to 10 
minutes with baseline ringer solution and then treated with 1µM ISP.  The contractile force was 
monitored for 5 minutes during ISP treatment and the largest contractile force was measured as 
the contractile response of ISP treatment at 5 minutes after ISP treatment.  After the force 
measurement, ISP was washed out by baseline ringer solution to confirm force level was 
returned to the baseline.  We repeated ISP treatment for 3 times and averaged in each construct. 
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3.2.4 Chronic left ventricular infarction model 
EFCT or ENCT recipient adult (Lewis or nude) rats were anesthetized using 3.0% 
isoflurane inhalation with 100% oxygen gas followed by endotracheal intubation and connection 
to a rodent volume controlled mechanical ventilator (Model 683, Harvard Apparatus, Holliston, 
MA).  The heart was exposed through a left thoracotomy, monitoring electrocardiogram (THM 
1000, VisualSonics, Toronto, Canada).  The proximal left anterior descending coronary artery 
was ligated with 7-0 polypropylene.  Myocardial ischemia was confirmed by regional cyanosis 
and changes in electrocardiogram (ST-segment elevation).  The incision was closed in layers 
with 4-0 silk continuous sutures(176).  A total of 45 rats underwent left coronary artery ligation. 7 
animals died within 24 hours of coronary artery ligation and 38 animals survived. These survived 
rats were considered as cardiac graft recipients. Therefore, survival rate at 2 weeks after 
permanent left coronary artery ligation was 83.3%(176). 
3.2.5 EFCT or ENCT implantation 
Two weeks following coronary artery ligation (pre-implantation), animals were 
anesthetized with isoflurane and the infarction size and cardiac function were assessed by 
transthoracic echocardiography. LV infarction size was estimated in a standard LV short-axis 
view by the percentage of scar area (akinetic or dyskinetic regions) to LV free wall area(176).  We 
excluded 4 Lewis rats due to insufficient LV infarction and 34 rats with infarcts greater than 25% 
of the LV free wall were included in the present study. We performed CM proliferation (histone 
H3) and apoptosis (caspase-3) assays at 3 days after EFCT graft implantation (n=6).  Eight EFCT 
implanted, 6 ENCT implanted, and 8 sham operated animals were studied for longitudinal 
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echocardiography and histological assessment at 8 weeks after graft implantation.  We also used 
3 additional nude rats with infarcts to allow EFCT cell tracking and to evaluate EFCT derived 
cell fate.  The LV anterior wall was exposed through left thoracotomy again.  Using 7-0 
polypropylene with peripheral sutures, the anterior infarcted myocardium was covered with 4 
engineered tissue constructs into the LV circumferential direction (Figure 3-1B).  For the sham 
operated group, a thoracotomy was performed 2 weeks after coronary ligation, but no EFCT 
implantation was performed.  EGFP positive transgenic rat EFCTs (EGFP-EFCTs) were 
implanted onto post-infarcted LV myocardium in nude rats. 
 
Figure 3-1. External shape of constructed EFCT, EFCT implantation onto post-infarcted LV surface and tissue 
structure of EFCT.  (A) Culture day 7 cylindrical shape EFCT is suspended within a mechanical testing 
chamber and is field stimulated to measure contractile force. Minor scale indicates 1mm.  Photograph of EFCT 
graft implantation onto the post-infarcted myocardium.  (B) Four EFCTs (indicated by *) were implanted to 
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cover the infarct myocardium. Scale bar indicates 5mm.  (C) Confocal microscope image of α-sarcomeric 
actinin and DAPI staining of culture day 7 EFCT tissue. CMs oriented into the longitudinal axis (white arrows) 
of the EFCT forming myocardial tissue like structure. (D) Confocal microscope image of culture day 7 chick 
EEECT tissue. Rat EFCT myocardial tissue architecture (C) is similar to chick EEECT (D).  Scale bars indicate 
20µm in C and D.  
3.2.6 Histological assessment 
Culture day 7 EFCTs or ENCTs were fixed with 4% paraformaldehyde/PBS for 15 
minutes.  For BrdU staining each tissue was incubated with 60µg/ml bromodeoxyuridine (BrdU, 
Sigma, St. Louis, MO) for 16 hours prior to fixation, then embedded in a 13% polyacrylamide 
gel oriented in the longitudinal direction of the construct, and 150µm thickness serial sections 
were made using a standard vibrating microtome (Vibratome-1000, Vibratome.com, St Louis, 
MO)(20).  For post-implant EFCT or ENCT tissue and LV myocardium, the hearts were exposed 
under 3.0% isoflurane inhalation with 100% oxygen gas and arrested by apical injection of 2 ml 
of a hypothermic arresting solution (28mmol/l NaCl, 100mmol/l KCl, 36mmol/l NaHCO3, 
2.0mmol/l MgCl2, 1.4mmol/l Na2SO4, 11mmol/l dextrose, 30mmol/l butanedione monoxime, 
10,000U/l of heparin).  The embedded frozen LV tissues were serially sectioned at 8µm in the 
LV transverse direction using a standard cryo-microtome (MICROM HM505E, Pacific 
Southwest Lab Equipment Inc. Vista, CA).  Sections were permeabilized with 0.1% Triton X-
100 and stained for BrdU using a mouse-monoclonal anti-BrdU antibody (Molecular Probes, 
Eugene, OR) and DAPI (Vector Laboratories, Burlingame, CA).  Mitotic phase CMs were 
identified by triple staining with anti-α-sarcomeric actinin (EA53, Sigma), anti-phospho-S10 
Histone H3 (Upstate cell signaling solutions, Temecula, CA) with Alexa Flour secondary 
antibodies, and DAPI (Vecta-Shield, Vector Labs, Burlingame, CA)(120).  To identify cellular 
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apoptosis, sections were triple-stained with anti-α-sarcomeric actinin (EA53, Sigma), anti-active 
caspase-3 (Abcam, Cambridge, MA), and DAPI.  Capillary vessels formation was identified 
using a triple staining of sections with anti-α-sarcomeric actin (Abcam), anti-CD31 (Abcam), 
and DAPI (Vecta-Shield).  
3.2.7 Identification of CM proliferation or CM apoptosis 
 We reconstructed 3D composite images from stacks of z-axis optical scans of each 
stained sample using a standard laser confocal microscope system (FV1000, Olympus, Tokyo, 
Japan) and Scion Image software (Scion Corp, MD)(120).  The images were visualized at different 
rotation angles to identify proliferating/apoptotic CMs by co-localization of phospho-histone 
H3/active Caspase-3 positive nuclei staining and α-sarcomeric actinin staining. To quantify total 
cellular and CM proliferation activities, 10-20 regions from multiple representative sections 
from each EFCT or ENCT tissue, or non-infarct areas of EFCT implanted myocardium (>200µm 
apart from graft tissue implantation site or infarction border in each section), which expressed α-
sarcomeric actinin similar to the normal, non-infarcted myocardium, were randomly chosen for 
analysis at 400x or 600x magnification.  Total cellular proliferation (both CM and non-CM 
fractions), and CM proliferation or apoptosis ratios were calculated as: [Total cellular 
proliferation] = [BrdU (+) nuclei] / [DAPI (+) nuclei] (%) and [CM proliferation or CM 
apoptosis] = [Histone H3 or Caspase-3 (+) nuclei within α-sarcomeric actinin (+) cells] / [DAPI 
(+) nuclei] (%), respectively.  To measure CM ratio of EFCT and ENCT at pre- and 8 weeks 
after graft implantation, we randomly captured at least 20 fields at 400x magnification of α-
sarcomeric actinin/DAPI sections in each tissue sample and the CM ratio was calculated as, [α-
sarcomeric actinin positive nuclei number]/[total nuclei number] x 100 (%). 
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3.2.8 Capillary density measurement of EFCT and ENCT implanted myocardium 
 We measured capillary density of EFCT (n=8), ENCT (n=6) and sham (n=8) post-infarct 
myocardium at 8 weeks after graft implantation by counting von Willebrand factor (vWF) 
positive cells.  Using a confocal microscope, 20 non-overlapped image fields at 400x 
magnification were randomly selected in each section and vWF positive cells were counted.  
Data were normalized as vWF(+) counts/mm2. 
3.2.9 Assessment of in vivo recipient cardiac function 
 LV function was measured by non-invasive echocardiography (Acuson Sequoia and 13-
MHz 15L8 probe) at pre-implantation (2 weeks after coronary artery ligation), 4 weeks, and 8 
weeks (10 weeks after coronary ligation) after graft implantation.  End-diastolic area (EDA) and 
end-systolic area (ESA) of the LV cavity were measured by endocardial planimetry, and %LV 
fractional area change (%FAC) was measured as [(LVEDA – LVESA)/LVEDA] x 100%.  
Echocardiography was performed using isoflurane anesthesia (1.5% with 100% oxygen) via nose 
cone. LV pressure was measured at 8 weeks after EFCT implantation prior to euthanasia for 
histological assessment.  Rats underwent anesthesia with isoflurane and intubation followed by 
introduction of a pressure-transducer tip Millar catheter (model SPR-1000, Millar Instruments, 
Austin, TX) retrograde from the right carotid artery into the LV. LV pressure was acquired to 
calculate EDP, Pmax, +dP/dtmax, and -dP/dtmin for an analysis with a custom LabVIEW virtual 
instrument. 
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3.2.10 Statistical analysis 
Data are expressed as mean ± SE. Student t-test was performed to compare the data of 
LV pressure measurement.  Paired Student t-test was performed to compare the data of in vitro 
active contractile force and contractile response to the ISP stimulation.  One-factor analysis of 
variance (ANOVA) with Turley post-hoc test was performed to compare capillary density.  Two-
factor ANOVA with a Tukey post-hoc test was performed to compare the BrdU, phospho-
histone H3, or active caspase-3 positive cells.  Two-factor repeated ANOVA with a Tukey test 
was performed to compare the echocardiogram data.  Statistical significance was defined by a 
value of P<0.05. All calculations were performed using SigmaStat (Systat Software Inc, Point 
Richmond, CA).  
3.3 RESULTS 
3.3.1 In vitro EFCT morphology and contractile force 
Both EFCT and ENCT displayed spontaneous tissue contraction from culture day 4 and 
EFCT CM orientation within engineered construct assessed by α-sarcomeric actinin staining was 
similar to culture day 7 chick EEECT using embryonic day 7 chick cardiac cells (Figure 3-1C 
and 3-1D)(20).  Culture day 7 EFCT and ENCT generated active contractile force in response to 
cyclic field electric stimulation and displayed a positive Frank-Starling response to increased 
tissue longitudinal length (P<0.05, Figure 3-2A).  While active contractile force of ENCT at L0.15 
was much higher than EFCT (P=0.001), physiologically maximum isoproterenol (ISP) 
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stimulation (1µM) did not increase contractile force in both tissues suggesting that both fetal and 
neonatal CM phenotypes within the cardiac construct remain immature (Figure 3-2B, Table 3-1). 
 
Figure 3-2. Culture day 7 EFCT and ENCT contractile force. (A) Representative contractile force waveform 
tracing at slack length (L0) and 15% stretched length (L0.15). EFCTs were field stimulated by an electric pacing 
stimulator at 1Hz. EFCT increased contractile force at Lmax. (B) Comparison of maximum active force at L0.15 
between EFCT and ENCT. ENCT active force was significantly higher than EFCT at culture day 7.    
 
Table 3-1. In vitro contractile response of EFCT and ENCT to β-adrenergic stimulation. Data are mean ± SE. 
Baseline active force at L0.15, *; P<0.05 vs. ENCT. Five minutes after 1µM isoproterenol (ISP) stimulation did 
not increase active contractile force in both EFCT and ENCT. Contractile force was measured under presence 
of 2mM [Ca2+] containing Ringer solution.  
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3.3.2 In vitro culture day 7 EFCT and ENCT total cellular and CM proliferation 
Total cellular proliferation ratio of culture day 7 EFCT assessed by BrdU (DNA synthetic 
phase) assay was significantly higher than that of culture day 7 ENCT [23.3 ± 3.0% (n=7) vs. 
1.69 ± 0.4% (n=8), P=0.001].  CM proliferation ratio of EFCT assessed by triple staining of 
phospho-histone H3 (mitotic phase), α-sarcomeric actinin, and DAPI, was also significantly 
higher than that of ENCT (16.0 ± 3.7‰ vs. 6.8 ± 0.7‰, P=0.018). 
3.3.3 EFCT graft survival after EFCT implantation onto post-infarcted syngeneic adult 
LV myocardium 
There were no early or late postoperative deaths related to graft implantation in any 
experimental group.  Two weeks after EGFP-EFCT implantation onto post-infarcted nude rat 
myocardial surface, GFP positive cells within EFCT did not migrate out from the implanted 
EFCT and maintained EFCT myocardial tissue integrity (Figures 3-3A to 3-3C).  At 8 weeks 
after Lewis rat graft implantation, the implanted grafts were still recognized without dislocation 
from the original implanted area and the grafts were merged with host LV surface by visual 
inspection (Figure 3-3D).  The implanted grafts were covered with thin connective tissue and no 
strong adhesions with the chest wall were found.  Hematoxylin-eosin (HE) staining of microtome 
sections revealed that implanted EFCTs and ENCTs were recognized as an eosin positive muscle 
like tissue at the implanted sites (epicardial surface) of infarcted myocardium in all hearts, which 
was not observed in the sham operated LVs (Figure 3-3E, upper panel).  Capillary vessel 
formation was also recognized within implanted EFCT. Implanted grafts were positive to α-
sarcomeric actinin and the high magnification images showed that CMs within implanted EFCTs 
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preserved a typical striated sarcomere structure (Figure 3-3E, middle and lower panels).  CM 
ratio identified by α-sarcomeric actinin positive nuclei of EFCT or ENCT at pre-implantation 
was similar to each other (60.9±3.8% in EFCT vs. 60.4±6.6% in ENCT, P=1.0, ANOVA), 
whereas CM / non-CM ratio of EFCT at 8 weeks after implantation was higher than that of 
ENCT (33.8±7.2% in EFCT vs. 13.4±2.7 in ENCT, P=0.039) suggesting that EFCT retains 
higher CM fraction than ENCT 8 weeks after graft implantation.  We note that typical tumor-like 
tissue formations assessed by HE staining were not found in all graft implanted LVs. 
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 Figure 3-3. Histological assessments of implanted EFCT fate within post-infarcted LV myocardium. (A-C) 
Representative fluorescent histological sections of 2 weeks after EGFP transgenic EFCT implantation onto 
post-infarcted nude rat LV myocardium. Cells within EFCT stayed within the implanted site and preserved the 
graft myocardial tissue structure in vivo. Green color indicates GFP signal, red color indicates α-sarcomeric 
actinin, and blue color indicates nuclei (DAPI). Scale indicates 50µm. (D) Implanted EFCTs were well merged 
onto host infarcted myocardial surface and thin connective tissue covered EFCT implantation site. (E) Yellow 
dot curves indicate implanted EFCTs and black dotted line indicates histological section of. Scale indicates 
10mm. (E) Implanted EFCT were recognized at epicardial implantation sites in all samples at 8 weeks after 
graft implantation. Capillary vessel formation was found within implanted EFCT (insert). 
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Immunohistochemistry revealed that implanted EFCT preserved myocardial tissue and the α-sarcomeric actinin 
staining showed typical striated muscle patterns indicating that EFCT maintained its myocardial tissue structure. 
Scale bars indicate 50µm (E insert), 500µm (HE staining, upper panel), 250µm (middle panel), and 20µm 
(lower panel), respectively. 
3.3.4 Capillary vessel formation within EFCT and ENCT implanted myocardium 
The vWF positive cells were recognized well within EFCT or ENCT implanted post-
infarcted myocardium (Figure 3-4A to C).  The capillary density of EFCT (133 ± 5 counts/mm2) 
or ENCT (115 ± 10 counts/mm2) implanted LV myocardium was significantly higher than 
infarction controls (68 ± 5 counts/mm2, P<0.05, ANOVA, Figure 3-4D and Table 3-2).  
However, the capillary densities within donor EFCT or ENCT grafts were the same (EFCT: 183 
± 16 counts/mm2, ENCT: 176± 10, respectively).  These results suggest that both EFCT and 
ENCT implantation promotes capillary vessel formation within post-infarcted myocardium and 
the capillary density within donor graft does not influence donor graft CM proliferation and 
apoptosis activities. 
 48 
 Figure 3-4. Capillary vessel formation of EFCT graft implanted post-infarct myocardium at 8 weeks after graft 
implantation and capillary density count in EFCT, ENCT implanted myocardium. (A) Triple staining of α-
sarcomeric actinin (green), von-Willebrand factor (vWF, red), and DAPI in EFCT graft implanted myocardium 
at low magnification, scale indicates 200µm. (B and C) Higher magnification images, scale indicates 100µm. 
Capillary formation (vWF positive nuclei) was detected though the post-infarcted myocardium and vessels also 
penetrated into EFCT graft.  (D) Capillary density assessed by vWF positive cell counting within post-infarcted 
myocardium indicates that both EFCT and ENCT increased capillary density significantly higher than sham-
operated myocardium (P<0.05), whereas these between EFCT and ENCT was not statistically different. 
3.3.5 In vivo EFCT graft CM proliferation and apoptosis activities 
We assessed phospho-histone H3 and active caspase-3 positive CM ratios within 
implanted EFCT and non-infarcted host myocardium at 3 days and these within EFCT, ENCT, 
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and non-infarcted host myocardium at 8 weeks after graft implantation (Figure 3-5, Table 3-2).  
Phospho-histone H3 positive CM ratios of EFCT at 3 days and 8 weeks after implantation 
remained at the same level as pre-implantation [12.8 ± 4.0‰ (pre-implantation), 16.7 ± 9.0‰ (3 
days), and 21.9 ± 4.1‰ (8 weeks), respectively, P=0.39] and were higher than the host non-
infarcted myocardium 8 weeks after graft implantation (0.8 ± 0.1‰, P=0.01 vs. EFCT at 8 
weeks, Figure 3-5C).  Phospho-histone H3 positive CM ratio of ENCT at 8 weeks after 
implantation was lower than that of EFCT (1.1 ± 1.2‰, P<0.001 vs. EFCT, Table 3-2).  Active 
caspase-3 positive CM ratio of EFCT at culture day 7 was 0.4‰ ± 0.1‰, which was lower than 
histone positive CM ratio (P<0.001 vs. CM Histone positive ratio).  While CM caspase-3 ratio 
increased at 3 days after graft implantation in comparison to pre-implantation (culture day7),  the 
caspase-3 positive ratios remained the same at 3 days and 8 weeks after implantation [2.3 ± 
1.5‰ (3 days), and 3.0 ± 1.0‰ (8 weeks), respectively, P=0.29].  The CM caspase-3 positive 
ratio of EFCT was at a similar level as the host non-infracted myocardium, whereas that of 
ENCT was not detected at 8 weeks after graft implantation (Figure 3-5D, Table 3-2). 
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 Figure 3-5. Cardiomyocyte proliferation and apoptosis of implanted EFCT and remote recipient myocardium. 
(A and B) Identification of phospho-histone H3 positive CM nuclei and caspase-3 positive CM nuclei, 
respectively. (C) Phospho-histone H3 positive CM ratios at 3 days and 8 weeks after the implantation were 
maintained at the same levels as pre-implantation. The CM proliferation rate was higher than recipient 
myocardium at both 3 days and 8 weeks. (D) Active caspase-3 positive CM ratios of implanted EFCT remained 
low and were at the same levels as recipient myocardium. *; P<0.05 vs. EFCT (Tukey post-hoc test, ANOVA).            
 
Table 3-2. Phospho-histone H3 and Caspase-3 positive CM ratios of EFCT and ENCT at 8 weeks after 
implantation. Data are mean ± SE. *; P<0.05 vs. ENCT. Remote LV; non-infarct LV myocardium which was at 
least 200µm apart from EFCT implant border. EFCT showed higher CM proliferation and apoptosis ratios in 
comparison to ENCT and Remote LV at 8 weeks after graft implantation. 
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3.3.6 Cardiac function of EFCT and ENCT implanted LV 
At 2 weeks after permanent coronary artery ligation (pre-implantation state, 0 week) LV 
EDA was increased approximately twice larger than pre-coronary artery ligation state (n=34, 
pre-coronary ligation EDA; 0.34 ± 0.02cm2, 2 weeks after ligation EDA:  0.68 ± 0.03cm2, 
%EDA change after coronary ligation; 199 ± 10% from pre-coronary artery ligation, P<0.001, 
paired t-test) and LV FAC was decreased less than half of pre-coronary artery ligation state (pre-
coronary ligation FAC; 61 ± 1.4%, 2 weeks after ligation FAC:  26 ± 2.6%, %FAC change after 
coronary ligation; 42 ± 4.0% of pre-coronary artery ligation state, P<0.001) indicating that the 
permanent coronary artery induced post-myocardial infarcted heart failure (LV dilatation and 
impaired LV contraction).  Longitudinal echocardiography after graft implantation showed that 
the sham operated LVs further increased EDA at 8 weeks (P<0.001, 8 weeks vs. 0 week), 
whereas EFCT or ENCT implanted LVs did not increase EDA indicating that implanted EFCTs 
or ENCT prevented further LV dilatation (Figure 3-6A).  LV FAC decreased in the sham 
operated LV by 8 weeks (P=0.030, 8 weeks vs. 0 week) whereas ENCT implanted LV sustained 
contractile function and that of EFCT significantly increased at 8 weeks (P=0.04, 8 weeks vs. 0 
week, Figure 3-6B).  At 8 weeks after graft implantation, LV FAC in EFCT was significantly 
higher than sham operated LVs (P=0.009) while the LV FAC of ENCT tended to higher than 
sham operated LV (P=0.07 vs. Sham).  LV pressure measurement revealed that EFCT implanted 
hearts showed higher heart rates, peak systolic pressures, and maximum dP/dt versus infarction 
controls and a lower minimum dP/dt.  End-diastolic pressure of EFCT implanted LV was the 
same level as sham operated LVs (Table 3-3). 
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 Figure 3-6. Echocardiographic assessment of EFCT and ENCT implanted post-infarcted myocardium. Data are 
expressed as % change in both LV EDA and FAC ± SE. The value of 100% EDA indicates EDA at cardiac 
graft implantation. (Left panel) Sham operated LV cavity area increased and contractile function decreased by 
8 weeks after graft implantation (*, P<0.05) while EFCT and ENCT implanted LV did not increase LV cavity 
area.  (Right panel) LV contraction of sham operated LV decreased by 8 weeks (*, P<0.05) whereas EFCT 
implanted LV increased LV contraction (*, P<0.05). ENCT implanted LV retained LV contraction by 8 weeks. 
EFCT implanted LVs at 8 weeks after graft implantation significantly increased LV FAC in comparison to 
sham operated LVs (P=0.009 vs. sham-operated LV) while ENCT implanted LV FAC tended to increase 
(P=0.07). Data support that implanted EFCTs attenuate LV remodeling of post-infarcted LV. *; P<0.05 within 
group (ANOVA). 0wk; pre-implantation, 4wks and 8wks; 4 weeks and 8 weeks after implantation. 
 
Table 3-3. Left Ventricular Pressure in 8 weeks after EFCT implantation. Data are mean ± SE. Heart rate, left 
ventricular peak systolic pressure, and maximum and minimum dP/dt in EFCT implanted hearts were 
significantly different from the sham operated LVs (*; P<0.05 vs. sham operated LV). Left ventricular end-
diastolic pressure of EFCT implanted hearts was not different from the infarction control (P=0.30).  
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3.4 DISCUSSION 
In the current study we found that EFCT maintained active CM proliferation within in 
vitro culture conditions (pre-implantation) and this proliferation activity was maintained for 8 
weeks after EFCT implantation onto post-infarcted adult myocardium without formation of 
tumor-like abnormal tissue (evaluated by HE staining in all sample sections).  The implanted 
EFCT graft also survived, preserved cardiac tissue structure, and improved the contractile 
function of the post-infarct LV.  
Our previous study of chick EEECT showed that EEECT maintains high cellular 
proliferation activity(20).  In this study, we constructed EFCT from gestational day 14 fetal rat 
cardiac cells in order to investigate the efficacy of an EFCT post-infarction cardiac repair 
paradigm.  Culture day 7 rat EFCT, which developmentally corresponds to gestational day 21 rat 
fetal hearts, displayed active cellular proliferation activity whereas culture day 7 ENCT, which 
developmentally corresponds to post-natal day 10, displayed a low CM proliferation rate similar 
to post-natal myocardium(173) .  We used the same method of tissue construction for these 2 types 
of cardiac tissue.  Therefore, our data indicate that the differences in in vitro CM proliferation 
activity between EFCT and ENCT parallel intrinsic differences in fetal and neonatal CM 
properties.  
Eschenhagen et al. first reported engineered heart tissue (EHT) from post-organogenesis 
chick embryonic or neonatal rat cardiac cells using a 3D liquid collagen-extracellular matrix / 
cell mixture culture method, which we adapted for EFCT construction in the current study(37).  
Their pioneering work and successful generation of ring-shaped EHT reported by Zimmerman et 
al. showed that EHT exhibits native mature myocardial-like tissue architecture and contractile 
properties(12, 177).  Cyclic mechanical stretch stimulation of EHT induced CM hypertrophy 
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(cellular growth) and increased the EHT contractile properties similar to mature adult 
myocardium(12, 118, 177).  The implanted EHTs maintained myocardial tissue for 4 weeks after the 
EHT implantation and electrically coupled with the recipient myocardium and attenuated further 
LV dilatation and preserved contractile function(13).  In the present study, active contractile force 
of culture day 7 ENCT was significantly higher than EFCTs, whereas contractile response to the 
physiologically maximum β-adrenergic stimulation (1µM, ISP) was the same in both construct. 
Zimmermann et al. have shown that culture 12 ring-shaped engineered heart tissues from neonate 
rat cardiac cells responds to β-adrenergic stimulation similar to mature myocardium under 
presence of 0.2mM [Ca2+](13, 118, 177).  In our study we did not see dramatic inotropic response of 
EFCT and ENCT to the ISP. However, we measured the active contractile force and contractile 
response to ISP under presence of 2mM [Ca2+] ion.  In our pilot study, both EFCT and ENCT did 
not generate contractile without presence of [Ca2+] ion and we believed that 2mM [Ca2+] 
concentration represents physiological extracellular [Ca2+] concentration.  Although we could 
not conclude that ENCT contractile properties represent more matured myocardium than EFCT, 
CM proliferation activity and peak active force of EFCT may indicate that CMs within EFCT 
remain more immature fetal CM phenotype(20, 120, 173, 178).  
Zimmermann et al. described that immunosuppression treatment was necessary to 
promote donor graft survival even in the syngeneic rat animal model(13, 177).  In the current study 
we did not treat animals with any immuno-suppressive drugs before or after the graft 
implantation.  Leor et al. reported that implanted fetal ventricular tissue fragments into post-
infracted rat myocardium survive and sustain cardiac function of recipient rat heart(172).  Roell et 
al. showed that embryonic CMs engraft well within post-infarcted myocardium sustaining 
recipient cardiac function(91, 167).  Although underlying mechanisms of EFCT survival without 
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immuno-suppression and its functional contribution to the recipient myocardium remain to be 
elucidated, our results support that immature fetal type CMs have active CM proliferation, 
engraftment without immunosuppression drug treatment, and functional contribution to the 
recipient injured myocardium.  Further studies are necessary to investigate whether the active 
CM proliferation is associated with immuno-tolerance for graft survival.       
Li et al. showed that fetal cardiac cells maintain proliferative activity and form a 
myocardium-like tissue within a 3D gelatin-mesh scaffold in vitro.  The implanted gelatin-mesh 
maintains the myocardial-like tissue architecture within post-infarcted myocardium and 
contributes to preservation of post-infarcted LV contraction(53).  In their study, however, whether 
the high cellular proliferation activity reflects CM proliferation was not investigated.  In the 
present study, we specifically analyzed CM proliferation and apoptosis activities.  EFCT 
displayed higher CM proliferation activity before graft implantation compared to ENCT and the 
higher CM proliferation activity at 8 weeks after EFCT implantation was maintained at the same 
level as pre-implantation, whereas CM proliferation activity at 8 weeks after ENCT implantation 
remained low.  Our previous study of EEECT showed that cyclic mechanical stretch stimulation 
increases both EEECT cellular proliferation and contractile function, which mimics the adaptive 
capacity of the developing fetal myocardium to altered mechanical loads(4, 96, 150).  We speculate 
that the implanted EFCTs were exposed to active mechanical deformation by recipient 
myocardial contraction, which might increase CM proliferation and the contractile properties 
resulting in EFCT tissue survival and prevention of further LV remodeling(4).  
In the present study we did not observe ENCT CM apoptosis activity at 8 weeks after 
implantation.  Although it remains to be elucidated whether ENCT CM death occurred in shortly 
after graft implantation (we did not investigate CM apoptosis in 3 days post-ENCT implant 
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myocardium), which was not observed in EFCT, we speculate that EFCT may maintain higher 
myocardial tissue survival (higher CM ratio of implanted graft at 8 weeks) by active CM 
proliferation with low CM apoptosis, whereas ENCT maintains myocardial tissue survival by 
protecting CM apoptosis, rather than CM proliferation at 8 weeks after graft implantation.  
Capillary density counting within post-infarct myocardium showed that both EFCT and ENCT 
promoted capillary formation, whereas the capillary density counting within graft did not show 
difference between EFCT and ENCT suggesting that capillary vessel formation was not related 
to CM proliferation and CM apoptosis activities.  These results suggest that the active CM 
proliferation of EFCT might be one of the critical factors for donor graft survival and functional 
contribution to the damaged recipient myocardium.   
3.4.1 Limitations 
Several limitations of the current study should be mentioned.  First, we used Matrigel as 
supplemental extracellular matrices (ECMs) for EFCT construction.  In our preliminary study we 
found that matrigel plays an important role in cell aggregate expansion within EFCT.  However, 
Matrigel is derived from mouse tumor cells, which is contraindicated for clinical use(179).  In 
addition, it remains unknown which ECM proteins and/or growth factors within Matrigel play a 
role in cell expansion and EFCT tissue formation.  Further studies are necessary to replace the 
Matrigel by clinically approved ECM/growth factor mixture.  Second, ECM and/or growth factor 
treatment itself may have beneficial effects on myocardial regeneration and recipient cardiac 
function(180, 181).  In the preliminary study, we attempted acellular collagen/Matrigel construct 
(same concentrations as EFCT) implantation onto infarcted myocardium.  However, acellular 
construct was too fragile to maintain tissue structure after the implantation and myocardial tissue 
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formation was not observed at the implantation site, which was seen in EFCT implanted LV.  
Therefore, we speculated that beneficial effects of EFCT implantation on recipient LV function 
is associated with survived EFCT, not ECM proteins and/or growth factor effects.  Further 
studies are required. Third, constructed engineered cardiac tissue samples were of adequate size 
for the rat animal LV infarction model.  However, simple nutrients/oxygen diffusion through 
EFCT may limit the size of constructs generated to repair larger injured hearts.  CM proliferation 
activity and contractile function are greatly influenced by the oxygen and nutrient distribution of 
the tissue(45, 182).  It remains unknown whether the high CM proliferation activity would be 
preserved in a larger-scaled engineered cardiac graft. Further studies are necessary to determine 
whether the high CM proliferation and low CM apoptosis activities within EFCT are purely 
intrinsic properties of fetal type CMs.  Forth, it remains to be elucidated whether our results of 
donor tissue survival and functional contribution to the recipient myocardium will be maintained 
over extended time periods at which finite CM proliferation activity within EFCT may be lost.  
In the present study we found that GFP(+) EFCT cells did not migrate out from the graft tissue 2 
weeks after implantation and the implanted Lewis rat EFCT survived at 8 weeks after 
implantation maintaining myocardial tissue structure.  We speculate that cells within EFCT may 
stay within the graft maintaining tissue structure.  However, we could not track fate of 
GFP(+)EFCT cells in prolonged period due to risk of allogeneic EFCT graft rejection between 
GFP(+)EFCT and nude rats.  Therefore, further study is necessary to track GFP(+)EFCT cells 
using near GFP(+) graft implantation onto GFP(-) host implantation using in-bred GFP 
transgenic rat implantation model(175).  Finally, the underlying mechanisms that regulate CM 
proliferation within EFCT following graft implantation are currently unknown and require 
further investigation.  Various potential cell sources of cellular cardiomyoplasty, including 
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stem/progenitor cell-derived CMs, are under investigation and each cell source may have unique 
mechanisms that regulate cell survival, proliferation, and functional integration(9, 32, 183, 184).  It 
also remains unknown the tumorogenic potential of active donor CM proliferation.  Therefore, 
elucidation of regulatory factors of CM proliferation will play a key role for optimal CM 
preparation for cardiac repair.   
3.4.2 Conclusion 
In conclusion, implanted EFCTs onto post-infarcted LV myocardium maintained active 
CM proliferation with minimal CM apoptosis, preserved myocardial tissue structure, and 
attenuated functional deterioration of post-infarcted LV.  Our findings suggest that active CM 
proliferation of donor cardiac tissue graft may play an important role for graft survival and 
functional contribution to the recipient injured myocardium which may be relevant in designing 
optimized donor CM preparation and culture approaches for cardiac repair paradigms. 
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4.0  ENGINEERED CARDIAC TISSUE FROM SKELETAL MUSCLE DERIVED 
STEM CELLS (MDSC-3DGB) 
4.1 INTRODUCTION 
Studies suggest that fetal, finitely proliferating CMs display the best cell survival, 
functional integration, and sustained cardiac recovery, and thus could be an optimal cell type for 
cardiac repair(75, 167).  However, the use of fetal heart cells is contraindicated for clinical use.  
Stem cells provide an alternative solution, and a range of cell types have been employed in 
cellular cardiomyoplasty strategies including bone marrow derived stromal and stem cells, 
fibroblasts, skeletal myoblasts, mesenchymal stem cells, embryonic stem cells, and resident 
cardiac stem cells(14).  However, despite some promising results(74), the rate of CM differentiation 
from transplanted stem cells remains insufficient to fully recover the recipient myocardial 
function(14, 33, 34, 75, 76).  Therefore, a preferred strategy for cellular cardiomyoplasty might be the 
delivery of progenitor/stem cell-derived CMs, rather than undifferentiated cells, into injured 
myocardial tissue(77).   
Skeletal muscle derived stem cells (MDSCs) are a somatic stem cell population obtained 
from skeletal muscle specimens in animals and humans that can be readily expanded in vitro and 
then transplanted as an autologous graft(76, 185, 186).  MDSCs are multipotent and have been shown 
to differentiate along skeletal and smooth muscle, bone, tendon, nerve, endothelial, and 
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hematopoietic lineages(185, 187, 188).  Previous studies, including our own work, have shown that 
MDSCs, isolated using variations of a modified preplate technique, can differentiate into CMs or 
cells with cardiac phenotypes and can facilitate cardiac repair(8, 76, 189-194).  However, none of the 
previous studies investigated whether differentiated MDSC-derived CMs generate contractile 
force similar to the native CMs.  In addition, undifferentiated MDSCs or MDSCs preconditioned 
with chemical reagents were used to evaluate in vivo CM differentiation from MDSCs, not 
transplanted MDSC-derived CMs in animal models of injured myocardium(32, 74).  Our recent 
studies have also shown that the rate of CM differentiation of transplanted MDSCs within acute 
myocardial infarction model is not sufficient to replace injured CMs and improvement of 
recipient cardiac function by MDSC transplantation is due to combined effects of myogenic 
differentiation of transplanted MDSC, angiogenesis, stimulation of recipient CM proliferation, 
and reduction of recipient CM apoptosis(8, 76).  Therefore, it remains unclear whether 
differentiated CM phenotypic cells replace recipient dead CMs and have contractile function that 
improves recipient cardiac function.   
The effects of various biomechanical stimuli on multipotent stem cells have been 
investigated to elucidate their roles in CM induction and differentiation.  Previous studies have 
shown that cell-cell interactions and specific culture conditions are often necessary prerequisites 
for efficient CM differentiation(17, 18, 195).  The culture of multipotent stem cells in aggregate 
spheres has been shown to facilitate cell-cell coupling, increase differentiation capacity, modify 
cellular metabolism, modulate the response to therapeutic agents(18, 27, 196), and stimulate the 
synthesis and release of extracellular matrix constituents(26).  Studies also suggest that 3D in vitro 
culture conditions may be optimal for donor CM preparation(12, 75, 167) and that tissue engineered 
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cardiac tissue constructs provide the requisite 3D environment for efficient cell survival, 
functional integration, and sustained cardiac recovery(12, 13).   
Thus, the objective of the present study was to develop a culture method which induces 
CM differentiation from MDSCs and facilitates myocardial tissue formation that enables us to 
directly evaluate the contractile properties of MDSC-derived CMs in vitro. We tested the 
hypothesis that the combined MDSC-aggregate formation and 3D collagen gel bioreactor can 
induce MDSCs to differentiate into cells with a CM phenotype and that the differentiated CMs 
form a working 3D cardiac like tissue in vitro. We determined that MDSC-aggregate formation 
followed by 3D gel bioreactor (3DGB) culture succeeded in generating cells with an immature 
CM phenotype mimicking the native fetal myocardium. Thus, our results suggest that MDSC-
3DGB is a useful 3D culture system to directly assess the contractile properties of differentiated 
CMs from MDSCs in vitro. We then tested the hypothesis that MDSC-derived CMs within 
MDSC-aggregate 3DGB would respond similarly to EEECT when subjected to cyclic 
mechanical stretch stimulation and EFCT when implanted on an injured myocardium. 
4.2 METHODS 
4.2.1 MDSC isolation 
MDSCs were isolated from neonatal Lewis rat hind-leg muscles using an established 
preplate technique(185-187, 197-199).  Briefly, 5 post-natal day 3 rat pups were euthanized with 5% 
isoflurane anesthesia followed by cervical truncation.  Gastrocnemius muscles were excised, 
minced in HBSS, and enzymatically digested. Briefly, tissue slurry underwent sequential 
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incubation of collagenase XI (0.2% collagenase XI), dispase (2.4 U/mL), and 2x trypsin.  
Isolated cells then underwent sequential preplating (24 hours interval between each preplate) 
until the 6th preplate phase(199) in standard MDSC growth medium containing high glucose 
DMEM w/ l-glutamine (Invitrogen, Carlsbad, CA), 10% horse serum (Invitrogen), 10% fetal 
bovine serum (FBS, Invitrogen), 0.5% chick embryo extract (US Biological, Swampscott, MA), 
and 1% anti-biotic/anti-mycotic solution (AAS, Invitrogen)(20, 26, 199). Our research protocol 
followed the National Institutes of Health (NIH) guidelines for animal care and was approved by 
the University of Pittsburgh's Institutional Animal Care and Use Committee and the Children’s 
Hospital of Pittsburgh Animal Research Care Committee.  
Isolated rat MDSCs were passaged 15 times and expanded to obtain enough cell number 
(at least 20 million cells per mL)(187, 197).  Fluorescent-activated cell sorting (FACS, FACS Aria, 
BD biosciences, San Jose, CA) revealed that cultured rat MDSCs were approximately 60% 
positive to Sca-1 antigen (BD biosciences), and negative to CD34 (BD biosciences), CD45 (BD 
biosciences), and c-kit (BD biosciences) antigens (Figure 4-1, Table 4-1). Zuba-Surma et al. 
have shown that Sca-1 (-) skeletal muscle stem cells are “inherently predisposed to undergo cardiac 
differentiation(190)”. Thus, we sorted Sca-1 (-) MDSCs which were expanded in standard two-
dimensional (2D) flasks for 48 hours to reach a cell number of 3 million. These Sca-1 (-) MDSCs 
maintained no Sca-1 expression throughout culture (Figure 4-2). 
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 Figure 4-1. FACS analysis of MDSCs. MDSCs were approximately 57.3 ± 2.8% positive to Sca-1 antigen, and 
negative to CD34, CD45, and c-kit antigens. (A and F) isotype control.  (B and G)  Sca-1. (C and H) CD34. 
(D and I) CD45. (E and J) c-kit. 
 
Table 4-1. FACS analysis of unsorted MDSCs and MDSC-3DGB. Data are mean ± SE. n; number of FACS 
sets; for MDSCs: 10 million cells/set, for MDSC-3DGB: 6 MDSC-3DGBs /set.  
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 Figure 4-2. Sca-1 staining of MDSC-aggregates. (A) Unsorted MDSC-aggregates. (B) Sca-1(-) sorted MDSC-
aggregates. Sac-1 expressed in unsorted MDSC-aggregates whereas the sorted Sca-1(-) MDSC-aggregates had 
no Sca-1 expression. Blue staining (DAPI) indicates nuclei. Scale bars indicate 20µm. 
4.2.2 MDSC-3-dimensional collagen gel bioreactor (MDSC-3DGB) construction 
Expanded MDSCs on the 2D flask were trypsinized using a 0.05% trypsin/EDTA 
solution (Invitrogen) and the cell suspension was cultured on a 100mm-dimeter suspension 
culture dish (Corning, Lowell, MA) for 24 hours at 37°C using a gyrating shaker (50 
rotations/min) to form 50 to 70µm diameter MDSC aggregates (MDSC-aggregate, 330-350 
cells/aggregate) under standard MDSC growth medium.  Acid-soluble rat tail collagen type-I 
solution (pH 3, Sigma, St. Louis, MO, USA) was neutralized with alkali buffer (0.2 M NaHCO3, 
0.2 M HEPES, 0.1 M NaOH) on ice. Matrigel (13% of total volume, BD biosciences) was then 
added and the cell suspension and matrix solution mixed to reach a final collagen type-I 
concentration of 0.67 mg/mL.  Approximately 200μL of the cell/matrix mixture was poured into 
the 20mm long x 2mm wide cylindrical cast of a Flexcell Tissue Train collagen type-I coated 
silicone membrane culture plate (FX4000TT, Flexcell International, Hillsborough, NC) and 
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incubated for 120 minutes (37°C, 5% CO2)(20) to form a cylindrical MDSC-3DGB. Each MDSC-
3DGB was cultured in a 5% FBS containing growth medium.  We compared the efficiency of 
CM induction from culture day 7 MDSC-3DGBs to; 1). Freshly formed MDSC-aggregates after 
24 hours rotation culture in standard culture medium; 2). 2-dimensional MDSC culture at culture 
day 7 (2D-MDSC) on rat tail collagen type-I (Sigma) coated tissue culture plates (Corning) with 
5% FBS and Matrigel (17% of total volume, a concentration equivalent to 3D culture, dissolved 
in cell suspension at the beginning of culture, BD biosciences); or 3). 3-dimensional MDSC 
culture (3D-MDSC) at culture day 7 in which the MDSCs were embedded into collagen gel 
without MDSC-aggregate formation. We also constructed engineered cardiac tissue from 
gestational day 14 fetal cardiac cells (EFCT) or neonatal day 1 cardiac tissue (ENCT) to 
investigate whether MDSC-3DGB contractile properties mimic engineered cardiac tissue from 
native immature cardiac cells.  For EFCT construction, pregnant mothers were anesthetized 
using 3% isoflurane inhalation with 100% oxygen and hysterectomy was performed. 
Immediately after hysterectomy, the mother was euthanized by induced asystole under 5% 
isoflurane anesthesia.  The excised uteri were transferred to a sterilized Petri-dish filled with cold 
PBS buffer and 1% antibiotic-antimycotic solution (Invitrogen), the fetuses were excised by 
hysterotomy, and the fetal hearts were harvested.  Isolated cells were preplated for 1 hour and 
then cultured on a gyratory shaker (50 rotations/min) for 24 hours to reaggregate viable CMs for 
the cell suspension for 3D construction.  For ENCT construction, neonatal day 1 rat pups were 
euthanized by cervical truncation under 5% inhaled isoflurane with 100% oxygen and the 
ventricular tissue was excised and pooled.  Great vessels and atrium were removed from each 
heart and ventricular tissue was collected and pooled.  Pooled ventricles were then enzymatically 
digested by 2mg/ml of collagenase type II followed by 0.05% trypsin-EDTA solution 
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(Invitrogen).  Isolated cells were preplated for 1 hour and then cultured on a gyratory shaker (50 
rotations/min) for 24 hours to reaggregate viable CMs for the cell suspension for each construct.  
Engineered cardiac tissue construction was the same as MDSC-3DGB and the constructed EFCT 
or ENCT was culture with 10% FBS containing growth medium for 7 days.  
4.2.3 RT-PCR 
Total RNA was prepared using Trizol solution (Invitrogen) and treated with TURBO 
DNA-free kit (Ambion, Austin, TX, USA). A cardiac α-actin primer was designed using Primer-
3 (For5’-3’ GCCCTGGATTTTGAGAATGA; Rev5’-3’ CCTTTTGCATACGATCAGCA, 
product size of 289bp).  Other primers, whose target genes were Nkx2.5, GATA4, α-and β-
cardiac myosin heavy chains (MHCs), and connexin-43 (Cx-43), were obtained from Qiagen 
Quanti-Tect Primer Assay with the target fragment sizes approximately 100 base pairs.  One step 
RT was performed with a total volume of 1µg RNA in a total volume of 25μL that used MuLy 
(Roches, Pleasanton, CA, USA) with the program: 42oC 15 min, 99oC 5min, 5oC 5min, 1 cycle.  
cDNA (1µL) was used for PCR which used the program: 94oC 2min, 95oC 50second, 58oC 30 
second, 72oC 1 min, 35 cycles 72°C 7 min extension.  For normalization of RT-PCR results, β-
actin was used as an internal control.  All PCR products were confirmed by University of 
Pittsburgh DNA Sequence Core Facilities, performed by Eppendorf Mastercycles.  All RT-PCR 
assays were completed in triplicate (total n=18 MDSC-3DGBs). 
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4.2.4 SDS-PAGE and Immunoblotting 
Whole cell lysates were prepared from native adult and gestational day 20 fetal hearts 
(n=6) and gastrocnemius muscle tissue (n=6), MDSC-3DGB tissue (n=18), 3D-MDSC (n=18), 
Stretch MDSC-3DGB (MDSC-3DGB subjected to cyclic mechanical stretch (0.5Hz, 5%) for 48 
hours) (n=6), and MDSC-aggregate (n=6 culture plates) pooled populations, and separated by 
SDS-PAGE (7.5% separating gel, Bio-Rad Laboratories).  Immunoblotting was carried out using 
routine protocols.  Each lane contained 20µg of total protein.  Mouse monoclonal β-actin 
antibody (Abcam, Cambridge, MA, USA), mouse monoclonal cardiac troponin-T (cTn-T, 
Abcam), mouse monoclonal anti-connexin-43 (Cx-43, Abcam), and mouse monoclonal cardiac 
troponin-I (cTn-I, Abcam) were visualized with IR-Dye 800 donkey anti-mouse secondary 
antibody (Rockland Immunochemicals, Gilbertsville, PA, USA).  Anti-phospho-S10 Histone H3 
(Upstate cell signaling solutions, Temecula, CA) was visualized with IR-Dye 680 donkey anti-
rabbit secondary antibody (Rockland Immunochemicals).  All proteins were visualized using an 
infrared western blot imaging system (Odyssey, LI-COR Biosciences Lincoln, NE, USA).  
Immunoblots were performed in triplicate and quantified using densitometry and an expression 
ratio was calculated (Odyssey, LI-COR Biosciences Lincoln, NE, USA).   
4.2.5 Confocal microscopy 
3D tissue constructs and fetal ventricular samples were fixed with 4% 
paraformaldehyde/PBS for 15 minutes and embedded in the 13% polyacrylamide gel.  150μm 
thick sections were made using a vibratory microtome (Vibratome-1000, Vibrotome.com)(20).  
2D-MDSC samples were fixed with 4% paraformaldehyde/PBS for 5 minutes.  Sections or 2D-
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MDSC samples were permeabilized with 0.1% Triton X-100 for 30 or 5 min, respectively, and 
stained for mouse monoclonal anti-cTn-T (Abcam), cTn-I (Abcam), α-sarcomeric actinin 
(Sigma), or Cx-43 (Abcam) primary antibodies and Alexa Fluor 488, Alexa Fluor 647, or Alexa 
Fluor 594 secondary antibodies (Invitrogen).  We reconstructed 3D projection images from 
stacks of z-axis optical scans using a standard laser confocal microscopy system (FV1000, 
Olympus, Tokyo, Japan) and Scion Image software (Scion Corp, MD, USA)(20).  The composite 
3D projection images were further processed using Adobe Photoshop software (Adobe, San Jose, 
CA, USA). 
4.2.6 Spontaneous beating activity 
Culture day 7 MDSC-3DGBs (n=8) were imaged at two different regions / construct 
using a digital video microscopy system and Scion Image Software with a CG-7 frame-grabber 
board (Scion Corp.) to determine baseline spontaneous beat frequency.  MDSC-3DGBs were 
then treated with 2μM of the non-selective β-adrenergic receptor agonist, isoproterenol (ISP) or 
1mM of the non-selective sodium and calcium ion channel inhibitor, cadmium chloride.  Five 
minutes after treatment, MDSC-3DGBs were imaged again, and were then incubated with fresh 
growth media for 15 min and re-imaged to determine a post-treatment baseline. 
4.2.7 Mechanical testing 
The passive and active force of MDSC-3DGB (n=7), 3D-MDSC (n=6), and EFCT (n=7) 
constructs was measured as previously described(20).  In brief, each construct was transferred 
from the Flexcell culture dish to the perfusion chamber of the muscle testing station containing a 
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cold (25oC) calcium free Ringer solution composed of (in mM): 135 NaCl, 4.0 KCl, 10 Trizma-
HCl, 8.3 Trizma-base, 11.0 glucose and gassed with 95% O2 /5% CO2 (pH 7.4).  One end of the 
construct was attached to a force transducer (model 403A, Aurora Scientific, Ontario, Canada) 
and the other end to a length controller mounted on a micromanipulator using 10-0 mono-
filament nylon sutures.  The buffer within the perfusion chamber (1.5mL total chamber volume) 
was then replaced with a warmed Ringer solution buffer (37oC, containing 2mM Ca2+) and 
perfused at a rate of 1 mL/min.  The construct was field-stimulated (1Hz, 4ms, 50-100V, 
rectangular pulses) using a stimulator (Harvard Apparatus, Holliston, MA, USA).  The 
longitudinal length of the construct was increased in 5% increments up to a 15% elongation from 
original length (L0.15).  The external diameters of the construct were recorded at each stretch 
increment using a digital video microscopy system (Model KPD-50, Hitachi, Japan, and Scion 
Image Software with a CG-7 frame-grabber board, Scion Corp.).   
4.2.8 Intracellular free calcium ion transient recording 
MDSC-3DGBs (n=3) or ENCTs  (n=5) were loaded for 30 min at 25°C with Fura 2-AM 
(Invitrogen) at a final concentration of 5μM within a custom-built muscle chamber equipped for 
the simultaneous measurement of force (force transducer 403A, high speed length controller 
model 22C and 322C, digital control system Series 600A, Aurora Scientific) and intracellular 
free calcium ([Ca2+]i) recording using fluorescent probes and IonOptix hardware and software 
(IonOptix Corporation, Milton, MA, USA).  The muscle chamber was perfused with 37°C 
Ringer solution at a rate of 1 mL/min. MDSC-3DGBs were field-stimulated (1 Hz, 5msec, 50V, 
Harvard Apparatus) and Fura-2 fluorescence was recorded at a sampling rate of 100 Hz by 
alternately illuminating the preparation with light of 340- and 380-nm wavelength while 
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measuring fluorescence at 510nm.  Acquired data was stored for offline analysis.  To 
characterize [Ca2+]i transients, the maximal ratio (F340/F380) and minimal ratio (F340/F380) for 10 
successive transients were calculated and averaged.  We also determined [Ca2+]i transients at 
L0.15, and pacing frequencies of 1 to 6 Hz. 
4.2.9 Mechanical stretch stimulation 
To determine the effect of cyclic mechanical stretch on MDSC-3DGB cell proliferation 
and contractile force we exposed culture day 5 MDSC-3DGB to uniaxial cyclic mechanical 
stretch (0.5Hz, 5% elongation).  In the preliminary study, we found that 0.5Hz, 5% strain of 
cyclic stretch increased both MDSC-3DGB contractile force generation and cellular proliferation 
activity with minimal technical loss due to detachment of the tissue from anchors of the culture 
plate.  We performed cyclic mechanical stretch stimulation for 48 hours beginning on culture day 
5.  For cyclic mechanical stretch stimulation, we also changed culture medium at 24 hours after 
the beginning of cyclic mechanical stretch stimulation. 
4.2.10 Chronic left ventricular infarction model 
MDSC-3DGB recipient adult rats were anesthetized using 3.0% isoflurane inhalation 
with 100% oxygen gas followed by endotracheal intubation and connection to a rodent volume 
controlled mechanical ventilator (Model 683, Harvard Apparatus, Holliston, MA).  The heart 
was exposed through a left thoracotomy, monitoring electrocardiogram (THM 1000, 
VisualSonics, Toronto, Canada).  The proximal left anterior descending coronary artery was 
ligated with 7-0 polypropylene.  Myocardial ischemia was confirmed by regional cyanosis and 
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changes in electrocardiogram (ST-segment elevation).  The incision was closed in layers with 4-
0 silk continuous sutures(176).   
4.2.11 MDSC-3DGB implantation 
12 week-old adult female Lewis rats weighing 200g to 250g were used (Harlan Sprague 
Dawley Inc., Indianapolis, IN) as recipients. Two weeks following coronary artery ligation (pre-
implantation), animals were anesthetized with isoflurane and the infarction size and cardiac 
function were assessed by transthoracic echocardiography.  LV infarction size was estimated in a 
standard LV short-axis view by the percentage of scar area (akinetic or dyskinetic regions) to LV 
free wall area(176).  LV infarctions greater than 25% of the LV free wall were included in the 
present study.  MDSC-3DGB implanted and sham operated animals were studied for 
longitudinal echocardiography and histological assessment at 8 weeks after graft implantation.  
Using 7-0 polypropylene with peripheral sutures, the anterior infarcted myocardium was covered 
with 4 engineered tissue constructs into the LV circumferential direction.  For the sham operated 
group, a thoracotomy was performed 2 weeks after coronary ligation, but no MDSC-3DGB 
implantation was performed. 
4.2.12 Assessment of in vivo recipient cardiac function 
 LV function was measured by non-invasive echocardiography (Acuson Sequoia and 13-
MHz 15L8 probe) at pre-implantation (2 weeks after coronary artery ligation), 4 weeks, and 8 
weeks (10 weeks after coronary ligation) after graft implantation.  End-diastolic area (EDA) and 
end-systolic area (ESA) of the LV cavity were measured by endocardial planimetry, and %LV 
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fractional area change (%FAC) was measured as [(LVEDA – LVESA)/LVEDA] x 100%.  
Echocardiography was performed using isoflurane anesthesia (1.5% with 100% oxygen) via nose 
cone. LV pressure was measured at 8 weeks after MDSC-3DGB implantation prior to euthanasia 
for histological assessment.  Rats underwent anesthesia with isoflurane and intubation followed 
by introduction of a pressure-transducer tip Millar catheter (model SPR-1000, Millar 
Instruments, Austin, TX) retrograde from the right carotid artery into the LV. LV pressure was 
acquired to calculate EDP, Pmax, +dP/dtmax, and -dP/dtmin for an analysis with a custom LabVIEW 
virtual instrument. 
4.2.13 Statistical analysis 
Data are expressed as mean ± SE. Student t-test was performed to compare the data of 
LV pressure measurement. One-factor analysis of variance (ANOVA) was used to compare the 
protein analysis and spontaneous beat frequency among experimental groups.  Two-factor 
repeated ANOVA was performed to compare the active stress-length relations and the 
echocardiogram data among experimental groups.  We performed a Tukey post-hoc test to 
determine individual differences between experimental groups.  Statistical significance was 
defined by a value of P<0.05.  All calculations were performed using SigmaStat (Systat Software 
Inc, Point Richmond, CA, USA). 
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4.3 RESULTS 
4.3.1 CM phenotype cell differentiation within MDSC-3DGB 
Prior to embedding MDSC-aggregates or MDSCs in 3D culture, we assessed the cellular 
proliferation activity of MDSC-aggregates. MDSC-aggregate formation significantly decreased 
MDSC cellular proliferation [16.6 ± 4.5% (n=3 experimental sets, P<0.05)] versus standard 2D 
culture [36.1 ± 2.8% (n=3)] (Figure 4-3).  
 
Figure 4-3.  BrdU assay of 2D-MDSC and MDSC-aggregates. (A) BrdU positive ratio of 2D-MDSC. (B) BrdU 
positive ratio of MDSC-aggregate. BrdU positive ratio of MDSCs decreased with MDSC-aggregate formation 
compared with 2D-MDSCs at culture day 1. MDSC-aggregates and 2D-MDSC were fixed with 4% 
paraformaldehyde/PBS for 5 minutes. Each sample was incubated with 60µg/ml bromodeoxyuridine (BrdU, 
Sigma, St. Louis, MO) for 1 hour prior to fixation(20). MDSC-aggregate samples were then embedded in a 13% 
polyacrylamide gel, and 150µm thickness serial sections were made using a standard vibrating microtome 
(Vibratome-1000, Vibratome.com, St Louis, MO)(20). Sections or 2D-MDSC were permeabilized with 0.1% 
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Triton X-100 for 30 or 5 minutes, respectively and stained for BrdU using an Alexa Fluor 594 conjugated 
mouse-monoclonal anti-BrdU antibody (Invitrogen) and DAPI (Vector Laboratories, Burlingame, CA). 
 
When MDSC-aggregates were cultured under standard 2D conditions, MDSC-aggregates 
attached to the culture dish bottom within an hour and MDSC-aggregates had completely 
disappeared and MDSCs were randomly oriented similar to standard 2D-MDSC culture at 24 
hours. MDSC-aggregates expanded within each 3DGB and the majority of cells aligned along 
the construct longitudinal axis forming a muscle-like tissue (Figure 4-4A) and the cells were 
noted to spontaneously beat by culture day 5, which was observed in all MDSC-3DGBs.  The 
cells within 3D-MDSC (without MDSC-aggregate formation) expanded along the construct 
longitudinal axis by culture day 3, which was faster than MDSC-aggregates placed in 3DGB.  
However, we noted a lower incidence of spontaneous beating cells at culture day 7 within the 
3D-MDSC constructs (6 of 36 constructs or 17%), which was substantially lower than the 
spontaneous beating rate of MDSC-3DGB constructs (48 of 48 constructs or 100%, P<0.05 by 
Fisher exact test).  Synchronous tissue contraction of MDSC-3DGB was observed by culture day 
7.  Histological assessment revealed that MDSC-3DGB contained cells with cardiac specific 
protein cTn-T organized in a striated pattern (Figure 4-4C), whereas the cTn-T positive cells in 
2D-MDSC were not organized in a clear striated pattern (Figure 4-4D).  MDSC-3DGB also 
expressed the cardiac specific protein cTn-I organized in a striated pattern similar to cTn-T 
(Figures 4-4E and 4-4F), whereas cTn-I was negative in 2D-MDSC.  FACS analysis based on 
cTn-T expression revealed that the fraction of cTn-T positive cells from culture day 7 MDSC-
3DGB was 18.6 ± 2.5% (from 6 MDSC-3DGBs in each FACS analysis, 3 independent sets of 
pooled MDSC-3DGBs) (Figure 4-5, Table 4-1).  Cx-43 was expressed in cTn-T positive cells 
within MDSC-3DGB and the Cx-43 expression pattern of cTn-T positive cells was not typical to 
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mature adult CMs, but was similar to CMs of gestational day 20 native fetal left ventricular 
papillary muscle (Figure 4-6).  
 
Figure 4-4. Histologic analysis of MDSC-3DGB.  (A) Phase contract image of culture day 7 MDSC-3DGB. 
Scale bar indicates 500µm. Red box indicates the area of the tissue where high magnification images are taken. 
(B) α-sarcomeric actinin expression in MDSC-3DGB. Scale bar indicates 500µm. (C) Cardiac specific 
troponin-T (cTn-T) expressed in oriented cells of MDSC-3DGB. Blue staining (DAPI) indicates nuclei. Scale 
bar indicates 50µm. White double arrow indicates MDSC-3DGB longitudinal axis. (D) cTn-T expression of 
MDSC-2D. Scale bar indicates 20µm. (E) cTn-T expression of MDSC-3DGB was a typical striated muscle 
pattern at a higher magnification. Scale bar indicates 20µm. (F) Cardiac specific troponin-I (cTn-I) also 
expressed in a typical striated pattern (white arrowheads). Scale bar indicates 20µm. 
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 Figure 4-5. FACS analysis of culture day 7 MDSC-3DGB. Cardiac specific troponin-T was expressed in 18.6 
±2.5% of cells within MDSC-3DGB at culture day 7. 
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 Figure 4-6. Connexin 43 expression pattern of native fetal left ventricular (LV) papillary muscle at gestational 
day 20 and MDSC-3DGB at culture day 7. (A) Native fetal left ventricular (LV) papillary muscle at gestational 
day 20 stained for α-sarcomeric actinin (green), (B) gap junction protein connexin-43 (red), and (C) merged.  
(D) Culture day 7 MDSC-3DGB stained for α-sarcomeric actinin (green), (E) gap junction protein connexin-43 
(red), and (F) merged. Cx-43 expression of MDSC-3DGB was similar to gestational day 20 fetal LV papillary 
muscle Cx-43 expression. Blue staining (DAPI) indicates nuclei.  Scale bars indicate 10µm. 
4.3.2 Cardiac specific gene and protein expression 
Cardiac specific genes were expressed in culture day 7 MDSCs, regardless of the culture 
condition (Figure 4-7); suggesting that 7 days culture can trigger cardiac gene expression of rat 
MDSCs.  Western blots showed that both MDSC-aggregates and 3D-MDSC and MDSC-3DGB 
groups expressed cTn-T and Cx-43 proteins (Figure 4-8A).  Native tissue protein expression 
shows that developmental stage alters cardiac specific protein expression in both heart and 
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skeletal muscle.  Maturation causes cardiac specific protein expression to increase in heart 
muscle and remain unchanged in skeletal muscle.  MDSC-3DGB had similar protein expression 
to gestational day 20 fetal heart (Figure 4-8A).  Densitometry analysis of each protein 
normalized to β-actin expression demonstrated that 3D culture (MDSC-3DGB and 3D-MDSC 
groups) was associated with higher cTn-T, Cx-43, and cTn-I expression versus MDSC-aggregate 
culture (P<0.05).  Within 3D culture groups, we noted that both cTn-I and Cx-43 expression 
levels were higher in the MDSC-3DGB group than in the 3D-MDSC group (P<0.05) (Figure 4-
8B).  Notably, MDSC-3DGB had similar cTn-I and Cx-43 expression levels as well as a cTn-
T/cTn-I ratio [9.1 ± 0.4 (n=3)] to gestational day 20 fetal heart  [9.3 ± 1.7 (n=3)] which was 
significantly different compared to adult ventricular tissue [0.8 ± 0.1 (n=4), (P<0.05) cTn-T/cTn-
I ratio as well as cTn-I and Cx-43 expression levels (P<0.05) (Figure 4-8B).  These data indicate 
that while MDSCs express cardiac specific genes at 7 days in culture, regardless of culture 
method, the cardiac specific protein expression profiles differed with culture method; specifically 
that MDSC-aggregate formation followed by 3DGB culture synergistically increased induction 
of cells with an immature CM phenotype.  
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 Figure 4-7. Cardiac specific mRNA expression. Lane 1: 2D-MDSC evaluated after 7 days in culture; Lane 2: 
MDSC-aggregate evaluated after 24 hours rotation culture; Lane 3: 3D-MDSC (without MDSC-aggregate 
formation) evaluated 7 days after tissue construction; Lane 4: MDSC-3DGB evaluated 7 days after tissue 
construction; Lane 5: adult rat ventricular tissue. 
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 Figure 4-8. Cardiac specific protein expression and quantification. (A) Representative western blot analysis of 
Lane 1: MDSC-aggregate evaluated after 24 hr rotation culture; Lane 2: 3D-MDSC (without MDSC-aggregate 
formation) evaluated 7 days after tissue formation; Lane 3: MDSC-3DGB evaluated 7 days after tissue 
formation; Lane 4: Gestational day 20 fetal rat ventricular tissue; Lane 5: Twelve week-old adult rat ventricular 
tissue; Lane 6: Gestational day 20 fetal rat lower leg skeletal muscle; Lane 7: Twelve week-old adult rat 
gastrocnemius muscle. (B) Densitometric data normalized to β-actin expression (Average Expression vs. β-
actin, %). *; P<0.05 vs. MDSC-aggregate culture normalized expression. †; P<0.05 vs. MDSC-3D culture 
normalized expression. ‡; P<0.05 vs. MDSC-3DGB culture normalized expression. Each lane contains 20 µg of 
protein per sample and experiments were repeated in triplicate. 
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4.3.3 Chronotropic effects of ISP and CdCl2 on MDSC-3DGB 
Culture day 7 MDSC-3DGBs were treated with ISP or cadmium chloride. Five minutes 
after treatment, ISP increased MDSC-3DGB spontaneous beat frequency [5.62 ± 0.54 Hz (n=8, 
P<0.05)] vs. pre-treatment [4.05 ± 0.20 Hz (n=8)] while cadmium chloride suppressed 
spontaneous beating activity [0.44 ± 0.16 Hz (n=8, P<0.05)] compared to pre-treatment [4.27 ± 
0.44 Hz (n=8)] (Figure 4-9).  No changes in pre-treatment baseline spontaneous beat frequency 
and post-treatment baseline spontaneous beat frequency were noted indicating reversible effects. 
These chronotropic responses do not occur in twitching mature skeletal muscle or skeletal 
myotubes(191).  
 
Figure 4-9. Effects of ISP and CdCl2 treatment on spontaneous beating activity of MDSC-3DGB. Culture day 7 
MDSC-3DGBs treated with 2μM ISP for 5 min. increased spontaneous beat frequency.  MDSC-3DGBs treated 
with 1mM CdCl2 for 5 min. decreased spontaneous beating. *; P<0.05 vs. pre-treatment. 
 82 
4.3.4 Contractile properties of 3D MDSC culture 
Upon field stimulation, both 3D-MDSC and MDSC-3DGB generated contractile force 
(Figure 4-10).  MDSC-3DGB generated contractile force similar to engineered cardiac tissue 
from native fetal cardiac cells (EFCT).  MDSC-3DGB as well as culture day 7 EFCT displayed a 
positive Frank-Starling response to increased construct length, whereas 3D-MDSC did not 
(P<0.05, Figure 4-10B and 4-10C).  MDSC-3DGB generated a greater maximum active force 
[0.41 ± 0.06 mN (n=7, P<0.05)] compared with 3D-MDSC [0.22 ± 0.04 mN (n=5)] which was 
approximately one third of EFCT [1.45 ± 0.39 mN (n=7), P<0.05] (Figure 4-10C). 
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Figure 4-10. Biomechanical testing of MDSC-3DGB. (A) MDSC-3DGB mounted on a mechanical testing 
station (white arrow). Scribed x-axis minor scale divisions represent 1 mm. (B) Representative contractile force 
tracing of MDSC-3DGB at increasing resting lengths. (C) Active force-strain relations of culture day 7 MDSC-
3DGB, culture day 7 MDSC-3D, and EFCT at strain deviations of 0 to 0.15.  †; P<0.05 vs. MDSC-3DGB. 
Active force increased in response to increased strain (positive Frank-Starling response, *; P<0.05, ANOVA). 
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4.3.5 Intracellular free calcium ion [Ca2+]i transients in MDSC-3DGB 
We further investigated calcium handling by simultaneously recording contractile force 
and [Ca2+]i transients from culture day 7 MDSC-3DGB in which we observed spontaneous tissue 
contraction. A rise in intracellular [Ca2+] preceded force generation (Figure 4-11A) and each 
[Ca2+]i transient was associated with a concurrent contraction.  MDSC-3DGB displayed a 
negative force-frequency relationship between 1 to 6 Hz based on reduced [Ca2+]i transients and 
active force at increasing pacing rates and was associated with increased diastolic ratio 
(suggesting increased diastolic [Ca2+]i and passive force) (Figure 4-11B), similar to immature 
myocardium(200, 201).  MDSC-3DGB force as well as [Ca2+]i transient developed calcium (Ratio = 
F340/F380) [0.48 ± 0.16 (n=3)] was similar to ENCT (engineered cardiac tissue from cardiac cells 
isolated from day 1 neonatal rats) [0.56 ± 0.11 (n=5)].  These data indicate that MDSC-3DGB 
display the intracellular calcium ion transient features of immature CM with incomplete 
maturation of excitation-contraction coupling. 
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 Figure 4-11. Simultaneous contractile force and intracellular [Ca2+] transient measurement of MDSC-3DGB.  
(A) Representative single beat force (red), fluorescence at 340 nm (green) and at 380 nm (blue), and the 
relative fluorescence [ratio (R=F340/F380)] (black) tracing of culture day 7 MDSC-3DGB electrically stimulated 
at 1 Hz at 50V and 4 msec duration.  A rise in intracellular [Ca2+] preceded force generation and each [Ca2+]i 
transient was associated with a concurrent contraction. (B) Culture day 7 MDSC-3DGB electrically stimulated 
at rates of 1 to 6 Hz at 50V and 4 msec duration.  MDSC-3DGB showed increased diastolic [Ca2+]i and reduced 
systolic [Ca2+]i transient ratios (black) associated with increased diastolic and decreased active force (red) at 
increasing pacing rates, similar to immature myocardium. 
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4.3.6 Effect of cyclical mechanical stretch on MDSC-3DGB CM and non-CM 
proliferation activity 
In 2.0 we found that EEECT responds to mechanical stretch with increased active force 
and CM, not non-CM, proliferation, which is similar to the developing fetal myocardium(120).  
Since the results of this study indicate the MDSC-derived CMs within MDSC-3DGB have an 
immature CM phenotype we investigated the impact of cyclic mechanical stretch on MDSC-
derived CM contractile force and proliferation in MDSC-3DGB. 
MDSC-3DGB were subjected to cyclic mechanical stretch (0.5Hz, 5% elongation) for 48 
hours beginning at culture day 5.  Histological assessment revealed that mechanical stretch 
significantly increased the phospho-histone H3 positive cell ratio only in the CM fraction not the 
non-CM fraction CM (Table 4-2).  
Table 4-2.  Effects of cyclic mechanical stretch on MDSC-3DGB CM and non-CM proliferation. Data are mean 
± SE. n; number of samples. *; P<0.05 vs. Control MDSC-3DGB within group. Stretch MDSC-3DGB: MDSC-
3DGB subjected to uniaxial cyclic mechanical stretch (0.5Hz, 5% elongation) 
 
Western blot analysis indicated that total cTn-T and cTn-I (normalized by β-actin) expression did 
not change in response to 48 hours cyclic mechanical stretch stimulation suggesting CM 
proliferation, not hypertrophy (Figure 4-12). Phospho-histone H3 and Cx-43 expression 
significantly increased following 48 hours cyclic mechanical stretch (Figure 4-12). 
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 Figure 4-12. Representative western blot of MDSC-3DGB expression following mechanical stretch 
stimulation. Stretch stimulation increased MDSC-3DGB Cx-43 and H3 expression *P<0.05 vs. normalized 
control MDSC-3DGB expression.  
 
MDSC-3DGB generated contractile force similar to EEECT. Cyclic mechanical stretch increased 
active contractile force versus control MDSC-3DGB (Figure 4-13).  
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 Figure 4-13. MDSC-3DGB contractile properties in response to mechanical stretch. Active force-strain 
relations of stretch (n=9) and non-stretched (n=8) MDSC-3DGB and engineered cardiac tissue from fetal 
cardiac cells (EEECT) (n=6) at 0 to 0.15 strains. The active stress increased in parallel with increases in strain 
(*, Frank-Starling law). Cyclic mechanical stretch stimulation significantly increased active force at given 
strain. (†; P<0.05 vs. non-stretch MDSC-3DGB). Data are mean ± SE. 
 
Results suggest that CMs within MDSC-3DGB respond to cyclic mechanical stretch with 
increased active force and CM proliferation, similar to EEECT and the developing fetal 
myocardium. 
4.3.7 MDSC-3DGB implantation on post-infarcted myocardium 
In 3.0 we found that implanted EFCTs onto post-infarcted LV myocardium maintained 
active CM proliferation with minimal CM apoptosis, preserved myocardial tissue structure, and 
attenuated functional deterioration of post-infarcted LV, which suggested that active CM 
proliferation of donor cardiac tissue graft may play an important role for graft survival and 
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functional contribution to the recipient injured myocardium.  Thus, we investigated whether 
MDSC-3DGB is implantable and improves injured recipient heart function, similar to EFCT.  
 Two weeks after a myocardial infarction via a left coronary artery ligation MDSC-3DGB 
was implanted on the injured myocardium (Figure 4-14).  
 
Figure 4-14. MDSC-3DGB implantation onto post-infarcted LV surface. (Left panel) Schematic of left 
coronary artery ligation generating myocardial infarction. Photograph of MDSC-3DGB graft implantation onto 
the post-infarcted myocardium. (Right panel) Four MDSC-3DGBs (indicated by arrows) were implanted to 
cover the infarct myocardium. 
 
There were no early or late postoperative deaths related to graft implantation in any 
experimental group.  Eight weeks after MDSC-3DGB implantation onto post-infarcted rat 
myocardial surface, cells within MDSC-3DGB did not migrate out from the implanted MDSC-
3DGB and maintained MDSC-3DGB myocardial tissue integrity.  The implanted grafts were still 
recognized without dislocation from the original implanted area and the grafts were merged with 
host LV surface by visual inspection.  Hematoxylin-eosin (HE) staining of microtome sections 
revealed that implanted MDSC-3DGBs were recognized as an eosin positive muscle like tissue 
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at the implanted sites (epicardial surface) of infarcted myocardium in all hearts, which was not 
observed in the sham operated LVs (Figure 4-15). We note that typical tumor-like tissue 
formations assessed by HE staining were not found in all graft implanted LVs. 
 
Figure 4-15. Histological assessment of implanted MDSC-3DGB fate within post-infarcted LV myocardium. 
Cells within MDSC-3DGB stayed within the implanted site and preserved the graft myocardial tissue structure 
in vivo.  Implanted MDSC-3DGBs were well merged onto host infarcted myocardial surface and maintained a 
muscle-like tissue layer (insert). Yellow dot curves indicate implanted MDSC-3DGB. 
 
At 2 weeks after permanent coronary artery ligation (pre-implantation state, 0 week) LV EDA 
was increased approximately twice larger than pre-coronary artery ligation state and LV FAC 
was decreased compared to the pre-coronary artery ligation state indicating that the permanent 
coronary artery ligation induced post-myocardial infarcted heart failure (LV dilatation and 
impaired LV contraction).  Longitudinal echocardiography after graft implantation showed that 
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the sham operated LVs further increased EDA at 8 weeks.  MDSC-3DGB tended to not increase 
EDA similar to EFCT implanted LVs indicating that implantation of MDSC-3DGB prevented 
further LV dilatation (Figure 4-16, left panel). LV FAC decreased in the sham operated LV by 8 
weeks whereas MDSC-3DGB implanted LV significantly increased contractile function at 8 
weeks, again similar to EFCT implanted LV (Figure 4-16, right panel).  
 
Figure 4-16. Echocardiographic assessment of MDSC-3DGB and EFCT implanted post-infarcted myocardium. 
Data are expressed as % change in both LV EDA and FAC ± SE. The value of 100% EDA indicates EDA at 
cardiac graft implantation. (Left panel) Sham operated LV cavity area increased and contractile function 
decreased by 8 weeks after graft implantation, (*, P<0.05, ANOVA) but MDSC-3DGB implanted LV tended to 
not increase LV cavity area. (Right panel) LV contraction of sham operated LV decreased by 8 weeks (*, 
P<0.05) whereas MDSC-3DGB and EFCT implanted LV increased LV contraction (*, P<0.05).  MDSC-3DGB 
and implanted LVs at 8 weeks after graft implantation significantly increased LV FAC in comparison to sham 
operated LVs (P=0.009 vs. sham-operated LV).  Data support that implanted MDSC-3DGBs attenuate LV 
remodeling of post-infarcted LV similar to EFCT implanted LVs. *; P<0.05 within group (ANOVA). 0wk; pre-
implantation, 4wks and 8wks; 4 weeks and 8 weeks after implantation. 
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4.4 DISCUSSION 
Previous studies have shown that stem cells isolated from skeletal muscle specimens have 
the ability to differentiate into CMs(76, 189, 191-194), however, the efficiency of CM differentiation 
remains unclear and with limited functional characterization.  In the current study we found that; 
1) Low serum growth medium treated rat MDSCs expressed cardiac specific genes similar to 
native adult myocardium, consistent with the findings from others in both human and mouse 
skeletal muscle derived cells; 2) the combination of MDSC-aggregate formation and 3DGB 
culture significantly increased cardiac specific protein expression, spontaneous beating cell 
activity, and contractile properties; 3) MDSC-3DGB subjected to cyclic mechanical stretch for 
48hrs increases active force and CM proliferation, similar to EEECT and the developing fetal 
myocardium; and 4) MDSC-3DGB survives and improves heart function in vivo.  Our results 
suggest that 3D microenvironmental cues provided by MDSC-aggregate and 3DGB culture play 
an important role in differentiation of cells with an immature functional CM phenotype from 
MDSCs and the 3DGB system provides the necessary environment to evaluate the contractile 
properties in vitro, which indicates increased CM proliferation and contractile force in response 
to mechanical stretch, and in vivo, which indicates survival and improvement of heart function 
similar to EFCT. 
Various experiments have highlighted the importance of the microenvironment on stem 
cell-derived CM induction, differentiation, and survival(61, 62).  Tamaki et al. have recently shown 
that skeletal muscle-derived multipotent Sk-34 cells can give rise to CMs and that cell-to-cell 
relationships and cellular milieu were important for this differentiation(193).  However, these 
results were achieved with co-culture with embryonic CMs, and there was no functional 
characterization of the SK-34 derived-CMs in vitro. Thus it is unclear how these cells function in 
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comparison to native CMs in either a healthy or diseased heart.  Rota et al. have shown that bone 
marrow stem cells can engraft into the injured myocardium and differentiate into functionally 
competent CMs and vascular structures by establishing a microenvironment necessary to adopt 
the cardiac phenotype(74).  However, despite these positive results there is still limited 
information on the use of physical stimuli and unique microenvironments to control CM 
induction from progenitor/stem cells, CM maturation, and contractile function.  
Three dimensional growth of cells in aggregate spheres has been shown to direct and 
facilitate cell-cell interactions as well as to modify the differential expression of both 
morphogenic and angiogenic pathways in CMs(17) and hepatocytes(25).  Cell aggregate culture has 
been shown to enhance CM gene expression patterns(17), increase the synthesis and release of 
ECM components(26), and accelerate CM differentiation efficiency of embryonic stem cells(27)  
and liver stem cells(18).  Similarly, Albrecht et al. found that chondrocyte matrix biosynthesis was 
dependent on cell cluster size, rather than overall cell density(28).  Aggregate culture has also 
been used to enhance survival and differentiation of various stem cell types(27, 29, 30), versus static 
culture.  These studies suggest that aggregation imparts many of the necessary structural cues 
required for maintaining differentiated phenotype, including proper dimensionality, shape, cell–
ECM, and cell–cell interactions.  
Cardiac cells within 3D cultured tissue display distinct features that are more 
representative of native myocardium than do cells within 2D culture(20, 47).  Bursac et al. 
investigated the effect of 3D vs. 2D culture on CM properties and found that the 3D 
microenvironment plays a critical role in maintenance of CM metabolism, sarcomere formation, 
cell-to-cell connections, and electrophysiological properties(31).  3D growth of fibroblasts(14, 32), 
endothelial cells(33), and mammary gland cells(34) also exhibits cell morphology and function 
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similar to native tissue over 2D culture(35).  In the current study we showed that the 3D culture 
condition increased differentiation of cells with a functional CM phenotype at both the gene and 
protein levels.  Furthermore the combination of MDSC-aggregate formation and 3DGB culture 
significantly increased expression of the cardiac specific proteins cTn-I and Cx-43 in comparison 
to the MDSC-aggregate group; indicating that MDSC-aggregate formation followed by 3DGB 
culture synergistically promoted differentiation and maturation of cells with a functional CM 
phenotype in vitro.  Chronotropic effects of ISP and cadmium chloride treatment clearly showed 
that MDSC-3DGB contractile properties are mimicking cardiac tissue, not twitching mature 
skeletal muscle or tissue derived from myoblasts.  MDSC-3DGB exhibited synchronous 
contraction and cardiac [Ca2+]i transients in response to electric field stimulation similar to 
engineered cardiac tissue from native CMs, suggesting that cells within MDSC-3DGB are a 
functional syncytium.  MDSC-3DGB exhibited a positive force-length (Frank-Starling) and a 
negative force-frequency relationship consistent with incomplete maturation of CM calcium 
cycling(20, 202) which was similar to engineered cardiac tissue from native fetal CMs.  These 
results suggested that the combination of MDSC-aggregate formation and 3DGB tissue culture 
was required for differentiation of cells with a functioning CM phenotype from MDSCs.  
Studies in cellular cardiomyoplasty showed that the microenvironment of the injured 
myocardium includes the release of matrix factors and cytokines that are clearly not conducive to 
supporting CM induction and/or survival from implanted stem cells(203, 204).  This may inhibit 
proper CM regeneration and/or lead to the potential for inappropriate differentiation in the 
absence of the proper cell-specific milieu.  Therefore, our MDSC-3DGB provides a novel 
method for studying and optimizing in vitro conditioning of the micromechanical environment 
with direct assessment of contractile properties, and its role in stem cell commitment to 
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functioning CMs from MDSCs in vitro.  Although the results of our current study clearly 
indicate that combined MDSC-aggregate formation and 3DGB culture drives induction of cells 
with a functioning cardiac phenotype from MDSCs and that the contractile properties mimic 
those of engineered tissue from native fetal cells, the underlying mechanisms as to how the 3D 
microenvironment regulates this induction from MDSCs remains unclear and necessitates further 
studies. 
4.4.1 Limitations 
There are several limitations that need to be mentioned.  A major limitation to the current 
study is that we can not definitively determine the state of the cardiomyocyte-like cells within 
MDSC-3DGB.   This is most likely due to the co-existence of many cardiac and skeletal muscle 
specific proteins (MHCs, troponins, etc.) as well as excitation-contraction coupling mechanisms 
which occur not only in cultured cells, especially those that are considered to be immature, but 
also within the developing tissue.  Cognard et al. have shown that “cardiac” and “skeletal” 
excitation-contraction coupling mechanisms co-exist in the developing skeletal muscle with the 
“cardiac” type dominant in the early phases of myogenesis and the “skeletal” dominating in more 
mature muscle(91).  Rose et al. have reported bone marrow-derived mesenchymal stromal cells 
that acquire expression of CM genes in in vitro co-culture with native CMs but that did not 
generate action potentials or display ionic currents typical of CMs, and thus remain functionally 
non-CM(205).  Therefore, further studies are necessary to determine whether CM phenotypic cells 
within MDSC-3DGB develop further and mature similarly to the native developing immature 
myocardium, and whether the 3DGB culture in its present form is able to do this.  In the present 
study, we showed that cTn-T positive cells consist of approximately 20% of the entire number of 
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MDSCs within the MDSC-3DGB, a population which may contain both undifferentiated MDSCs 
and MDSCs differentiated into other types of cells.  Thus, it is necessary to develop a method to 
enrich CM phenotype cells from the MDSC-3DGB.  It is likely that more contractile apparatuses 
within each differentiated CM as well as more CMs within MDSC-3DGB (~20% compared to 
~60-70% within EFCT) and a better organization and communication within the tissue would 
serve to increase the contractile properties to be similar to the EFCT or native tissue, however 
further studies are necessary.  Similarly, it is also necessary to observe the CM phenotypic cells 
within MDSC-3DGB over longer culture periods.  It is possible that the CM phenotypic cells 
will 1) acquire a more mature CM phenotype, 2) remain an immature CM population, or 3) 
return to an undifferentiated state. It remains unknown whether CM differentiation and 
maturation from MDSCs require other types of cells in vitro.  Previous studies have shown that 
preconditioned MDSCs transplanted into injured myocardium survive and differentiate into a 
more matured CM phenotype based on histological assessment(191-193), while in the current study, 
differentiated cells exhibited a more immature CM phenotype. The factors which drive 
differentiated CM phenotypic cells toward a more mature CM phenotype remain unknown. The 
studies investigating MDSC-3DGB response to mechanical stretch and survival on post-infarcted 
myocardium are preliminary and an increased sample size is necessary to come to a valid 
conclusion.  Similarly, investigation into the underlying mechanisms that play a role in the noted 
response of increased CM proliferation and contractile properties similar to EEECT are 
necessary, p38MAPK and Akt could play a role similar to EEECT or other MAP-kinases, such 
as JNK, or ERK that have also been closely associated with the regulation of CM growth, 
survival, and proliferation may directly or indirectly participate in the regulation of both CM and 
non-CM responses to cyclic mechanical stretch.   
 97 
4.4.2 Conclusion  
In summary, our results suggest that 3D environmental cues provided by MDSC-
aggregate formation and 3DGB culture are complementary and sufficient to trigger 
differentiation of cells with an immature functioning CM phenotype from rat skeletal MDSCs in 
vitro and that this 3DGB culture responds to mechanical stretch with increased CM proliferation 
and contractile properties similar to EEECT and the native immature myocardium.  MDSC-
3DGB can be implanted on the injured myocardium and improve contractile function post injury.   
MDSC-3DGB can be used as a method to directly assess the contractile properties of 
differentiated CMs from MDSCs in vitro.  This novel induction approach may be useful in 
generating scalable, functioning, donor CMs for cardiac repair and regeneration. 
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5.0  EFFECT OF MECHANICAL STRAIN ON CARDIOMYOCYTE 
DIFFERENTIATION WITHIN MDSC-3DGB 
5.1 INTRODUCTION 
The regulation of stem cell differentiation has been a challenge in regenerative medicine. 
The decision made by a stem cell to commit to a particular program is highly context dependent 
and requires multiple targets in different pathways to be simultaneously perturbed to switch the 
response between growth, differentiation, and apoptosis.  Time-varying changes in stresses and 
strains significantly influence the fundamental cellular response in terms of cell morphology, 
phenotype, and function of growing cardiac tissue(92-95).  Various methods have been used to 
manipulate endogenous and exogenous progenitor cells to differentiate into CMs(127) with the 
focus being on chemical or growth factors and co-culture.  However, previous studies have 
shown that soluble induction factors tend to be less selective than mechanical factors in driving 
cell specification(128).  
The role of the mechanical environment on cardiomyocyte (CM) growth, proliferation, 
maturation, and death have been well documented(4, 92-105).  Mechanical strain has been shown to 
reprogram gene expressions, increase protein synthesis, and trigger adaptive responses in muscle 
phenotype via the expression of contractile proteins within engineered cardiac tissue.  We have 
shown previously in 2.0 and 4.0 that when subjected to cyclic mechanical stretch EEECT and 
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MDSC-3DGB responds by increasing cellular proliferation, not hypertrophy, and contractile 
function; specifically, that mechanical stretch positively regulates CM proliferation, but not non-
CM proliferation(20, 120).  However, few studies have been devoted to understanding the role of 
the mechanical environment on CM induction from progenitor/stem cells(121-123).  Understanding 
the role of mechanical forces on CM induction is essential because there is clear evidence that 
cardiac cells within 3-dimensional (3D) cultured tissues display distinct features that are more 
representative of native tissues(20-22) that do not occur in 2D culture(23, 24), including increased 
contractility and mechanical properties(36-38, 74, 178, 206). 
We have shown in 4.0 that skeletal muscle-derived stem cells differentiate into cells with 
an immature functioning CM phenotype within a three-dimensional engineered tissue construct 
(MDSC-3DGB)(209).  MDSC-3DGB expressed cardiac specific genes and proteins, and 
contractile force and intracellular calcium ion transients similar to engineered cardiac tissue from 
native cardiac cells.  However, only approximately 20% of these cells differentiate into CMs and 
they are not evenly distributed without the construct.  MDSC-3DGB generated force that was 
approximately 10% of the force generated by EFCT.   Most tissue engineered cardiac constructs 
generate less than 15% of the developed stress of natural isolated myocardial trabeculae(13, 20, 120, 
207-209).  Thus a way to improve the number of CMs within MDSC-3DGB as well as the force is 
necessary.  We will use MDSC-3DGB as a model to analyze mechanically driven stem cell 
derived CM differentiation with the hypothesis being that as MDSC-3DGB development 
proceeds, MDSC-derived CM induction, maturation, and contractile function will increase with 
the rates dependent upon the location within MDSC-3DGB via MDSC morphology changes: 
evidenced by cell size, shape, and orientation changes due to the construct strain variations. 
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5.2 METHODS 
5.2.1 MDSC-3DGB construction 
MDSCs were isolated according to 4.2.1.  GFP positive (+) and negative (-) MDSCs were 
expanded on 2D flasks and were trypsinized using a 0.05% trypsin/EDTA solution (Invitrogen).  
The cell suspension of GFP(-) to GFP(+) cells at a 5:1 ratio, respectively, was cultured on a 
100mm-dimeter suspension culture dish (Corning, Lowell, MA) for 24 hours at 37°C using a 
gyrating shaker (50 rotations/min) to form 50 to 70µm diameter MDSC aggregates (MDSC-
aggregate, 330-350 cells/aggregate) under standard MDSC growth medium. Acid-soluble rat tail 
collagen type-I solution (pH 3, Sigma, St. Louis, MO, USA) was neutralized with alkali buffer 
(0.2 M NaHCO3, 0.2 M HEPES, 0.1 M NaOH) on ice. Matrigel (13% of total volume, BD 
biosciences) was then added and the cell suspension and matrix solution mixed to reach a final 
collagen type-I concentration of 0.67 mg/mL.  Approximately 200μL of the cell/matrix mixture 
was poured into the 20mm long x 2mm wide cylindrical cast of a Flexcell Tissue Train collagen 
type-I coated silicone membrane culture plate (FX4000TT, Flexcell International, Hillsborough, 
NC) and incubated for 120 minutes (37°C, 5% CO2)(20) to form a cylindrical MDSC-3DGB. Each 
MDSC-3DGB was cultured in a 5% FBS containing growth medium. 
5.2.2 3D Mechanical strain mapping  
15 µm diameter red fluorescent polymer microspheres (Thermo Scientific, Fremont, CA) 
were mixed with the cell suspension and incorporated within MDSC-3DGBs.  Triangular arrays 
of microspheres were tracked throughout the construct and over development.  The microsphere 
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3D (x, y, z) orientation was determined by capturing digital images of the x-y plane at various 
positions on the x-z plane of a construct (Figure 5-1) using a standard laser confocal microscopy 
system (Leica SP5, Leica Microsystems, Mannheim, Germany) and post-processing using 
custom made MatLAB code (Appendix A).  3D image correlation was performed step-wise, i.e. 
between the nth and (n+1)th developmental day end-point image stacks, and the resulting 
displacement vectors of each microsphere triplicate were determined and differentiated directly 
to give the strain map.  MDSC-3DGB strain variations were quantified temporally, over 
development at culture days 1 (the day after tissue construction), 3, 5, 7, and 9, and spatially, the 
construct constrained ends (END) and the unconstrained middle (MID)) for n=8 constructs.  
MDSC-3DGB-END is defined as the 4 mm from the edge of the Tissue Train culture plate 
anchors.  The MDSC-3DGB-MID is defined beginning from 5.5 mm from the edge of the Tissue 
Train culture plate anchor and extending 4 mm.  
 
Figure 5-1. 3D mechanical strain mapping schematic.  
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5.2.3 Analysis of cell shape, size, and orientation 
5.2.3.1 Cell shape 
To determine cell shape, the cell geometry will be approximated from the images by 
segmentation of the GFP (+) cells within the chimeric construct (using custom made MatLAB 
software, Appendix A). Briefly, the extracted green color channel from the RGB images was 
thresholded and binarised. A MatLAB algorithm was employed to generate a 3D (x, y, z) 
orientation for each cell by adding the images together and the GFP (+) cell shape was 
characterized by its eccentricity using the following equation where the 
eccentric ratio (ER) is defined as the cell minor axis over the major axis. Values of eccentricity 
range from 0 to 1 with 0 being a perfect circle and 1 an extremely stretched ellipse. 
5.2.3.2 Cell size 
To analyze cell size, in addition to the above calculation, 3D volume rendering from the 
segmented cell shape was calculated to determine cell size. Briefly, the individual (x, y, z) pixel 
coordinates for each cell was converted into a volume (µm3) based on the image scale using a 
custom made MatLAB program (Appendix A). 
5.2.3.3  Cell orientation 
To determine cell orientation, principle component analysis (PCA) was employed using 
the cell shape data. The orientation was quantified by determining each segment vector length 
and the angle from the three principle cell directions to the sample coordinate axes using a 
custom made MatLAB program (Appendix A).  
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5.2.4 Determination of MDSC-derived CM differentiation within MDSC-3DGB 
MDSC-3DGB CM differentiation was quantified over development at time points 
between culture day 1 (the day after tissue construction) and culture day 9 at 48 hour intervals to 
determine the phenotypic state of the MDSC-CM within each construct region (END or MID). 
To determine MDSC-derived CMs combined histology and western blot analysis was assessed.  
5.2.4.1 Histological Assessment 
 
MDSC-3DGB-END and MDSC-3DGB-MID samples were fixed with 4% 
paraformaldehyde/PBS for 15 minutes and embedded in the 13% polyacrylamide gel. 150μm 
thick sections were made using a vibratory microtome (Vibratome-1000, Vibrotome.com)(20).  
Sections were permeabilized with 0.1% Triton X-100 for 30 and stained for mouse monoclonal 
anti-cTn-T (Abcam), cTn-I (Abcam), Cx-43 (Abcam), anti-phospho-S10 Histone H3 (Upstate 
cell signaling solutions, Temecula, CA), or monoclonal skeletal fast myosin heavy chain (sk-
fMHC) (Sigma, St. Louis, MO) primary antibodies and Alexa Fluor 647 or Alexa Fluor 594 
secondary antibodies (Invitrogen).  We reconstructed 3D projection images from stacks of z-axis 
optical scans using a standard laser confocal microscopy system (FV1000, Olympus, Tokyo, 
Japan) and Scion Image software (Scion Corp, MD)(20).  The composite 3D projection images 
were further processed using Adobe Photoshop software (Adobe, San Jose, CA).  Total cell 
number per region (END vs. MID) was calculated as [DAPI (+) nuclei].   CM cell ratio (%) per 
region was calculated by [Cardiac troponin-T expression area] / [DAPI (+) expression area] (%). 
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5.2.4.2 Western Blot analysis  
Whole cell lysates were prepared from MDSC-3DGB tissue (n=9) at each developmental 
day (1, 3, 5, 7, and 9) pooled populations, and separated by SDS-PAGE (10% separating gel, 
Bio-Rad Laboratories). Immunoblotting was carried out using routine protocols. Each lane 
contained 20µg of total protein. Mouse monoclonal β-actin antibody (Abcam, Cambridge, MA), 
mouse monoclonal cardiac troponin-T (cTn-T, Abcam), mouse monoclonal anti-connexin-43 
(Cx-43, Abcam), mouse monoclonal cardiac troponin-I (cTn-I, Abcam), anti-phospho-S10 
Histone H3 (Upstate cell signaling solutions, Temecula, CA), and monoclonal skeletal fast 
myosin heavy chain (sk-fMHC) (Sigma, St. Louis, MO) were visualized with IR-Dye 800 or IR-
680 donkey anti-mouse secondary antibody (Rockland Immunochemicals, Gilbertsville, PA, 
USA).  All proteins were visualized using an infrared western blot imaging system (Odyssey, LI-
COR Biosciences Lincoln, NE, USA).  Immunoblots were performed in triplicate and quantified 
using densitometry and an expression ratio was calculated (Odyssey, LI-COR Biosciences 
Lincoln, NE, USA). 
5.2.5 Mechanical testing 
The passive force of MDSC-3DGB END and MDSC-3DGB MID (n=6) was measured as 
previously described(20).  In brief, each construct was cut into its respective regions (END and 
MID) and each region was then transferred from the Flexcell culture dish to the perfusion 
chamber of the muscle testing station containing a cold (25oC) high potassium calcium free 
Ringer solution composed of (in mM): 82 NaCl, 60 KCl, 10 Trizma-HCl, 10 Trizma-base, 11.0 
glucose and gassed with 95% O2 /5% CO2 (pH 7.4).  One end of the construct was attached to a 
force transducer (model 403A, Aurora Scientific, Ontario, Canada) and the other end to a length 
 105 
controller mounted on a micromanipulator using 10-0 mono-filament nylon sutures.  The buffer 
within the perfusion chamber (1.5mL total chamber volume) was then replaced with a warmed 
Ringer solution buffer (37oC, containing 2mM Ca2+) and perfused at a rate of 1 mL/min.  The 
longitudinal length of the construct was increased in 5% increments up to a 15% elongation from 
original length (L0.15).  The external diameters of the construct were recorded at each stretch 
increment using a digital video microscopy system (Model KPD-50, Hitachi, Japan, and Scion 
Image Software with a CG-7 frame-grabber board, Scion Corp.). 
5.2.6 Statistical analysis  
Data are expressed as mean ± SE.  One-factor analysis of variance (ANOVA) was used to 
compare the protein analysis among experimental groups.  Two-factor ANOVA was performed 
to compare the spatial and temporal strain relations among experimental groups.  Two-factor 
repeated ANOVA was performed to compare the passive stress-strain relations among 
experimental groups.  We performed a Tukey post-hoc test to determine individual differences 
between experimental groups.  Statistical significance was defined by a value of P<0.05.  All 
calculations were performed using SigmaStat (Systat Software Inc, Point Richmond, CA, USA). 
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5.3 RESULTS 
5.3.1 Cell morphology 
MatLAB assisted post-processing of time-lapse confocal imaging allowed us to follow 
the behaviors of many GFP (+) cells within MDSC-3DGB.  Morphogenetic deformations result 
from variation in the speed or direction of cell trajectories that change the relative positions of 
cells(210).  To quantify deformations of a single cell over time, we followed a cell within a 
microsphere domain.  The domain was defined by a central microsphere triplicate and a small 
number of microspheres neighboring all sides of the cell that were found in every image at every 
time point.  The intrinsic cell morphology changes were determined by: 1) cell shape change; 
defined as eccentricity; 2) cell size: defined as volume changes; and 3) cell orientation changes.  
We estimated cell shape and size changes from traced cell outlines based on their best-fit 
ellipses.  The best fit ellipses’ principle axes relative to the construct coordinate axes were then 
used to determine cell orientation changes.  
The cells within MDSC-3DGB were randomly oriented at culture day 1 at both the 
construct end (END) and middle (MID). The cells expanded and were oriented along the 
construct longitudinal axis by culture day 3 at both the END and MID and this orientation 
persisted throughout culture (Figure 5-2, Table 5-1).  
 107 
 Figure 5-2. MDSC-3DGB cell orientation over culture.  (A) Image of culture day 7 MDSC-3DGB to indicate 
direction of orientation scale with the longitudinal direction of the tissue equal to 90o.  (B) Rose plot of average 
MDSC-3DGB cell orientation at culture day 1 (D1) and culture day 7 (D7). Cells were oriented randomly at 
culture day 1 (D1) at both the construct END (black) and MID (blue) and in the longitudinal direction (indicated 
at 90o) of the construct at culture day 7. 
 
Table 5-1. MDSC-3DGB cell orientation over culture. Data are mean ± SE. Culture day 1 (D1) MDSC-3DGB 
cell orientation was significantly different from every other culture day. *; P<0.05 vs. D1 orientation. There was 
no statistical differences between END and MID at any culture day.   
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 The cells within MDSC-3DGB started out round at culture day 1, eccentricity E = 0.60 ± 
0.03 at the END and E = 0.62 ± 0.03 at the MID with no significant differences between the 
regions.  Cells at both the END and MID become more elliptical over time, however, cells at the 
END become more elliptical by culture day 3, E = 0.88 ± 0.05 vs. E = 0.77 ± 0.04 at the MID.  
By culture day 5 cells at the END and MID are both similarly elliptical and this similarity 
continues throughout culture (Table 5-2). 
Table 5-2. MDSC-3DGB cell eccentricity change over culture. Data are mean ± SE. MDSC-3DGB END and 
MID cell eccentricity was similar at D1 but significantly different at D3. MDSC-3DGB MID cell eccentricity 
was again similar to END eccentricity by D5 and continued to be similar throughout the rest of culture. *; 
P<0.05 vs. MID eccentricity for each respective culture day.  
 
When assessing cell size changes we noted that the cells became larger and more elongated over 
time, regardless of the spatial placement (END or MID).  The cells became even larger and more 
elongated at the END compared to the MID (Figure 5-3, Table 5-3).  
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 Figure 5-3. MDSC-3DGB cell shape change over culture days 1-7. (A) A schematic illustrating the orientation of 
the MDSC-3DGB for the cell shape analysis with the x-y plane and the x-z plane represented.  (B) A representative 
cell from the construct end (END) and middle (MID) visualized at 2 different planes, the x-y plane and the x-z 
plane, at culture days 1, 3, 5, and 7 (D1-D7). Scale bar indicates 10 µm. Arrow indicates the longitudinal direction 
of the construct.  
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Table 5-3. MDSC-3DGB cell shape change over culture. Data are mean ± SE. MDSC-3DGB END cell shape was 
significantly different at every culture day whereas MID D1 and D3 shape was not significantly different. MDSC-
3DGB END cell shape was significantly different from MDSC-3DGB MID at every culture day except D1. *; 
P<0.05 vs. previous culture day volume for each respective region (END or MID).  t; P<0.05 vs. MID respective 
culture day.    
 
Cells at the END expanded over 15 fold of their original size over the culture period whereas 
cells at the MID expanded only 6 fold.  The cells at the END expanded at a steady approximately 
2 fold increase in volume every 48hrs whereas the cells at the MID were not significantly larger 
at D3 but then increase in size at a similar rate of 2 fold increase every 48hrs to the cells at the 
END by culture day 5 (Table 5-3).  Thus cell morphology in terms of cell shape and size 
changes; cell volume and eccentricity changes, is significantly different between the MDSC-
3DGB END and MID whereas cell orientation changes are not significantly different between 
the END and MID.  
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5.3.2  3D Mechanical Strain  
MatLAB assisted post-processing of time-lapse confocal imaging allowed us to follow 
the behaviors of many red fluorescent microsphere triplicates within MDSC-3DGB.  To quantify 
3D mechanical strain we followed a microsphere triplicate that was found in every image at 
every time point.  The centroid of each microsphere within the triplicate was determined and the 
segment length and angle with respect to the MDSC-3DGB coordinate axes was determined and 
a strain map generated (Figure 5-4). 
  
Figure 5-4.  Schematic of MDSC-3DGB mechanical strain calculation. (A) Image of culture day 7 MDSC-3DGB to 
indicate direction of orientation scale with the longitudinal direction of the tissue equal to 90o and the orientation of 
the MDSC-3DGB x-y plane and the x-z plane represented   Selected box indicates area where image was taken. 
Representative microsphere triplicates (yellow) followed from (B) culture day 1 to (C) culture day 3.  Lowercase 
letters represent the microsphere at D1 whereas Uppercase letters represent the microsphere at D3. Green lines 
indicate the segments that were analyzed (B-C).  (D) The segment displacements were differentiated directly to 
generate a strain map of the corresponding region. (E) The average strain magnitude and direction for the region, in 
this case D1-3 END, was determined. 
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It was observed at every time point that cells grow and populate the collagen scaffold 
regardless of whether or not microspheres were embedded.  Based on this observation, the 
degree to which the microspheres are interfering with or inhibiting cell growth is minimal.  Also, 
the stiffness of the construct with or without embedded microspheres is unchanged at multiple 
time points. Thus it can be inferred that the microspheres are not a major contributor toward 
changes in the stiffness of the engineered tissue.  There was little to no strain in the x-z plane; 
END average strain magnitude 0.02 ± 0.03 and MID average strain magnitude 0.01 ± 0.01 over 
culture, thus, we determined the average strain direction with respect to the x-y plane only.  
MDSC-3DGB END strain magnitude was similar over every time point.  MDSC-3DGB END 
principal strain direction became parallel to the longitudinal direction of the MDSC-3DGB at 
culture day 7.  MDSC-3DGB MID strain magnitude was significantly higher at D1-3 and D3-5 
vs. END but was similar at D5-7.  MDSC-3DGB MID principal strain direction became parallel 
to the longitudinal direction of the MDSC-3DGB by D5 which was significantly faster than the 
END (Table 5-4).  
Table 5-4. MDSC-3DGB mechanical strain change over culture. Data are mean ± SE. Regional mechanical 
strain was maintained at a lower value in the ENDs whereas strain at the MID started higher and decreased to 
similar levels as the ENDs by D7. Strain angle was parallel to the longitudinal direction of the MDSC-3DGB by 
D7 *; P<0.05 vs. previous culture day value for each respective region (END or MID).  t; P<0.05 vs. END 
respective culture day value. 
 
The END strain angle directions range was larger at D1-3 and D3-5 compared to MID 
strain angle directions range, but was similar by D5-7.  The mechanical strain magnitude within 
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MDSC-3DGB is lower at the END vs. MID till day 7 and this is correlated with the larger more 
elongated cells at the END vs. MID. 
 
5.3.3 Cardiomyocyte Differentiation  
As stated in 4.0 MDSC-3DGB expressed cardiac specific genes and proteins, and 
contractile force and intracellular calcium ion transients similar to engineered cardiac tissue from 
native cardiac cells. Okada et al., have shown that donor cells differentiate into both skeletal 
muscle and cardiac muscle phenotypes in vivo, sustaining recipient injured myocardial function. 
These donor cells also express skeletal muscle specific fast myosin heavy chain (sk-fMHC) 
within infarcted myocardium(76).  We have shown that some cells within MDSC-3DGB express 
skeletal muscle specific and cardiac specific genes and proteins both in vitro and in vivo. Within 
MDSC-3DGB only approximately 20% of cells differentiate into CMs and they are not evenly 
distributed without the construct.  It has been widely accepted that terminally differentiated 
mature cardiac muscle does not express proteins that are specific to skeletal muscle. However, 
studies have shown that several skeletal muscle specific proteins, such as skeletal muscle specific 
troponins or ion channels, are transiently present in the developing heart(89, 90).  Similarly, 
“cardiac” and “skeletal” excitation-contraction coupling mechanisms co-exist in the developing 
skeletal muscle with the “cardiac” type dominant in the early phases of myogenesis and the 
“skeletal” dominating in more mature muscle(91).  These studies suggest the co-existence of many 
cardiac and skeletal muscle specific proteins (MHCs, troponins, etc.) as well as excitation-
contraction coupling mechanisms within the developing tissue, but also within cultured cells, 
especially those that are considered to be immature.  Therefore, it remains to be elucidated 
whether MDSC derived sk-fMHC positive cells are terminally differentiating skeletal muscle 
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cells or potentially differentiating cardiomyocytes.  Thus, we investigated the presence of sk-
fMHC within the developing myocardium as well as MDSC-3DGB. 
5.3.3.1 Sk-fMHC presence within the developing myocardium  
  The presence of sk-fMHC within the myocardium from gestational day (GD) 13 and 20, 
neonatal day (ND) 4, post-natal day (PND) 10 or 17 (juvenile), and adult Lewis rat myocardium 
and skeletal muscle was assessed using immunohistochemical staining, western blot, and PCR 
(Detailed methods found in Appendix B).  sk-fMHC was expressed as a typical striated cardiac 
muscle pattern throughout the entire gestational day 13 (GD13) ventricular myocardium (Figure 
5-5A and 5-5B).  At this gestational day, cardiac troponin-I (cTn-I) was negative.   
 
Figure 5-5. Sk-fMHC presence within GD13 myocardium. (A) sk-fMHC expression. (B) sk-fMHC expression 
of red boxed area in panel A shown at a higher magnification. cTn-I expression was negative. Scale bars 
indicate 500 µm in A and 20µm in B. 
 
By gestational day 20 (GD20) striated sk-fMHC expression was restricted to the LV papillary 
muscle (Figure 5-6A), whereas LV myocardial wall expressed sk-fMHC without striation 
(Figure 5-6B). Cardiac troponin-I was very weakly expressed without striation.  At neonatal day 
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4 (ND4) sk-fMHC was expressed in both the LV papillary muscle (Figure 5-6C) and LV 
myocardium (Figure 5-6D), however, typical striation was completely lost in both. Cardiac 
troponin-I expression was weakly expressed without striation pattern similar to GD20.  
 
Figure 5-6. Sk-fMHC and cTn-I presence within GD20 and ND4 papillary muscle and LV myocardial wall.  
(A) sk-fMHC expression within GD20 papillary muscle (B) and LV myocardial wall. (C) sk-fMHC expression 
within ND4 papillary muscle (D) and LV myocardial wall. cTn-I expression was weakly expressed without 
striation in both GD20 and ND4 myocardium. Scale bars indicate 20 µm. 
 
By post natal day 17 (PND17), equivalent to a juvenile, the LV myocardium did not express sk-
fMHC whereas cTn-I was expressed with a typical striated pattern (Figure 5-7A). Conversely, 
PND17 skeletal muscle expressed sk-fMHC as a typical striated muscle pattern and did not 
express cTn-I (Figure 5-7B). 
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 Figure 5-7. Sk-fMHC and cTn-I presence within PND17 myocardium and skeletal muscle. (A) sk-fMHC 
expression in PND17 skeletal muscle; cTn-I expression was negative. (B) cTn-I expression within PND17 
myocardium; sk-fMHC was negative. Scale bars indicate 20 µm. 
 
Western blot analysis indicated that in the myocardium, sk-fMHC is expressed in 
decreasing amounts until PND10 (juvenile) and is not expressed in the adult myocardium, 
whereas cTn-I is expressed in increasing amounts at all developmental stages.  In skeletal 
muscle, sk-fMHC is expressed at high levels at all developmental stages while cTn-I is expressed 
in a low amount only in GD20 (Figure 5-8).  
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 Figure 5-8. Western blot analysis of developing myocardium. Lane 1: GD20; Lane 2: ND4; Lane 3: PND10; 
Lane 4: Adult. Top panel: myocardium; Bottom panel: skeletal muscle. 
 
PCR analysis indicated that sk-fMHC is expressed in the developing myocardium up to PND10, 
but is not present in the adult myocardium and cardiac α-MHC is present at all stages of 
development.  Conversely, in skeletal muscle, sk-fMHC is expressed at all developmental stages 
except for the adult myocardium and cardiac α-MHC is not present in the adult skeletal muscle 
(Figure 5-9).   
 
Figure 5-9. Gene expression of developing myocardium. Lane 1: GD13 heart; Lane 2: GD20 heart; Lane 3: 
ND4 heart; Lane 4: PND10 heart; Lane 5: Adult heart (AH); Lane 6: Adult skeletal muscle (ASkM). 
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In summary, this shows evidence for the first time that skeletal muscle specific fast myosin 
heavy chain is transiently expressed in the developing immature myocardium.  This indicates 
that the expression of skeletal muscle specific proteins does not necessitate differentiation into 
skeletal muscle, specifically that MDSC-derived sk-fMHC expressing cells can be potentially 
differentiating cardiomyocytes.  
5.3.3.2 Cardiomyocyte differentiation within MDSC-3DGB 
Histological analysis indicated that cardiac specific protein expression as well as skeletal 
fast myosin heavy chain (sk-fMHC) expression increased over culture.  Cell density was similar 
at both the END and MID at all time points.  The CM ratio (% Area based on cTn-T/DAPI 
expression) was increased at D3 and D5 at the END vs. the MID and was similar at D7 and D9 
(Table 5-5). 
Table 5.5.  CM ratio of MDSC-3DGB. CM ratio was defined as the [(area of cTn-T (+) expression / area of 
DAPI (+) expression)*100] within a confocal image. Data are mean ± SE. CM ratio was increased at the END 
vs. MID at D3 and D5 and was similar at D7,and D9. *; P<0.05 vs. END respective culture day value. 
 
 
We looked at the passive force of the MDSC-3DGB END and MID at culture days 3, 5, 7, and 9.  
At lengths greater than their resting length, muscle tissue develops tension or force.  This force is 
passive since it exists whether or not the muscle is active.  Passive force was used here as a 
measure of tissue stiffness.  A stiffer tissue will develop more force during a given amount of 
elongation.  The stiffer the tissue the steeper the slope of its stress-strain curve.  Over culture 
MDSC-3DGB becomes stiffer regardless of END or MID.  When we compare the MDSC-3DGB 
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END vs. MID at their respective culture days we find that the % increase in stress relative to the 
baseline stress (stress generated at resting length) is similar at D3, but significantly increased at 
the MID at D5, and again is similar at D7 and D9 (Figure 5-10). 
 
Figure 5-10. Passive stress-strain relation of MDSC-3DGB END and MDSC-3DGB MID. Passive stress-strain 
relations of MDSC-3DGB END (n=12) and MID (n=12) at 0 to 0.15 strains. The passive stress increased in 
parallel with increases in strain (*, Frank-Starling law). The passive stress of D5 MID at 0.1 and 0.15 strains 
was significantly increased compared to the END. (*; P<0.05 vs. MDSC-3DGB END). Data are mean ± SE. 
 
We looked at expression of cTn-T, cTn-I, Cx-43, and sk-fMHC expression at culture 
days 1-9 at 48hr intervals at the END and MID. CM proteins or sk-fMHC were not expressed at 
D1. Cx-43 was expressed at the END but not the MID at D3, but by D5 and throughout culture 
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the expression was maintained at both the END and MID.  cTn-T was expressed at the END with 
a weaker expression at the MID at D3 and was seen as a typical striated pattern at both the END 
and MID at D5 and throughout the rest of culture.  cTn-I was not expressed in either the END 
and MID until D5 and typical striations were not seen until D7 for either the END or MID. sk-
fMHC was expressed similarly at both the END and MID at D3 and D5.  A similar characteristic 
striation pattern was seen at D7 at the END and MID.  The typical striation pattern was lost at D9 
at the END but was maintained at the MID.  This CM protein expression over culture is 
summarized in Figure 5-11.  
 
Figure 5-11. Summary of CM protein and sk-fMHC expression in MDSC-3DGB END vs. MID. ; indicates start 
of expression. Colored arrows indicate continued expression.    
 
Along with the presence of expression and striation with cTn-I and sk-fMHC we also 
investigated the co-expression of these proteins based on the results of the expression of sk-
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fMHC in the developing myocardium.  At D5 we saw expression of cTn-I and sk-fMHC within 
MDSC-3DGB, however, these areas of expression rarely overlapped and striations were not seen 
in either (Figure 5-12). 
 
Figure 5-12. MDSC-3DGB D5 cTn-I and sk-fMHC expression.  There was no co-expression of cTn-I and sk-
fMHC expression at D5. 
 
At D7 we saw typical striation patterns of expression of both cTn-I and sk-fMHC within MDSC-
3DGB.  There were areas of co-expression of cTn-I and sk-fMHC, with the areas of co-
expression only ever having one protein with striations.  The areas of co-expression of both 
striated cTn-I and sk-fMHC was not seen (Figure 5-13). 
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 Figure 5-13. MDSC-3DGB D7 cTn-I and sk-fMHC expression.  Typical striation patterns were seen in both 
cTn-I (red arrows) and sk-fMHC (green arrows). There areas of co-expressed had only cTn-I or sk-fMHC 
striated expression. 
 
At D9 we still saw typical striation patterns of expression of both cTn-I and sk-fMHC within 
MDSC-3DGB.  There were areas of co-expression of cTn-I and sk-fMHC, with the areas of co-
expression having one or both proteins with striations (Figure 5-14). 
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 Figure 5-14. MDSC-3DGB D9 cTn-I and sk-fMHC expression.  Typical striation patterns were seen in both 
cTn-I (red outlined areas with red arrows) and sk-fMHC (green arrows with red outlined areas). There areas of 
co-expressed had either cTn-I or sk-fMHC striated expression or both cTn-I and sk-fMHC striated expression. 
 
Western blot analysis of MDSC-3DGB at culture days 1-9 at 48hr intervals at the END 
and MID analyzed expression of cTn-T, cTn-I, Cx-43, sk-fMHC, and phospho-Histone H3 (a 
marker of proliferation) (Figure 5-15A).  Densitometry analysis of each protein normalized to β-
actin expression demonstrated that CM specific protein expression increased with culture similar 
to the histological analysis (Figure 5-15B).  Specifically H3 expression was significantly 
decreased at the END vs. MID at D1 and D3 and significantly increased at D7 (P<0.05).  H3 
expression was similar at D5 and D9.  cTn-I was not expressed at D1 or D3 in either the END or 
MID, however expression was significantly increased at the END vs. MID at D5.  D7 and D9 
had similar expression of cTn-I. Cx-43 was not expressed at D1.  Expression was similar at D3, 
but was significantly increased at D5 END vs. MID and was similar at D7 and D9.  sk-fMHC 
expression remained low compared to the CM specific protein expression at all culture days with 
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expression being significantly decreased at D5 END vs. MID. cTn-T expression was 
significantly increased at D3 and D9 END vs. MID. 
 
Figure 5-15. Western blot analysis of MDSC-3DGB. (A) Representative western blot analysis of Lane 1: 
culture day 1 MDSC-3DGB END; Lane 2: culture day 1 MDSC-3DGB MID; Lane 3: culture day 3 MDSC-
3DGB END; Lane 4: culture day 3 MDSC-3DGB MID; Lane 5: culture day 5 MDSC-3DGB END; Lane 6: 
culture day 5 MDSC-3DGB MID; Lane 7: culture day 7 MDSC-3DGB END; Lane 8: culture day 7 MDSC-
3DGB MID; Lane 9: culture day 9 MDSC-3DGB END; Lane 10: culture day 7 MDSC-3DGB MID. (B) 
Densitometric data normalized to β-actin expression (Average Expression vs. β-actin, %). *; P<0.05 vs. END 
respective culture day normalized expression, colors correspond to each respective protein.  Each lane contains 
20 µg of protein per sample and experiments were repeated in triplicate. 
 
 125 
 125 
The combination of histological and western blot analysis show that over culture MDSCs within 
MDSC-3DGB differentiate into CMs throughout the construct.  However, this CM 
differentiation is differential with the END having faster differentiation, an increased number of 
CMs, decreased proliferation, and decreased sk-fMHC expression. On the other hand, the MID 
has increased proliferation, slower differentiation, less CMs, maintenance of sk-fMHC 
expression, and a decrease in CM specific proteins.  
MDSC-3DGB cell morphology changes, driven by mechanical strain cues, are correlated 
with CM differentiation and are dependent upon the time of MDSC-3DGB development (Figure 
5-16).  
 
Figure 5-16. MDSC-3DGB mechanical strain correlated with cell morphology and CM differentiation. MDSC-
3DGB END represented by triangles. MDSC-3DGB MID represented by squares. The colors represent different 
markers: strain magnitude (Black), CM differentiation (Blue), and Cell growth (Fold increase over previous 
culture day) (Red). 
 
The mechanical strain at the END starts low and remains low throughout culture which is 
correlated with larger more elongated cells that have an increased CM differentiation.  In 
contrast, the mechanical strain at the MID starts high and decreases to a similar level as the END 
by D7.  The initial high strain early in development is correlated with significantly increased 
proliferation, smaller cells, and less CM differentiation.  The decrease in MID strain to levels 
similar to END strain later in development is correlated to a decrease in proliferation, an increase 
in cell growth, and an increase in CM differentiation that is similar to the END. By D7, the strain 
as well as CM differentiation and cell morphology is similar between the END and MID.  
5.4 DISCUSSION  
Mechanical strain has been shown to reprogram gene expressions, increase protein 
synthesis, and trigger adaptive responses in muscle phenotype via the expression of contractile 
proteins within engineered cardiac tissue. Our previous study showed that MDSC-3DGB 
expressed cardiac specific genes and proteins, and contractile force and intracellular calcium ion 
transients similar to engineered cardiac tissue from native cardiac cells(209). However, the 
efficiency and directed location of this CM differentiation remain limited. The current study has 
demonstrated that spatially and temporally distributed mechanical displacements and strains can 
be mapped with micron-scale resolution in MDSC-3DGB as groups of cells begin to grow, 
proliferate, and differentiate measurably within a 3D collagen gel bioreactor.  We found that the 
MDSC-3DGB mechanical strain is correlated with cell morphology: evidenced by cell shape, 
cell size, and cell orientation, and CM differentiation which is time-dependent.  The END had 
low strain and increased cell size and CM differentiation, whereas when the MID had high strain 
compared with the END, it had increased proliferation, decreased cell size, and decreased CM 
differentiation. Later in development, when the MID had a similar strain to the END, the cell 
morphological changes, CM differentiation, and cell proliferation were similar.  
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The commitment of a particular stem cell to a particular lineage is dependent upon 
several factors, of which we focus on cell morphology: cell shape, size, and orientation, and the 
mechanical environment in this study.  The mechanical strain seen from D1-D5 within the 
MDSC-3DGB END was significantly decreased compared to the MID but by D7 the mechanical 
strain seen at the END and MID was similar.  While we only measure one facet of mechanical 
force, regional mechanical strain, other mechanical factors as well as chemical, growth factor, 
matrix, and morphogenic factors also have been shown to affect cell differentiation.  Recent 
studies have shown that the surface microenvironment in which certain stem cells grow plays a 
key role in initiating and controlling differentiation.  For example, by changing the elasticity of 
the substrate, the polymer material to which the cells adhere or the number of cells on the surface 
all influence the differentiation process(236, 237).  Studies have shown that cells on the periphery of 
a pattern are able to sense the edge or corners of the pattern and are able to influence the total 
differentiation rate of the cells within the pattern.  This pattern edge phenomenon is well known 
to influence cell division, cell cytoskeleton dynamics, and migration from patterns(238-241) and has 
recently been observed for stem cell differentiation(242).  While much is know about how soluble 
factors and adhesion receptors regulate differential gene expression, the molecular basis for how 
mechanical signaling controls gene transcription and differentiation programs is only now 
coming into focus(214).  The means by which cells integrate multiple mechanical (and soluble) 
cues to generate an appropriate response can be seen in cell shape changes.  
Tensegrity, a theory proposing that biological structures stabilize and regulate themselves 
through a balance of tensional and compressive forces, is an effective way of explaining cellular 
responses to mechanical stimuli(133, 246).  For instance, a shape change from a round to flattened 
morphology can profoundly alter the organization of the actin cytoskeleton and the assembly of 
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focal adhesions(243, 244). Similarly, when human or rabbit corneal fibroblasts were placed on 
collagen and the ECM local tension was reduced, the cells responded by first rapidly contracting, 
and then re-spreading(245).  The changing substrate tension upset the tensional homeostasis of the 
cell and caused the initial contraction which began a signaling pathway conducted by the 
cytoskeleton that resulted in a reduction of internally-generated forces and a gradual re-spreading 
of the cells(246).  The cytoskeleton converts a given set of cues into a varity of outputs.  
Generalized cell deformation, via mechanical cues, has been shown to produce discrete changes 
in cellular phenotype(132, 134, 135, 137).  In this study, cells within MDSC-3DGB at D1 are round at 
both the END and MID which is accompanied by high proliferation, significantly higher at the 
MID than the END, as well as a lack of CM differentiation.  By D3 the cells at the END double 
in volume and elongate adopting a spread shape.  At this time the large elongated cells also start 
to express CM specific proteins.  In contrast, cells at the MID do not significantly increase in 
size and maintain significantly increased proliferation and have less CM specific protein 
expression compared to the END. A review by Cohen et al. explores how mechanical forces are 
integrated through cell shape and the actin cytoskeleton and transduced into biochemical signals 
that target the activity and expression of transcription factors and chromatin remodeling enzymes 
directly involved in gene expression(214).  Thus a change in cell shape as directed by the temporal 
and spatial differences in mechanical strain can be sufficient to cause lineage specification, 
specifically to differentially increase CM differentiation within MDSC-3DGB.   
At D5 and D7 the cells at the MID and END have similar eccentricity and increase in cell 
size, however at D5 there are still significant differences observed in CM differentiation, 
observations that were not seen at D7.  Of the markers of interest noted above, only cell 
orientation had no significant differences between the END or MID at any time point.  Within 
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MDSC-3DGB the cells quickly orient, by D3, parallel to the longitudinal direction of the 
construct regardless of the cell placement within the END or MID. A study by Costa et al.(211) 
suggests cells align parallel to a local free boundary rather than to local lines of tension.  The 
geometrical constraints of the MDSC-3DGB could be the determining factor in the cell 
orientation within MDSC-3DGB, regardless of the mechanical strain differences within the END 
and MID.  However, mechanical strain plays a role in stem cells differentiation and proliferation, 
and a study has shown that the effects of the strain were dependent on the orientation with 
respect to the strain axis(212).  Within MDSC-3DGB, the principle strain direction becomes 
parallel to the longitudinal axis of the construct by D3-5 at the MID and by D5-7 at the END.  At 
these times, the CM differentiation is significantly increasing in both expression and maturity, as 
evidenced by cTn-I expression and increased striations.  Thus while the construct cylindrical 
geometry might dictate the cell orientation, the orientation parallel to the principle strain 
direction might be necessary for the CM specific lineage specification.   
In 4.0 we found that the MDSC-derived CMs within MDSC-3DGB are similar to 
immature native CMs(209).  However, it is also known that several skeletal muscle specific 
proteins, such as skeletal muscle specific troponins or ion channels, are transiently present in the 
developing heart(89-91).  This is important to note because of the cell source used here and the 
presence of skeletal muscle specific and cardiac specific genes and proteins within MDSC-
3DGB both in vitro and in vivo.  When we looked at the presence of a specific skeletal muscle 
specific protein, fast skeletal myosin heavy chain (sk-fMHC), in the developing immature 
myocardium we found transient expression.  As development progresses, sk-fMHC became 
negative and the myocardium then expressed cardiac specific troponin-I.  Fast skeletal muscle is 
more prone to fatigue, utilizes ATP quickly, and uses less oxygen, whereas cardiac muscle is 
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made to resist fatigue and generally needs more oxygen.  Thus, from a physiological standpoint, 
the benefit of sk-fMHC in the immature developing fetal heart may be that the shorter, quicker 
contraction allows blood ejection throughout the system necessary for adapting rapid fetal 
growth prior to the establishment of coronary artery circulation and conduction system.  As the 
myocardium matures, the contraction pattern shifts towards less rapid but continuous contraction 
under an aerobic condition, when the coronary circulation and conduction system are developed 
and sk-fMHC expression decreases. Continued expression of sk-fMHC would be detrimental 
because if fast muscle tissue were to exist in the post-natal and adult heart, it would fatigue much 
faster, leading to higher levels of cardiac failure.  Thus, the presence of sk-fMHC and co-
expression with cTn-I within MDSC-3DGB is consistent with an immature CM phenotype.  
 CM specific protein cTn-I and sk-fMHC expression increases, albeit variably, with 
development of MDSC-3DGB.  Of interest the patterns of expression, determined by striation, 
also differ with respect to developmental stage. In striated muscle, like cardiac or skeletal 
muscle, contractile properties result from a strictly defined organization of functional proteins 
within the sarcomere.  The presence of striated patterns of expression of the cardiac and skeletal 
muscle specific proteins: cTn-T, cTn-I, and sk-fMHC, evaluated here are evidence of functional 
maturation of the contractile structures.  We first see diffuse cTn-T expression at D3 and striated 
structure at D5 which is maintained throughout culture. sk-fMHC is diffusely expressed at D3 
and cTn-I at D5.  Both acquire a striated pattern by D7.  This is consistent with previous studies 
of muscle development.  However, we see noted differences in the co-expression patterns of sk-
fMHC and cTn-I from D5: beginning with diffuse non-overlapping patterns of expression at D5, 
to co-expression of one diffuse and one striated pattern of expression at D7, to co-expression of 
both striated patterns of expression at D9.  The results that sk-fMHC is transiently expressed in 
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the developing immature myocardium is the first to provide evidence of non-cardiac specific 
MHCs in the developing heart, and to date there have been no studies on the developmental 
changes in expression patterns of these proteins.  Thus, further studies are necessary. 
Although the current study clearly shows that the mechanical strain directed cell 
morphology changes are correlated with CM differentiation within MDSC-3DGB, the 
mechanisms by which mechanical strain affects MDSC-derived CM differentiation within 
MDSC-3DGB are not yet clear.  Some key issues remain to be settled, including: the mechanism 
by which MDSCs sense mechanical strain, the signal transduction pathways active in MDSCs, 
the interaction of different signaling pathways in modulating expression of mechano-responsive 
genes, the crosstalk between mechanical and chemical signaling pathways in MDSCs, and 
investigation of the molecular mechanisms by which signaling pathways activated or repressed 
by mechanical strain lead to the CM differentiation of the MDSC-3DGB.  
5.4.1 Limitations 
The limitations noted in 4.4.1 apply here.  
There are also several more limitations to the current study that need to be discussed. 
First, the method used to determine 3D MDSC-3DGB regional mechanical strain was developed 
independently for this study. We used several methods to verify and validate the robustness of 
calculations and confidence of results, including use of commercially available elastic 
registration analysis from ImageJ (Appendix A.1) as well as analysis by hand.  Even though all 
method results were not statistically different and we are confident of the quantitative values 
generated in this study, the qualitative comparisons of MDSC-3DGB END and MID provide 
results significant enough for similar conclusions to be drawn.  Additionally the imaging method 
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was limited by the spatial resolution of the camera and the Flexcell plate geometry necessary for 
construction of the MDSC-3DGB.  Additionally while image stacks were taken and the 3D 
orientation of the microspheres analyzed, the sample itself was not guaranteed to be perfectly 
planar to the camera, indeed the planar position of the MDSC-3DGB changed from image time-
point to image time-point.  Preliminary data and previous studies have indicated that the 
movement in the x-z plane was minimal, which was consistent with the results of this study. 
Second, we only report average MDSC-3DGB regional mechanical strain. These values 
may or may not be the mechanical strain all or any cells within the region see.  Our methods 
implicitly use the assumption that the region studied can be treated as homogeneous, which, of 
course, does not necessarily hold.  
Third, we show significant correlation between mechanical strain guided cell morphology 
changes and CM differentiation. However, the mechanical environment is only one of the many 
factors shown to affect cell fate changes. The chemical environment as well as cell density and 
cell-cell and cell-ECM contacts also play a role(213) and one or the other or complementary 
signals along with the mechanical cues measured here might be necessary.  The chemical 
environment as well as cell density and cell-cell and cell-ECM contacts also play a role(213) and 
one or the other or complementary signals along with the mechanical cues measured here might 
be necessary.  Cell-cell contacts, both hetero- and homotypic, have been shown to play a crucial 
role in cardiomyocyte induction from stem cells(61, 62). Similarly, the importance of the ECM on 
stem cell fate has been shown with particular emphasis on the interactions of ECM ligands with 
cell surface receptors, ECM geometry, or ECM elasticity.  The nutrient and oxygen distribution 
within MDSC-3DGB may also play a role in the cell distribution, proliferation, and 
differentiation of the construct.  MDSC-3DGB gets its oxygen and nutrient supply through 
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simple diffusion.  Oxygen tension has been shown to influence cell proliferation and 
differentiation in a number of tissues, as well as in mouse embryonic stem cells(251).  The 
distribution of oxygen and nutrients within MDSC-3DGB also influences the cell distribution 
(localized to the outer circumference of the construct) and may affect the differentiation 
independent of the mechanical strain.   Previous studies have shown that cells on the periphery of 
a pattern are able to influence the total differentiation rate of the cells (through influencing 
cytoskeletal dynamics) or proliferation rate (through influencing cell division) within a 
pattern(238-242).  Independent of the physical properties mentioned here, the stimulus-response 
decisions made by a stem cell can be further complicated temporally by systems biology(247): 
tissue-specific patterns of ligand and receptor expression(248), as well as by sequential autocrine 
and paracrine inductive loops(249) that arise as cell populations develop and adapt(250).  While we 
note no significant changes in cell density within MDSC-3DGB at all time points, we did see a 
difference in tissue stiffness at D5. This difference in tissue stiffness may play a role in the 
disparate CM differentiation seen here.  Despite the studies indicating cell shape as a read-out for 
integration of multiple applied and cell-generated mechanical forces, an interesting study by 
McBeath(137) found that cell shape alone is not sufficient to dictate lineage commitment.  Thus, 
more in-depth methods of assessing the multiple factors and pathways involved in directed cell 
differentiation would be necessary.  
In this study we note that by D9, a loss of cardiac specific protein expression at the MID. 
It remains unknown whether sustained CM differentiation or maturation from MDSCs require 
additional factors not present in the quiescent developing MDSC-3DGB. Further studies 
investigating these factors over a longer time period are necessary.  
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5.4.2 Conclusion  
In summary, our results suggest that MDSC-3DGB mechanical strain guided cell 
morphology changes: evidenced by cell shape, size, and orientation are correlated with CM 
differentiation and this is time-dependent.  This information is the first step in investigating the 
role of mechanical strain in CM lineage directed cell differentiation within a stem cell engineered 
tissue. This may be useful in providing the information necessary to generate an engineered 
tissue with a mechanical environment that can control and direct stem cell fate changes.  
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6.0  CONCLUSION 
The overall goal of this doctoral thesis was to determine the role of mechanical strain on 
CM differentiation within a 3D engineered tissue to use as a system for evaluation of strategies 
for enhancing directed CM differentiation and tissue contractile properties.  Substantial progress 
towards this goal was made by a combination of testing new strategies for monitoring differential 
CM differentiation and contractile function, such as using MDSCs in a 3D collagen gel 
bioreactor to induce CM differentiation and applying mechanical strain to determine the 
responsive cell type, and by developing new tools and methods for characterizing CM 
differentiation and cell morphology changes.  The following section summarizes the main results 
of the four research-focused chapters of the thesis. A final section provides suggestions for future 
research building on this work. 
6.1 THESIS SUMMARY  
The first half of the thesis, chapters 2 and 3, explored in depth engineered cardiac tissue 
from native ventricular cells.  In chapter 2, we investigated which cell type, CM or non-CMs, 
was the responsive cell population in an accepted response of increased proliferation and 
contractile properties to mechanical stretch and investigated one possible signaling pathway that 
could be involved in the stretch mediated responses observed.  By isolating CMs from non-CMs 
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histologically in a control and mechanically stretched EEECT, we reported that while both CMs 
and non-CMs proliferate within EEECT, CMs, but not non-CMs, increase proliferation in 
response to cyclic mechanical stretch stimulation. Analysis of p38MAPK activation in response 
to mechanical stretch demonstrated significant increases in phosphorylation, which preceded 
increases in EEECT contractile force and CM proliferation.  In contrast, the inhibition of 
p38MAPK significantly decreased CM proliferation activity and the negative effects of 
p38MAPK inhibition overrode the positive cyclic mechanical stretch stimulation effects on 
EEECT contractile function and CM proliferation. The significant increase in cellular 
proliferation in the CM population only within EEECT is an important finding because it 
provides a method of targeting a single cell population with a global non-specific perturbation 
within a fully connected tissue, without affecting the non-CM population or the tissue 
architecture.   
In chapter 3, we investigated the implantation of EFCT and ENCT on a post-infarcted 
myocardium.  We found that the proliferating fetal CMs within EFCT graft maintain CM 
proliferative activity in vivo, survive as a donor myocardial tissue, and contribute to the cardiac 
functional recovery of injured recipient myocardium whereas ENCT maintains a significantly 
lower proliferation activity and functional recovery of the injured myocardium.  These results 
suggest that the maintenance of high proliferation activity is a factor that contributes to increased 
functional recovery of the injured myocardium. 
In the second half of this thesis we investigated the use of a stem cell population, 
specifically skeletal muscle derived stem cells (MDSCs), within the 3D collagen gel bioreactor 
used to generate EEECT or EFCT.   In chapter 4, we showed that the 3D environmental cues 
provided by MDSC-aggregate formation and 3D collagen gel bioreactor (3DGB) culture are 
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complementary and sufficient to trigger differentiation of cells with an immature functioning CM 
phenotype in vitro.  We also investigated the MDSC-3DGB response to mechanical stretch and 
implantation on an injured myocardium to see if the MDSC-3DGB immature CM phenotype 
would respond similarly to chapter 2’s EEECT and 3’s EFCT.  MDSC-3DGB culture responded 
to mechanical stretch with increased CM, not non-CM, proliferation and increased contractile 
properties similar to EEECT.  MDSC-3DGB could be implanted on the injured myocardium, 
survive, and improve contractile function post injury, similar to EFCT.  The magnitude of 
contractile force, increased CM proliferation, and improvement of recipient injured myocardial 
function is significantly less in MDSC-3DGB than EEECT and EFCT respectively, however the 
CM fraction, ~20% in MDSC-3DGB as opposed to the 60-70% CM fraction within EEECT and 
EFCT, could be responsible.  These results are important because although the MDSC-3DGB 
has incomplete CM differentiation compared with engineered cardiac tissue from native 
ventricular cells, it still behaves similarly.   
The distribution of the CM fraction was not uniform within MDSC-3DGB, suggesting 
that the CM differentiation in response to the 3DGB environment is a spatial- and temporal-
dependent process, which may be characterized more fully with a system that encompasses 
longitudinal and regional study of the tissue formation.   
Such a measurement system was developed in chapter 5 of this thesis. Custom generated 
MatLAB code for post-processing of live time-lapse confocal imaging was generated for the 
longitudinal and regional study of MDSC-3DGB.  Mechanical strain directed cell morphology 
changes: evidenced by cell shape, size, and orientation changes were significant factors in 
directing CM differentiation from MDSCs within MDSC-3DGB.        
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In summary we have investigated the role of mechanical forces in CM proliferation 
within an engineered cardiac tissue from native ventricular cells.  Additionally we have used a 
3D engineered tissue culture system to induce CM differentiation from skeletal muscle derived 
stem cells. Lastly, we have developed a system to quantify the longitudinal and regional 
differences to determine the role of mechanical forces in directed CM differentiation within a 3D 
engineered tissue.  
6.2 FUTURE DIRECTIONS  
While cell shape appears to play a major role in governing the response of stem cells to 
mechanical forces, it is not yet clear whether this, along with other factors, converge on a single 
mechano-sensitive cellular compartment or molecule, and a mechano-transduction pathway 
connecting tension to mechano-responsive transcriptional machinery remains elusive(214).  Focal 
adhesions, which are areas that attach the actin cytoskeleton to the matrix bound integrins, likely 
factor into tension-dependent mechano-transduction. Cell generated traction forces are 
transmitted to the extracellular matrix at focal adhesions(215-217), which implies the development 
of stress within these structures, and these stresses regulate the assembly/disassembly of focal 
adhesions(215, 218-221). Focal adhesions are also molecular signaling hubs implicated in the 
recruitment and activation of key mechano-sensitive kinases such as FAK, Src, and ERK(222-225).  
Thus, investigation into the role of focal adhesions in the differentially directed CM 
differentiation via mechanically directed cell morphological changes seen in MDSC-3DGB 
would be of particular interest.   
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In addition to focal adhesions, MAPK signaling and primary cilia can also play a role in 
mechano-transduction.  MAPK signaling is distinctive in that it can be activated in response to 
numerous types of applied forces(226), sits at a cross-roads between soluble factor and adhesion 
signaling (like RhoA(227, 228)), and regulates differentiation of stem cells(229, 230).  p38MAPK 
signaling has already been shown to play a role in CM specific proliferation in EEECT.  Since 
MDSC-3DGB responds similarly to mechanical stretch, it will be interesting to investigate 
whether the signaling pathways activated by mechanical stretch in EEECT are also similar. 
Primary cilia develop from and are anchored to the centriole, the cell’s microtubule 
organizing center.  They have been shown to act as mechano-sensors in a number of cell types 
including: osteocytes, chondrocytes, and kidney cells.  Primary cilia have also been shown to 
play a key role in development in a number of cellular biological processes including the 
regulation of proliferation, differentiation, and cell cycle progression.  They have also been 
shown to play key roles in controlling the Hedgehog signaling pathway(231, 232), one of the major 
determinants of embryonic patterning(233, 234).  Given the presence of primary cilia in cultured 
stem cells including MDSCs and MDSCs within MDSC-3DGB (unpublished data) and 
embryonic stem cells(235), exploring the role of primary cilia in mechanical regulation of 
differentiation, perhaps by altered Hedgehog signaling, represents an exciting future direction for 
stem cell research.  
As of yet, no stem-cell specific mechano-sensory mechanisms have been proposed, and 
any number of aforementioned mechanisms may contribute to mechanical control of stem cell 
differentiation. Thus, MDSC-3DGB as well as the quantitative methods used to measure the 
temporal and spatial variations in MDSC-3DGB directed CM differentiation is an ideal in vitro 
platform to investigate these questions in depth.     . 
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APPENDIX A 
ALGORITHM FOR MORPHOLOGICAL ASSESSMENT AND 3D STRAIN MAPPING 
See section 5.2 for explanation of use of this code. The code is implemented by typing 
CellAnalysis at the MatLAB command prompt. The functions: makefilelist.m, process2d.m, and 
CellBrowser.m are called and a GUI to generate a 3D plot of images in which each component is 
a different color and where one can export component orientation, major axis, minor axis, 
volume, and centroid parameters, etc. to an excel spreadsheet for statistical analysis is created. 
CellAnalysis.m 
function [  ] = CellAnalysis( input_args ) 
%----------------------------------------------------- 
% Cell shape, size, orientation, alignment analaysis 
% Kelly clause with help from Peter Backeris 
% last modified: 01/09 
% Master File for executing cell morphology or microsphere analysis 
%----------------------------------------------------- 
 
%------------------------------------------------------------- 
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% Code to generate list of 2D images to be analyzed as a stack 
%------------------------------------------------------------- 
 
A = makefilelist(); 
 
% --------------------------------------------------------------- 
% Code to generate the watershed segmentation 
% and to make a new file list of the generated segmented images 
% --------------------------------------------------------------- 
 
B = process2d(A); 
 
%------------------------------------------------------------------------------------ 
% code to call GUI to generate 3D plot of images in which each component is a  
% different color and where one can export component properties to an excel spreadsheet 
%for statistical analysis 
%------------------------------------------------------------------------------------ 
 
CellBrowser(B); 
 
end 
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makefilelist.m 
function [ filenamelist ] = makefilelist(  ) 
%----------------------------------------------------- 
% Code to generate list of 2D images to be analyzed as a stack 
% Image files should be 8 bit greyscale Tiff (*.tif) images and should be named with a 
%increasing number at the end.  
% the filename should be something like ‘IMG0’ or  ‘IMG1’ plus the number at the end 
%scaling from ‘0001’ to  ‘9999’.  
% The full name would be for the first file ‘IMG10001.tif’.  
%---------------------------------------------------------------------------- 
prompt = {'Enter number of first image (i.e. "3" for IMG10003):','Enter number of last 
image (i.e. "100" for IMG10100):'}; 
dlg_title = 'Input images to be used for the analysis'; 
num_lines= 1; 
def     = {'1','100'}; 
answer = inputdlg(prompt,dlg_title,num_lines,def); 
F2 = str2num(cell2mat(answer(1,1))); 
F = str2num(cell2mat(answer(2,1))); 
 
% Choose first name of images 
G = 'PIC1'; 
prompt = {'Enter Image Name (first 4 letters):'}; 
dlg_title = 'Input images to be used for the analysis'; 
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num_lines= 1; 
def     = {'IMG1'}; 
answer = inputdlg(prompt,dlg_title,num_lines,def); 
G = cell2mat(answer(1,1)); 
 
E='.tif'; 
 
namelist(1:F-F2+1,1)=G(1,1); 
namelist(1:F-F2+1,2)=G(1,2); 
namelist(1:F-F2+1,3)=G(1,3); 
namelist(1:F-F2+1,4)=G(1,4); 
 
% create the numberlist 
num=((10000+F2):(10000+F))'; 
   
% Creation of final results 
filenamelist=namelist; 
str=num2str(num); 
filenamelist(:,5:8)=str(:,2:5); 
 
filenamelist(1:F-F2+1,9)=E(1,1); 
filenamelist(1:F-F2+1,10)=E(1,2); 
filenamelist(1:F-F2+1,11)=E(1,3); 
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filenamelist(1:F-F2+1,12)=E(1,4); 
 
% Save results 
[FileNameBase,PathNameBase] = uiputfile('filenamelist.mat','Save as "filenamelist" in 
image directory (recommended)'); 
cd(PathNameBase) 
save(FileNameBase,'filenamelist'); 
 
end 
 
process2d.m 
function [lstack] = process2d( filenamelist ) 
 
% --------------------------------------------------------------- 
% Code to generate the watershed segmentation 
% and to make a new file list of the generated segmented images 
% --------------------------------------------------------------- 
 
[r,c]=size(filenamelist);  
 
for i = 1:r           % run through all images    
   I1 =  imresize(imread(filenamelist(i,:)),.5); 
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     I2 = im2bw(I1, graythresh(I1)); 
    I2 = bwareaopen(I2, 20); 
    I2 = imfill(I2,'holes'); 
     filename = filenamelist(i,:); 
    newname = strrep(filename,'.tif', 'a.tif'); 
     imwrite(I2, newname); 
    segfilenamelist(i, :) = newname; 
    stack(:,:,i) = I2; 
     
end 
 
lstack = bwlabeln(stack); 
maxi = max(max(max(lstack))); 
   volumes = regionprops(lstack, 'Area'); 
   [x1,y1] = size(I2); 
   for x = 1:maxi 
       a1 = volumes(x).Area; 
       if (a1>20000) 
       lstack(find(lstack==x))=0; 
       end  
       if (a1<100) 
        lstack(find(lstack==x))=0; 
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            end 
   end 
  lstack = bwlabeln(lstack);  
 
  %{ 
  [FileNameSeg,PathNameSeg] = uiputfile('SegFilenameList.mat','Save as 
"SegFilenameList" in image directory (recommended)'); 
cd(PathNameSeg) 
save(FileNameSeg,'segfilenamelist') 
  %} 
 
CellBrowser.m 
 function varargout = CellBrowser(varargin) 
% CELLBROWSER M-file for CellBrowser.fig 
%      CELLBROWSER, by itself, creates a new CELLBROWSER or raises the 
%      existing singleton*. 
% 
%      H = CELLBROWSER returns the handle to a new CELLBROWSER or the  
%      handle to the existing singleton*. 
% 
%      CELLBROWSER('CALLBACK',hObject,eventData,handles,...) calls the  
%local function named CALLBACK in CELLBROWSER.M with the given  
%input arguments. 
% 
%      CELLBROWSER('Property','Value',...) creates a new CELLBROWSER or  
%      raises the existing singleton*.  Starting from the left,  
%property value pairs are applied to the GUI before %CellBrowser_OpeningFcn 
gets called.  An unrecognized property %name or invalid value makes property 
application stop.  All %inputs are passed to CellBrowser_OpeningFcn via 
varargin. 
% 
%      *See GUI Options on GUIDE's Tools menu.  Choose "GUI allows only  
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%one instance to run (singleton)". 
% 
% See also: GUIDE, GUIDATA, GUIHANDLES 
 
% Edit the above text to modify the response to help CellBrowser 
 
% Last Modified by GUIDE v2.5 08-Feb-2009 00:47:41 
 
% Begin initialization code - DO NOT EDIT 
gui_Singleton = 1; 
gui_State = struct('gui_Name',       mfilename, ... 
                   'gui_Singleton',  gui_Singleton, ... 
                   'gui_OpeningFcn', @CellBrowser_OpeningFcn, ... 
                   'gui_OutputFcn',  @CellBrowser_OutputFcn, ... 
                   'gui_LayoutFcn',  [] , ... 
                   'gui_Callback',   []); 
if nargin && ischar(varargin{1}) 
    gui_State.gui_Callback = str2func(varargin{1}); 
end 
 
if nargout 
    [varargout{1:nargout}] = gui_mainfcn(gui_State, varargin{:}); 
else 
    gui_mainfcn(gui_State, varargin{:}); 
end 
% End initialization code - DO NOT EDIT 
 
 
% --- Executes just before CellBrowser is made visible. 
function CellBrowser_OpeningFcn(hObject, eventdata, handles, varargin) 
% This function has no output args, see OutputFcn. 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
% varargin   command line arguments to CellBrowser (see VARARGIN) 
stack = varargin{1}; 
handles.multselect=0; 
 
%retrieve centroid information 
cellinfo = regionprops(stack,'Centroid'); 
 
%store cell volume information 
handles.Volume = regionprops(stack, 'Area'); 
 
%find number of cells 
maxi = max(max(max(stack))); 
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%store centroid z parameter for each cell to nearest integer 
for k = 1:maxi 
zstack(k) = round(cellinfo(k).Centroid(3)); 
end 
 
%create array to store height of each cell 
handles.zheight = zeros(1,maxi); 
 
 
%find and store height of each cell 
z = 1:maxi; 
for i = 1:size(stack,3) 
    h = ismember(z,stack(:,:,i)); 
    handles.zheight = handles.zheight + h; 
   
   
     
end 
 
%get bounds of planes containing cell centroids (may not be some of the end 
%planes) 
 
maxm =max(zstack); 
minm = min(zstack); 
 
 
 
 
 
%find 2d cell information based on the cell's centroid z parameter 
for m = minm:maxm 
    temp = stack(:,:,m); 
    x = find(zstack==m); 
    temp1 = ismember(temp,x); 
    temp(temp1==0) = 0; 
     
    R = regionprops(temp, 'MinorAxisLength', 'MajorAxisLength','Orientation', 
'Eccentricity'); 
     for n = 1:size(x,2) 
         
       handles.celldata(x(n),1) = R(x(n),1); 
     end 
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end 
 
%zheight will now hold ellipsoid volume 
for p = 1:maxi 
     
    handles.zheight(p) = (1/3)*3.14*(handles.celldata(p).MajorAxisLength) 
*(handles.celldata(p).MinorAxisLength)*handles.zheight(p); 
end 
 
 
%color each cell randomly 
rgb = rand(maxi,3); 
handles.prev_cell = 0; 
 
 
%plot cell patch objects 
for i = 1:maxi 
     
p = patch(isosurface(stack==i, .8)); 
reducepatch(p, .3); 
set(p,'facecolor',rgb(i,:),'edgecolor','none','buttondownfcn', {@selectcell,i},  'tag', 
num2str(i)); 
 
end 
 
%set plot properties 
set(handles.axes1,'projection','perspective'); 
box on; 
 
light('position',[1,1,1]) 
light('position',[-1,-1,-1]) 
 
set(handles.axes1,'xlim',[0 512], 'ylim',[0 512]) 
zscale= .5; 
set(handles.axes1,'DataAspectRatio',[1,1,zscale]) 
 
 
 
 
 
% Choose default command line output for CellBrowser 
handles.output = hObject; 
 
% Update handles structure 
guidata(hObject, handles); 
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% UIWAIT makes CellBrowser wait for user response (see UIRESUME) 
% uiwait(handles.figure1); 
 
%executes when a cell patch object is clicked with mouse 
function selectcell(hObject, eventdata, j) 
     
    if (strcmp(get(hObject,'Selected'), 'on')) 
        set(hObject,'Selected', 'off'); 
    else 
 
    handles = guidata(gcf); 
     
    %fill in table fields with cell information 
    temp(1,1)= j; 
    temp(2,1)= handles.celldata(j).MajorAxisLength; 
    temp(3,1)= handles.celldata(j).MinorAxisLength; 
    temp(4,1)= -(handles.celldata(j).Orientation); 
    temp(5,1)= handles.celldata(j).Eccentricity; 
    temp(6,1)= handles.Volume(j).Area; 
    temp(7,1)=handles.zheight(j); 
    set(handles.uitable1, 'data', temp); 
    if (get(handles.checkbox1,'Value') == 0) 
       set(handles.prev_cell, 'Selected', 'off'); 
    end 
    set(hObject, 'Selected', 'on'); 
     
    handles.prev_cell = hObject; 
    guidata(gcf,handles); 
    end 
     
 
% --- Outputs from this function are returned to the command line. 
function varargout = CellBrowser_OutputFcn(hObject, eventdata, handles)  
% varargout  cell array for returning output args (see VARARGOUT); 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
 
% Get default command line output from handles structure 
varargout{1} = handles.output; 
  
 
 
% --- Executes on button press in checkbox1. 
function checkbox1_Callback(hObject, eventdata, handles) 
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% hObject    handle to checkbox1 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
 
% Hint: get(hObject,'Value') returns toggle state of checkbox1 
 
 
% --- Executes on button press in pushbutton2. 
function pushbutton2_Callback(hObject, eventdata, handles) 
% hObject    handle to pushbutton2 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
h = findobj('Selected', 'on'); 
sizeh = size(h); 
 
%construct table containing selected cell information 
 
if (sizeh>0) 
t = {'Cell Number', 'Major Axis Length', 'Minor Axis Length', 
'Orientation','Eccentricity', 'Pixel Volume', 'Ellips. Volume (cubic um)'}; 
    for i = 2:sizeh+1 
        t{i,1} = str2num(get(h(i-1),'tag')); 
  t{i,2} = handles.celldata(str2double(get(h(i-1),'tag'))).MajorAxisLength; 
t{i,3} = handles.celldata(str2double(get(h(i-1),'tag'))).MinorAxisLength; 
t{i,4} = handles.celldata(str2double(get(h(i-1),'tag'))).Orientation; 
t{i,5} = handles.celldata(str2double(get(h(i-1),'tag'))).Eccentricity; 
        t{i,6} = handles.Volume(str2double(get(h(i-1),'tag'))).Area; 
        t{i,7} = handles.zheight(str2double(get(h(i-1),'tag'))); 
         
    end 
    [filename,pathname] = uiputfile('cell_data','Save your cell data'); 
  
    if pathname == 0 %if the user pressed cancelled, then we exit this callback 
        return 
    end 
%construct the path name of the save location 
     saveDataName = fullfile(pathname,filename);  
 
     
    xlswrite(saveDataName, t); 
     
end    
 
 
% --- Executes on button press in pushbutton4. 
function pushbutton4_Callback(hObject, eventdata, handles) 
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% hObject    handle to pushbutton4 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
h = findobj('Selected', 'on'); 
set(h, 'Selected', 'off'); 
A.1 IMAGEJ ALGORITHM 
We also used ImageJ to verify and validate the robustness of calculations and confidence 
of results from the MatLAB code found above. This code used a commercially available ImageJ 
elastic registration plugin, bUnwarpJ, along with a macro file provided by Dr. Lance Davidson to 
make the absolute and x- and y- displacement files between two images.   
 
Macro: “MakeAbsDisp1 from Raw[1]” 
{ 
 file = File.openDialog("Select the Raw File"); 
 path = File.directory(); 
 
 bigstring = File.openAsString(file); 
 
 absdisWindow = raw2abs(bigstring, path); 
} 
 
 
 
function raw2abs(bigstring, path) 
{ 
 lines = split(bigstring, "\n"); 
 
 widstr = split(lines[0], "="); 
 heistr =  split(lines[1], "="); 
 
 width = parseInt(widstr[1]); 
 height = parseInt(heistr[1]); 
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 // real data starts at lines[4]. 
 
 newImage("rawX", "32-bit", width, height, 1); 
 selectWindow("rawX"); 
 
 for (i=4; i<4+height; i++)  
 { 
 
  pixels = split(lines[i],""); 
  for (j=1; j<width; j++) 
  { 
   x = j-1; 
   y = i-4; 
   setPixel(x, y, x - parseFloat(pixels[j-1])); 
  } 
 
 } 
 
 // *** this is the line I want to start the Y data. 
 
 newImage("rawY", "32-bit", width, height, 1); 
 selectWindow("rawY"); 
 
 for (i=6+height; i<6+(2*height); i++)  
 { 
 
  pixels = split(lines[i],""); 
  for (j=1; j<width; j++) 
  { 
   x = j-1; 
   y = i-(6+height); 
   setPixel(x, y, y - parseFloat(pixels[j-1])); 
  } 
 } 
 
 imageCalculator("Multiply create 32-bit", "rawX","rawX"); 
 imageCalculator("Multiply create 32-bit", "rawY","rawY"); 
imageCalculator("Add create 32-bit", "Result of rawX","Result of rawY"); 
 run("Square Root"); 
 rename("AbsDisp");save(path+"AbsDisp.tif"); 
 
 // 
 // close all other windows 
 // 
 
 selectWindow("rawX"); save(path+"deltaX.tif"); close(); 
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 selectWindow("rawY"); save(path+"deltaY.tif"); close(); 
 selectWindow("Result of rawX"); close(); 
 selectWindow("Result of rawY"); close(); 
 
 return "AbsDisp"; 
} 
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APPENDIX B 
SK-FMHC PRESENCE WITHIN THE DEVELOPING MYOCARDIUM: METHODS  
The presence of sk-fMHC within the myocardium from gestational day (GD) 13 and 20, neonatal 
day (ND) 4, post-natal day (PND) 10 or 17 (juvenile), and adult Lewis rat myocardium and 
skeletal muscle was assessed using immunohistochemical staining, western blot, and PCR.    
B.1 IMMUNOHISTOCHEMICAL STAINING 
Heart samples were fixed with 4% paraformaldehyde/PBS for 15 minutes and embedded 
in the 13% polyacrylamide gel. 150μm thick sections were made using a vibratory microtome 
(Vibratome-1000, Vibrotome.com)(120)  and stained for mouse monoclonal sk-fMHC (Sigma, St. 
Louis, MO, USA) and cardiac specific Troponin-I (cTn-I, Abcam, Cambridge, MA, USA) 
primary antibodies and Alexa Fluor 488 or Alexa Fluor 594 secondary antibodies (Invitrogen, 
Carlsbad, CA, USA).   
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B.2 SDS-PAGE AND IMMUNOBLOTTING 
Fresh frozen heart samples were used. Protein was extracted from pooled samples and 
immunoblotting was carried out using routine protocols. Each lane contained 20µg of total 
protein. Mouse monoclonal β-actin antibody (Abcam), mouse monoclonal cardiac troponin-I 
(cTn-I, Abcam), and mouse monoclonal sk-fMHC (Sigma) were visualized with IR-Dye 800 
donkey anti-mouse secondary antibody (Rockland Immunochemicals, Gilbertsville, PA, USA). 
All proteins were visualized using an infrared western blot imaging system (Odyssey, LI-COR 
Biosciences Lincoln, NE, USA). Immunoblots were performed in triplicate (n=3 in each 
developmental stage).   
B.3 RT-PCR 
Fresh frozen pooled heart samples were used. Total RNA was prepared using Trizol 
solution (Invitrogen) and treated with TURBO DNA-free kit (Ambion, Austin, TX, USA). 
Primers, whose target genes were α-cardiac MHC, and sk-fMHC were obtained from Qiagen 
Quanti-Tect Primer Assay with the target fragment sizes approximately 100 base pairs. One step 
RT was performed with a total volume of 1µg RNA in a total volume of 25μL that used MuLy 
(Roches, Pleasanton, CA, USA) with the program: 42oC 15 min, 99oC 5min, 5oC 5min, 1 cycle.  
cDNA (1µL) was used for PCR which used the program: 94oC 2min, 95oC 50second, 58oC 30 
second, 72oC 1 min, 35 cycles 72°C 7 min extension. For normalization of RT-PCR results, β-
actin was used as an internal control. All PCR products were confirmed by University of 
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Pittsburgh DNA Sequence Core Facilities, performed by Eppendorf Mastercycles. All RT-PCR 
assays were completed in triplicate (n=3 in each developmental stage). 
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